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ABSTRACT
The shikimate pathway is the major biosynthetic route by which plants and 
micro-organisms produce the aromatic amino acids and a plethora of other natural 
products. The details of this pathway are discussed in Chapter 1, together with a 
review of the recent syntheses of shikimic acid and of later intermediates in the 
shikimate pathway.
Our synthesis of analogues of shikimic acid, which are of interest as 
potential enzyme inhibitors, is described in Chapter 2. Starting from the Diels-Alder 
adducts of N-alkyloxycarbonyl-1,2-dihydropyridines and methyl acrylate, these 
were ring opened upon treatment with base to afford 5-(N-alkyloxycarbonylamino- 
methyl)cyclohexa-l,3-diene-l-carboxylates. Deprotection yielded the amino acid 
(±)-5-homogabaculine, the 5-homologue of naturally occurring gabaculine.
The cw-hydroxylation of these dienes, either through osmylation or through 
the use of a ‘wet* Pr6vost reaction, gave 5-homoshikimate derivatives. Deamination 
was achieved via displacement o f a disulphonimide to afford (±)-5-homoshikimic 
acid. An improved route to this compound involved the conversion of a 
trifluoroacetamide derivative to the corresponding acetate via nitrosation. These 
studies also led to a range of 5-substituted shikimic acid analogues.
The synthesis of a carba analogue of 5-enolpyruvylshikimic acid, was 
accomplished by addition of an a-acrylate synthon to a 5-iodomethyl shikimate.
Finally, the syntheses of homochiral products were studied utilising a chiral 
acrylate in the initial Diels-Alder cycloaddition. The use of Lewis acid catalysts 
induced decomposition of the dihydropyridine used, however, the thermal reaction 
afforded the diastereomeric cycloaddition adducts which were separable. Thus, both 
enantiomers of a key intermediate in the earlier syntheses became available.






ATP - adenosine triphosphate 







C.I. - chemical ionisation




DAHP - 3-deoxy-D-arabinoheptulosonic acid 7-phosphate




2D COSY - two dimensional correlated spectroscopy
d.e. - diastereomeric excess






DMSO - dimethyl sulphoxide
E.L - electron ionisation
EPSP - 5-enolpyruvylshikimate-3-phosphate
Et - ethyl
FAB - fast atom bombardment 
GABA - y-aminobutyric acid 
h - hour
HMPA - hexamethylphosphoramide
HOMO - highest occupied molecular orbital
IR - infrared
J  - coupling constant
LDA - lithium diisopropylamide
LUMO - lowest unoccupied molecular orbital
Me - methyl
MEM - 2-methoxyethoxymethyl 
min - minute
morph-DAST - morpholinosulphur trifluoride 
m.p. - melting point
NAD+, NADH - nicotinamide adenine dinucleotide, reduced form 
NADP+, NADPH - nicotinamide adenine dinucleotide phosphate, 
reduced form
NBS - N-bromosuccinimide 
NMO - N-methylmorpholine N-oxide 
NMR - nuclear magnetic resonance 
n.O.e - nuclear Overhansen effect 
Ns - p-nitrobenzenesulphonyl
(v)
Nu - nucleophile 
PCC - pyridinium chlorochromate 
PEP - phosphoenolpyruvate 
Ph - phenyl




Rp - retention factor
S-3-P - shikimate-3-phosphate
SN1 - substitution nucleophilic unimolecular
Sn2 - substitution nucleophilic bimolecular
TBDMS - rm-butyldimethylsilyl
Tf - trifluoromethylsulphonyl (triflyl)
TFA - trifluoroacetic acid 
TFAA - trifluoroacetic anhydride 
THF - tetrahydrofuran 
TLC - thin layer chromatography 
TMS - Trimethylsilyl
TPAP - tetra w-propylammonium perruthenate 
Ts - p-toluenesulphonyl (tosyl) 
p-TSA - p-toluenesulphonic acid
(vi)
NOMENCLATURE
The nomenclature of cyclohexene and cyclohexane compounds referred to in 
this thesis, is based on shikimic acid nomenclature, even though this may not 
necessarily conform to IUPAC convention. This permits analysis of any compound 
without reference to the nomenclature for that particular compound, and 
furthermore, allows direct comparison of NMR data.
The numbering system employed labels the carboxylate substituted carbon as 
C-l and proceeds anticlockwise around the ring, through the double bond. More 
highly substituted derivatives are named as depicted below. All other compounds 
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1.1 The Shikimate Pathway
1.1.1 Introduction
The glucose-derived shikimate pathway and the acetate-derived polyketide 
pathway are the major routes for the biosynthesis of aromatic compounds in plants 
and micro-organisms.1 The former leads to the aromatic amino acids, 
L-phenylalanine, L-tyrosine and L-tryptophan and is named after a key intermediate 




Shikimic acid was first isolated by Eykmann,2 in 1885, from the fruit of 
Illicium religiosum and it is from the Japanese name for this plant, shikimi-no-ki, 
that the name for this compound was derived. The structure and absolute 
stereochemistry was later proven by the work of Fischer and Dangschat,3 
Freudenberg4 and Karrer.5
The true importance of shikimic acid was not appreciated until the 1950’s 
with the work of Davis.6 Mutant strains of Escherichia coli and Aerobacter 
aerogenes were produced, which had a growth requirement for five aromatic 
compounds (L-phenylalanine, L-tyrosine, L-tryptophan, p-aminobenzoic acid and 
p-hydroxybenzoic acid). Certain mutants were found to accumulate shikimic acid,
1
while other mutants, blocked at a different point in the pathway, were found to be 
able to utilise shikimic acid to replace the aromatic substrates. These observations 
identified shikimic acid as a common precursor for each of these aromatic 
compounds. Further studies by Davis, Sprinson,7 Gibson8 and subsequent workers, 
revealed a well defined series of eight intermediates, leading from glucose, first to 
shikimic and then to chorismic acid.
1.1.2 The Common Pathway
The main stem of the shikimate pathway from carbohydrate to chorismate 
is generally referred to as the common pathway (Figure 1.1). The mechanisms for 
each stage remain debateable, however, the sequence of intermediates is clear.
Oxidation of glucose by the pentose phosphate pathway affords 
D-erythrose-4-phosphate (3) and, by glycolysis, phosphoenolpyruvate (PEP, 2). The 
condensation of these produces the seven-carbon saccharide 3-deoxy-D-arabino- 
heptulosonic acid (DAHP, 4). The mechanism of the DAHP synthase reaction has 
been the subject of some speculation.ld Originally a concerted process was 
postulated (Figure 1.2), in which nucleophilic attack at the phosphorus atom of PEP 
results in cleavage of the P-O bond and generation of a reactive enol pyruvate anion 
which can rapidly add to (3).
:Nu




Figure 1.2 Postulated Mechanism for DAHP Synthase
2
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(8)
Figure 1.1 The Common Pathway.
3
However, later kinetic studies suggested that DAHP synthase operated by a 
‘ping-pong’ mechanism, in which one of the products of the reaction was released 
before both substrates had bound to the enzyme. Since PEP tended to stabilize the 
enzyme against denaturation, it seemed logical to suggest that an enzyme bound 
enolpyruvyl complex was formed initially and phosphate released. Experiments with 
180  labelled substrates showed that the reaction involved C-O as opposed to P-0  
bond cleavage. On the basis of these findings an alternative mechanism was 
proposed (Figure 1.3), in which the substrate PEP was first transferred to a 
nucleophilic group on the enzyme, such as a carboxyl group. Elimination of 
phosphate leaves an enolpyruvyl-enzyme complex, which undergoes acyl-oxygen 
cleavage and initiates the aldol condensation with the second substrate (3).
Figure 1.3 Postulated ‘Ping-pong’ Mechanism for DAHP Synthase.
3-Dehydroquinate synthase catalyses the conversion of DAHP (4) to 








The cation Co2+ has been used in mechanistic studies, but Zn2+ is more likely 
required in vivo. The proposed mechanism (Scheme 1.4), involves an oxidation at 
C-5 which acidifies the C-6 proton and facilitates the elimination of phosphate. 
Subsequent reduction of the ketone gives the enol pyranose (11), which ring opens 
















Scheme 1.4 Proposed Mechanism for 3-Dehydroquinate Synthase.
This is a remarkably complex sequence of reactions for what is a relatively 
small, monomeric enzyme. Studies by Knowles9 have suggested that the enzyme is 
not directly responsible for the p-elimination of phosphate. Instead, it is argued that
5
the substrate (10) is bound to the enzyme in a suitable conformation, such that one 
of the phosphoryl group oxygens is appropriately positioned to abstract the C-6 
proton. Elimination then follows inexorably from the lability of the C-6 proton, due 









Bartlett has synthesised the intermediate (11) by photochemical removal of 





Photolysis of (12) in neutral aqueous solution effected a rapid, quantitative 
conversion to dehydroquinate (5). These results suggest that additionally, the
6
enzyme is not responsible for the last two steps of Scheme 1.4. Rather, 
dehydroquinate synthase produces the enol pyranose (11), which then rapidly and 
stereospecifically rearranges outside the active site to give 3-dehydroquinate (5).
The dehydration of 3-dehydroquinate (5) to 3-dehydroshikimate (6) is 
catalysed by 3-dehydroquinase and proceeds stereospecifically in a cis fashion. The 
active site of the enzyme is known to contain a lysine residue which forms a Schiff 
base with the keto group of 3-dehydroquinate, the arrangement of catalytic groups 




















Scheme 1.6 Proposed Mechanism for 3-Dehydroquinase.
The next two steps in the common pathway are more straightforward. 
Shikimate dehydrogenase catalyses the reduction of dehydroshikimic acid, in the 
presence of NADPH, to give shikimic acid, which is then phosphorylated by 











The formation of 5-enolpyruvylshikimate-3-phosphate (5-EPS-3-P) (8) 
constitutes the biochemically remarkable transfer of an intact enolpyruvyl group 
from PEP (2) to the 5-hydroxyl of (7), for which an addition-elimination sequence 
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(8)
Scheme 1.8 Proposed Mechanism for 5-EPS-3-P Synthase.
The tetrahedral intermediate (13) has been isolated and characterised by Anderson.12 
Although stable under alkaline conditions, it hydrolyses readily at neutral pH and 
the configuration of the ketal carbon has not been elucidated. Further evidence for 
this mechanism was obtained by studying the enzyme catalysed reaction with 13C 
labelled PEP and NMR resonances due to the enzyme bound tetrahedral
intermediate were observed.13 A separate study by Evans,14 in which resonances due 
to an enzyme free tetrahedral intermediate were claimed, was later shown to be in 
error,15 the signals observed being due to the novel shikimate ketal (14), 
subsequently isolated by Sammons.16 This side product is formed at equilibrium, but 




The final step of the common pathway involves the formation of chorismic 
acid (9) from 5-EPS-3-P (8), catalysed by chorismate synthase. Labelling 
experiments have shown that only the 6-pro-R hydrogen is lost and thus the overall 
transformation is a trans- 1,4-elimination. Concerted 1,4-eliminations in cyclohexene 
systems proceed predominantly in a cis fashion, therefore, mechanisms involving a 
two stage process have been proposed. It is possible, however, that the enzyme 
causes the substrate to adopt a suitable conformation, such that a concerted 
trans- 1,4-elimination is possible.
Floss17 has speculated that a two-stage mechanism, in which an ‘X-group’ 
on the enzyme participates, might account for the overall rra«s-elimination (Scheme 
1.9).
An interesting alternative proposed by Ganemld involves a suprafacial
3,3-rearrangement of (8) to the allylic isomer, wo-EPSP (15), followed by 
trans- 1,2-elimination (Scheme 1.10). However, iso-EPSP was synthesised by 
Bartlett18 and was shown not be converted to chorismate by chorismate synthase, 











Scheme 1.9 Proposed ‘X-group’ Mechanism for Chorismate Synthase.
iso-EPSP (15)
— -  Q J U  «
OH
Scheme 1.10 Proposed Mechanism for Chorismate Synthase via iso-EPSP.
Chorismic acid is an unstable intermediate which can react in a variety of 
ways. From here the common pathway ends and the shikimate pathway branches out 
in several directions.
1.1.3 The Role of Quinic Acid
Quinic acid (16), widely found in the plant kingdom, is formed by an 
off-shoot of the common pathway. Once formed, by the reduction of
10
3-dehydroquinate (5) by NADPH, a reaction which is catalysed by quinate 
dehydrogenase (Scheme 1.11), it is not easily metabolised again. However, some 
micro-organisms are able to convert quinic acid into 3-dehydroquinate and thus 






1.1.4 Branch Point Metabolism
At chorismic acid the common pathway fragments into different routes, 
leading to the aromatic amino acids and diverse other compounds (Scheme 1.12). 
Amination of chorismic acid leads through anthranilic acid (18) to tryptophan (20). 
The other two aromatic amino acids phenylalanine (21) and tyrosine (22), are 
formed via rearrangement of chorismic acid to prephenic acid (19), in what is 
formally at least, a Claisen rearrangement. A unique reaction in biosynthesis, that 
has been proven to proceed through a chair-like transition state (Scheme 1.13).19
Another route from chorismate leads via p -aminobenzoic acid (17) to the 
folate group of coenzymes. The isoprenoid quinones which participate in electron 










































Scheme 1.12 Biosynthesis of Aromatic Compounds from Chorismic Acid
1.2 Syntheses of Shikimic acid
Chemists continue to be attracted to the stereospecific and chiral synthesis 
of shikimic acid and of structural variants, which may exhibit useful biological 
activity. The first total synthesis of shikimic acid was published in 1960 by Raphael 
et a/.20 Since then, many different approaches to both racemic and optically active 
forms of shikimic acid have been reported, which have recently been reviewed.21 In 
this section the more recent synthetic studies will be reviewed, covering the 
literature from 1984 to date.
1.2.1 Campbell, Sainsbury et al.
Campbell, Sainsbury et al. have published a number of brief syntheses of 
racemic methyl shikimate (28) and methyl 5-epi-shikimate (26).21 The starting 
material was the Diels-Alder adduct (23) of furan and methyl acrylate,23 which was 
c/s-hydroxylated and then protected as the acetonide (24) (Scheme 1.14). Base 
mediated opening of the oxabicyclo ring led to the acetonide of methyl 5-epi- 
shikimate (25), which was deprotected to afford (26). Direct attempts to invert the 
stereochemistry at C-5 of (25) were unsuccessful, however, dehydration under 
Mitsunobu24 conditions yielded the diene (27), which on hydroboration, oxidation 
and deprotection gave methyl shikimate (28).
A more concise route was developed by reversing the order of the 
cw-hydroxylation and ring opening reactions (Scheme 1.15). Thus, initial ring 
opening of the adduct (23) afforded the diene (29), which on cfr-hydroxylation 
yielded methyl shikimate (28) and methyl 5-epi-shikimate (26) in a 5:1 ratio. The 
stereoselectivity was improved by first protecting the hydroxyl of (29) as the 
TBDMS ether (30), which on osmylation and deprotection, gave (28) in 26% overall 




















Scheme 1.14 Reagents: (a) 0 s 0 4, H20 2, Me2CO; (b) (MeO)2CMe2, p-TSA, 
M e^O; (c) LiN(TMS)2, THF, -78°C; (d) aq. AcOH, 55°C; (e) DEAD, Ph3P, THF; 





















Scheme 1.15 Reagents: (a) LiN(TMS)2, THF, -78°C; (b) TBDMSOTf, 2,6-lutidine, 
CH2C12,0°C; (c) O sQ 4 , H20 2, Me2CO; (d )  #i-Bu4NF, THF, 0°C.
A further variation25 employed a ‘wet’ Prevost reaction on the diene (30) to 
afford the hydroxy-acetate (31) (Scheme 1.16). Hydrolysis and deprotection gave 
rise to methyl shikimate in a similar overall yield (26%) from the adducts (23), but 









Scheme 1.16 Reagents: (a) AgOAc, I2, AcOH, H20 , 70°C; (b) aq. NH3, MeOH; (c) 
«-Bu4NF, THF, 0°C.
1.2.2 Rodrigo et al.
A synthesis by Rodrigo et al.,26 published in the same year as the 
Campbell-Sainsbury route, detailed a similar approach to racemic shikimic acid, but 













Scheme 1.17 Reagents: (a) LDA, THF, -78°C; (b) Protection; (c) O s04, Py; (d) 
*-Bu4NF, THF; (e) OH', H20 .
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The overall yield from (32) was 32% and these workers also duplicated the Bath 
route from the Diels-Alder adduct (23) of furan and methyl acrylate.
1.23  Birch et al.
The optically active form of the key intermediate (30), used in the synthesis 
of Campbell and Sainsbury (Section 1.2.1), was prepared by Birch et a l.?1 using 
iron tricarbonyl as a lateral control group. (-)-Methyl shikimate was prepared from 
either of the resolved iron tricarbonyl complexes (33), obtained from
1,4-dihydrobenzoic acid and previously used in an enantiospecific synthesis of 
gabaculine.28
Starting from the (+) complex (33a) (Scheme 1.18), the cationic salt (34a) 
was formed, which had previously been shown to react with nucleophiles solely at 
the 5-exo position.29 Thus, reaction of (34a) with aqueous sodium hydrogen 
carbonate afforded the alcohol complex (35). Protection as the TBDMS ether and 
decomplexation, yielded the (+) enantiomer of the Bath intermediate (30), which 
was converted into (-)-methyl shikimate via cw-hydroxylation and deprotection as 
before.
Starting from the (-) complex (33b), a similar procedure led to the alcohol 
complex (36), having the wrong configuration at C-5. Inversion was achieved by 
Jones oxidation to the carbonyl compound, followed by a stereospecific reduction 
using sodium borohydride and zinc chloride, directed by the complexing group, to 
afford the alcohol complex (37). Protection and decomplexation gave the required 
diene (30).
Therefore, although the initial complex (33) required resolution, both 






































Scheme 1.18 Reagents: (a) Ph3C+ PF6‘, CH2C12; (b) NaHC03, MeCN, H20; (c) 
TBDMSC1, (/-Pr)2NEt, DMF; (d) Me3NO, PhH; (e) 0 s 0 4, Me2CO; (f) /z-Bu4NF, 
THF; (g) Cr03, Py, CH2C12; (h) NaBH4, ZnCl2, Et20; (i) TBDMSOTf, (i-Pr)2NEt, 
DMF.
17
1.2.4 Koizumi et al.
An enantioselective synthesis of methyl shikimate was reported by 
Koizumi et al.30 An asymmetric Diels-Alder reaction of menthyl (S)s-3-(2-pyridyl- 
sulphinyl)acrylate (38)31 with 3,4-dibenzyloxyfuran (39)32 (Scheme 1.19), yielded a 
mixture of exo and endo adducts, from which the major endo adduct (40) could be 
separated. Reduction of (40) to the sulphide (41), followed by reduction of the ester 
gave the alcohol (42). Treatment with Raney-nickel resulted in desulphurisation and 
hydrogenation of the double bond to give the endo-cis-dibenzyloxy derivative (43). 
Oxidation and esterification yielded the methyl ester (44), which upon ring opening, 
debenzylation and acetylation afforded (-)-methyl triacetylshikimate (45).
SOPy
(38) (39) (92% d.e.)







Scheme 1.19 Reagents: (a) Et2AlCl; (b) PBr3, DMF, 0°C; (c) LiAlH4, Et20; (d) 
Raney-Ni, EtOH; (e) Cr03, Py, Me2CO; (f) CH2N2, MeOH, Et20; (g) LiN(TMS)2, 
THF, -78°C; (h) TMSC1, Nal, MeCN; (i) Ac20 , Py.
18
1.2.5 Koreeda et al.
The use of 3,4-dibenzyloxyfuran (39) as a precursor to shikimic acid, was 
also reported simultaneously by Koreeda et al?3 in a synthesis of racemic methyl 
triacetylshikimate (Scheme 1.20). The Diels-Alder reaction of (39) with methyl 
acrylate, catalysed by zinc iodide, yielded the adduct (46) as a mixture of exo and 
endo adducts (ratio 15:1). The endo adduct was subsequently hydrogenated to afford 
the required endo-cis-dibenzyloxy derivative (47). Ring opening, debenzylation and 
subsequent purification of the resulting triol, as its triacetate, afforded methyl 
triacetylshikimate (45) in 60% overall yield from (39).
i r
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Scheme 1.20 Reagents: (a) Znl2; (b) H2, Pt02, EtOAc; (c) LiN(TMS)2, THF, -78°C; 
(d) BF3.OEt2, EtSH, CH2C12,0°C; (e) Ac20 , Py.
1.2.6 Koreeda et al.
Koreeda has also recently published a concise total synthesis of racemic 
shikimic acid from (IE, 3E)-4-acetoxy-l-phenyldimethylsilyl-1,3-butadiene (4S).34 
This was essentially an improved version of his earlier synthesis35 and demonstrates 
the use of the diene (48) as a surrogate for (IE, 3E)-l,4-diacetoxy-1,3-butadiene 
(Scheme 1.21). The Diels-Alder reaction of (48) with 2-(trimethylsilyl)ethyl
19
acrylate (49) yielded the adduct (50) as the major product. cfs-Hydroxylation 
afforded the diol (51), which was subjected to Flemming’s one-pot buffered 
oxidation procedure36 to yield the triol (52). Base mediated elimination produced 
2-(trimethylsilyl)ethyl shikimate (53), which was deprotected to yield shikimic acid 
in 55% overall yield from (48). The use of the 2-(trimethylsilyl)ethyl ester avoided 
the problematic hydrolysis of methyl shikimate, which often results in aromatisation 




















Scheme 1.21 Reagents: (a) hydroquinone monomethyl ester (cat.), xylenes, reflux; 
(b) 0 s 0 4, NMO, THF, H20; (c) KBr, AcOOH, AcOH, AcONa; (d) DBU, THF; (e) 
«-Bu4NF, THF.
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1.2.7 Fleet et al.
Shikimic acid has been synthesised from carbohydrates37 and also from 
quinic acid 38 However, by far the most elegant approach starting from an optically 
active natural product, is that due to Fleet et a/.39
Benzyl 2,3-0-isopropylidene-a-D-lyxofuranoside (54), obtained from 
D-mannose,40 was converted to the triflate (55). Reaction with the sodium salt of 
rm-butyldimethoxyphosphorylacetate gave (56). On debenzylation and treatment 
with base, (56) underwent an intramolecular Wadsworth-Emmons olefination to 
afford rm-butyl 3,4-isopropylideneshikimate (57). Deprotection yielded (-)-shikimic 























Scheme 1.22 Reagents: (a) Tf20 , Py; (b) [(Me0)2P(0)CHC02tBu]- Na+, DMF, 
15-crown-5; (c) H2, Pd-C; (d) NaH; (e) 60% aq. TFA.
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1.2.8 Mirza et al.
An intramolecular olefination was also employed in the recent synthesis 
reported by Mirza et a/.41 Indeed, this synthesis is very similar to that of Fleet et al.
D-Mannose was converted into the suitably protected D-lyxose-5-aldehyde 
(58)40 which was condensed with triethylphosphonoacetic acid to afford (59). 
Hydrogenation gave the hemiacetals (60), which on treatment with base underwent 
an intramolecular olefination to yield ethyl 4,5-isopropylideneshikimate (61). 

















Scheme 1.23 Reagents: (a) (Et0)2P(0)CH2C02Ht, N-methylmorpholine, TiCl4, 
CC14, THF; (b) H2, Pd-C, EtOH; (c) NaOEt, EtOH; (d) aq. NaOH, EtOH; (e) Dowex 
50W-X4 (H+), H20 .
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1.3 Synthesis of Later Intermediates in the Shikimate Pathway
1.3.1 Shikimic Acid 3-Phosphate
The only reported total synthesis of shikimic acid 3-phosphate, is that 
described by Bartlett et al.,42 in a total synthesis of shikimic acid (Scheme 1.24). 
Iodo-lactonisation of cyclohex-3-ene-l-carboxylic acid (62), followed by DBU 
induced elimination, afforded the lactone (63), which was converted to the epoxide
(64). Opening of this epoxide with trimethylsilyl bromide, followed by elimination 
of the trimethylsilyl bromohydrin with DBU and aqueous workup gave the alcohol
(65). Epoxidation afforded the epoxy alcohol (66), which upon methanolysis, 
yielded (±)-methyl shikimate in 46% overall yield from (62). The former had 
previously been prepared by Ganem43 in another synthesis of shikimic acid.
Controlled methanolysis of (66) at a lower temperature gave the epoxy diol 
(67). Protection as the bis(ethoxyethyl) ether and opening of the epoxide, afforded 
the selectively protected shikimate derivative (68), in which the 3-hydroxyl is free. 
Phosphorylation was accomplished by using bis(p-nitrophenylethyl) phosphoro- 
chloridate44 to yield the phosphate triester (69). Deprotection of the phosphate by 
treatment with DBU, followed by hydrolysis and cleavage of the acetal protecting 
groups, yielded (±)-3-phosphoshikimic acid (7), which was purified by ion exchange 
chromatography of the sodium salt.
1.3.2 5-EnolpyruvyIshikimate-3-phosphate (5-EPS-3P)
The construction of the enolpyruvyl functionality of 5-EPS-3-P and 
chorismic acid, was first demonstrated by Berchtold et a l45 in a synthesis of 
5-enolpyruvylshikimate (70) (Scheme 1.25). The carbonate derivative of (-)-methyl 
shikimate was reacted with dimethyloxomalonate to afford the hemiketal (72). 
Treatment with thionyl chloride followed by reduction, yielded (73), which was 
























Scheme 1.24 Reagents: (a) I2, KI, NaHC03, H20; (b) DBU, THF, reflux; (c) 
3,5-dinitroperbenzoic acid, CH2C12, reflux; (d) TMSBr, Ph3P, MeCN then DBU, 
reflux; (e) K2C 03, MeOH, 0°C; (f) ethyl vinyl ether, PPTS, THF; (g) K2C 03, 
MeOH; (h) bis(p-nitrophenylethyl) phosphorochloridate, Py, DMAP, CH2C12; (i) 
DBU, CHC13; (j) aq. NaOH; (k) Dowex 50W-X8 (H+), H2Q.
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iodide, which upon heating underwent decarboxylation and elimination to afford
(75). Hydrolysis of (75) gave 5-enolpyruvylshikimic acid (70) or ‘compound Z^.46 
Compound has been observed as a secondary metabolite from hydrolytic 






















Scheme 1.25 Reagents: (a) (Me02C)2CO, PhH, reflux; (b) SOCl2, Py, THF, 0°C; (c) 
Zn, 90% aq. AcOH, 0°C; (d) CH2=NMe2+ I', Et3N, CH2C12; (e) Mel, CH2C12, 
reflux; (f) DMSO, 80°C; (g) aq. NaOH; (h) Amberlite IR 120 (+), H2Q.
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The first synthesis of 5-EPS-3-P was reported by Ganem et al.A1 The 
acetonide o f (-)-methyl shikimate (76) was converted to the alkoxymalonate (77), by 
the Rh2(OAc)4 catalysed insertion of dimethyl diazomalonate (Scheme 1.26). 
Reaction of (77) with Eschenmoser's reagent, quatemisation and 
decarboxylation/elimination, in a similar sequence to that used by Berchtold,45 led 
to the enolpyruvate (78). Deprotection afforded the diol (79), which could be 
selectively hydrolysed to yield the monoacid (80). Cyclisation o f (80) gave the 
bicyclic lactone (81) and thus allowed phosphorylation selectively at the C-3 
hydroxyl group. This was achieved via the bis(p-nitrophenylethyl) phosphite, which 
was oxidised to the phosphate (82). The ‘one-pot* deprotection o f (82) furnished 
5-EPS-3-P (8) as the tetrasodium salt after ion-exchange chromatography.
A similar synthesis was published by Bartlett et a/.48 (Scheme 1.27), in 
which the early steps are virtually identical. However, the bicyclic lactone (81) was 
produced by direct cyclisation o f the diol (79) with potassium carbonate. 
Phosphorylation was achieved using tetrabenzylpyrophosphate to afford the 
phosphate triester (83). Cleavage of the benzyl esters, with trimethylsilyl bromide, 
followed by alkaline hydrolysis, gave 5-EPS-3-P, which was obtained as the 





























r  = p-n o 2c 6h4(c h 2)2-
Scheme 1.26 Reagents: (a) (MeO20 )2CN2, Rh2(OAc)4, PhH, reflux; (b) 
CH2=NMe2 + I', Et3N, CH2C12; (c) Mel, CH2C12; (d) DMSO, 95°C; (e) 80% aq. 
AcOH, 70°C; (f) aq. NaOH (1.1 equiv.), THF; (g) DCC, DMAP, THF; (h) PC13, Py, 
THF then p-N 02C6H4(CH2)20H; (i) I2, H20 , -78 to 0°C; (j) DBU, Py; (k) aq. 
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Scheme 1.27 Reagents: (a) (M e02C)2CN2, Rh2(OAc)4, PhH, 85°C; (b) CH2=NMe2+ 
I \ Et3N, CH2C12; ( c )  Mel, MeCN, reflux; (d) 65% aq. AcOH, THF, 70°C; (e) 
K2C 03, MeCN; (f) LDA, [(Bn0)2P(0)]20 , THF, -78°C; (g) TMSBr, Py, CH2C12, 
0°C; (h) aq. NaOH then ion-exchange resin.
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1.3.3 Chorismic Acid
The total synthesis of (±)-chorismic acid was first reported in 1982 by 














(k) xo  CO,H
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(90) (9)
Scheme 1.28 Reagents: (a) NBS, AIBN, CC14, reflux; (b) /i-Bu3SnH, AEBN, PhH, 
reflux; (c) m-CPBA, CH2C12; (d) DBU, CH2C12; (e) (Me02C)2CN2, Rh2(OAc)4, 
PhH, 65°C; (f) CH2=NMe2+ T, Et3N, CH2C12; (g) Mel, CH2C12; (h) DMSO, 80°C; 
(i) (PhSe)2, NaBH4, MeOH; (j) aq. NaOH, THF, 0°C; (k) H20 2, DMA, Me2 CO, -35 
to 20 °C.
Bis allylic bromination of (84) gave a mixture of dibromides, that were
29
debrominated to afford the diene (85). Epoxidation of (85) yielded (86), which was 
isomerised to (87) on treatment with DBU. The enolpyruvyl side chain was 
constructed using either Ganem’s47 or Berchtold’s own45,49 procedure to afford (88). 
Opening of the epoxide with PhSe' gave (89), which was hydrolysed to the diacid 
(90). Selenoxide elimination from (90), in the presence of 3,5-dimethoxyaniline as a 
PhSeOH scavenger, yielded chorismic acid (9). The hydrolysis of (89) was carried 
out before selenoxide elimination, since hydrolysis of dimethyl chorismate gave 
poor yields of chorismic acid due to aromatisation.
A total synthesis of (±)-chorismic acid was also published in 1982 by 
Ganem et a l? 1 The bicyclic allylic alcohol (92) was first prepared in five steps from
1,4-dihydrobenzoic acid (91)52 (Scheme 1.29). Protection of the hydroxyl as its 
MEM ether, saponification and esterification yielded (93). Attachment of the 
enolpyruvyl functionality to (93) proved difficult, but was achieved in a stepwise 
manner as follows. Coupling of (93) with dimethyl diazomalonate, catalysed by 
Rh2(OAc)4, afforded (94), which was cyclised to give the bicyclic lactone (95). 
Alkylation of (95) with Eschenmoser’s salt could not be achieved. However, 
Potier’s salt was employed successfully, followed by quatemisation to yield (96). 
Finally the ‘one-pot* hydrolysis, decarboxylation and p-elimination in aqueous 
sodium hydroxide afforded chorismic acid (9). Dimethyl chorismate could also be 




































Scheme 1.29 Reagents: (a) Br2, CH2C12; (b) aq. NaHC03; (c) NBS, (PhCO^, 
CC14, reflux; (d) NaOAc, HMPA; (e) 10% aq. H2S 04, THF, reflux; (f) MEM-Et3N+ 
Cl', MeCN, reflux; (g) aq. KOH, THF; (h) Mel, HMPA; (i) (M e02C)2CN2, 
Rh2(OAc)4, PhH, 65°C; (j) p-TSA, PhH, H20; (k) CH2=NMe2+ CF3C 02'; (1) 




The enantiospecific synthesis of chorismic acid has been accomplished by 
both Berchtold and Ganem. The former has described the synthesis of an 
enantiomerically pure intermediate for his earliest synthesis of chorismic acid,45,49 
from quinic acid.53 The key intermediate (87) used in his second synthesis (Scheme 
1.28), was also prepared in chiral form.54 An enantioselective enzymatic hydrolysis 
of the n-butyrate ester (97), followed by inversion of the configuration of the 
carbinol carbon of (+)-(98), yielded (-)-(87) (Scheme 1.30). The enolpyruvyl side 
chain was attached in a different manner, via coupling with methyl 
diazophosphonoacetate and reaction with formaldehyde to afford (-)-(88). 
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Scheme 1.30 Reagents: (a) cholesterol esterase, H20 , pH 7.8, 0 to 5°C; (b)
i-Pr02CN=N C 02-/-Pr, Ph3P, AcOH, THF; (c) NaOMe, MeOH; (d) 
M e02CC(N2)P(0)(0M e)2, Rh^n-Q H ^CO ^, PhH, reflux; (e) LiN(TMS)2, THF, 
-78°C; (f) H2CO, -78°C.
An alternative approach to Berchtold’s epoxide (-)-(87) was developed 
recently by Ganem et al.55 The reaction of (-)-methyl shikimate (28) with
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2-acetoxyisobutyryl bromide56 furnished tratts-bromoacetate (99) (Scheme 1.31). 
Transesterification of (99), with sodium methoxide in methanol, led to the epoxide 
(100). This epoxide, also known as methyl 3,4-anhydroshikimate, had previously 
been reported in the literature,57 although the specific rotation was different from 
that observed by Ganem.55 This discrepancy was attributed to a Payne 
rearrangement to (87), previously undetected by the earlier workers.58 Prolonged 
exposure of (100) to sodium methoxide produced a 1:3 equilibrium mixture of 
(100):(87). The ‘one-pot’ conversion of the bromoacetate (99) to the epoxide (87) 







Scheme 1.31 Reagents: (a) a-acetoxyisobutyryl bromide, MeCN, 0°C; (b) NaOMe, 
MeOH, 0°C, 30 min; (c) NaOMe, MeOH, 0°C, 30 min then 50°C, 35 min.
A concise synthesis of Ganem’s key intermediate (93)51 has recently been 
published by Posner et al.59 The cycloaddition of a 1,2-dioxygenated alkene (102) 
with a 3-sulphonyl-2-pyrone (101), yielded the bicyclic lactone (103) (Scheme 
1.32). The presence of the electron withdrawing sulphonyl group on the 2-pyrone
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and an electron rich alkene, facilitates this inverse-electron-demand Diels-Alder 
reaction under milder conditions. Thus cycloreversion, with loss of C 02 and 
subsequent aromatisation, which occurs at more forcing conditions, is avoided. 
Methanolysis of (103) afforded the highly functionalised cyclohexene (104). 
Protection of the hydroxyl as the MEM ether (105), followed by reductive cleavage 
of the sulphonyl group, gave the mono-protected trans-diol (93), which had 












Scheme 1.32 Reagents: (a) 80°C, 36 h; (b) NaOMe, MeOH, 0°C; (c) *-Pr2NEt, 
MEMC1, CHC13, reflux; (d) Zn, THF, sat. aq. NH4C1.
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1.4 Inhibition of Enzymes of the Shikimate Pathway.
The shikimate pathway only operates in plants and micro-organisms. The 
three aromatic amino acids cannot be produced by de novo synthesis in animals, but 
must be obtained from the diet. This makes the shikimate pathway a particularly 
attractive target for the design of specific enzyme inhibitors. Compounds which 
fulfil this function would be potential herbicides or antibiotics, o f low environmental 
impact.
Inhibitors are divided into two major classes, irreversible and reversible.60 
Irreversible inhibitors react covalently with an enzyme preventing substrate binding 
or catalysis. Reversible inhibitors undergo rapid equilibrium binding with the 
enzyme and are further classified as competitive, uncompetitive or non-competitive, 
depending on whether they bind to the free enzyme, enzyme-substrate complex or 
both, respectively.
As an inhibitor target, the most important enzyme in the shikimate pathway 
is 5-enolpyruvylshikimate-3-phosphate synthase, which catalyses the conversion of 
shikimate-3-phosphate to 5-EPS-3-P. This enzyme is effectively inhibited by 
glyphosphate (106) (/V-[phosphonomethyl]glycine),61 the active ingredient of the 
broad spectrum herbicide Roundup®.
1.4.1 Synthesis of 5-EPS-3-P Synthase Inhibitors
Bartlett et al. have synthesised a number of analogues62 of the unstable 
tetrahedral intermediate (13), involved in the 5-EPS-3-P synthase reaction. Stable 





extra binding affinity that these species (and transition state structures) experience.63
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Two strategies were chosen in order to stabilise the ketal phosphate structure of the 
tetrahedral intermediate (13).
In the first, the phosphate was replaced by a phosphonate moiety. Although 
the phosphonates produced do not arise from an isosteric replacement of the side 
chain phosphate, there are examples in which phosphonates are more tightly bound 
than homophosphonates as replacements for phosphates.64
The phosphonates were synthesised from the acetonide of (-)-methyl 
shikimate (76) (Scheme 1.33). Rhodium diacetate coupling of (76) with methyl 
(dibenzylphosphono)diazoacetate, followed by methylation, afforded the 
diastereomeric phosphonates (107). Deprotection and cyclisation gave the lactones 
(108), which were phosphorylated prior to chromatographic separation. 
Deprotection of both diastereomers yielded the phosphonate analogues (109) and 
(110), which were purified as their sodium salts.
Both phosphonates (109) and (110) were shown to be competitive 
inhibitors of 5-EPS-3-P synthase, with respect to 5-EPS-3-P, with binding constants 
Kj of 0.015 pM and 1.1 pM respectively. Compound (109) is the most potent 
inhibitor of 5-EPS-3-P synthase yet reported, binding more than a magnitude greater 
than glyphosphate itself. Since compound (109) binds much tighter than (110), it 
was suggested that this infers that the side chain of the natural intermediate (13) also 
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Scheme 1.33 Reagents: (a) (Bn0)2P(0)C(N2)C02Me, Rh2(OAc)4, PhH, reflux; (b) 
KH, Mel, THF; (c) p-TSA, aq. MeCN; (d) p-TSA, PhH, reflux; (e) LDA, 
[(Bn0)2P]20 , THF, -78 to 10°C; (0 TMSBr; (g) aq. NaOH.
The second strategy involved the introduction of electron-withdrawing 
substituents onto the methyl group of (13), in order to destabilise the oxacarbonium 
ion presumably involved in the decomposition process. The trifluoropyruvate 
phosphate analogues were synthesised from the acetonide of (-)-methyl shikimate
(76) (Scheme 1.34). Reaction of (76) with methyl trifluoropyruvate gave the
37
hemiketal, which was phosphorylated to afford the diastereomeric phosphates (111). 
Lactone formation, further phosphorylation and deprotection, as before, yielded the 
trifluoromethyl analogues (112) and (113).
Again, both compounds were competitive inhibitors of 5-EPS-3-P synthase, 
with respect to 5-EPS-3P, with binding constants Kj of 0.026 pM and 0.032 pM, 
respectively. The essentially identical affinity of the two trifluoromethyl analogues, 
cast doubt on the suggestion that the absolute configuration of the tetrahedral 
intermediate (13), may be determined from the differing affinities of the two 
phosphonate analogues.
.O P C ^  
CO,Me
(76) (111) o







Scheme 1.34 Reagents: (a) CF3C(0)C 02Me, PC13; (b) p-N02C6H4(CH2)20H; (c) 
m-CPBA; (d) H30 +; (e) K2C 03; (f) [N 02C6H4(CH2)20 ]2PNi(Pr)2; (g) m-CPBA, (h) 
DBU, BSA; (i) aq. NaOH.
Recently, two new inhibitors of 5-EPS-3-P synthase have been prepared, by 
Anderson, Knowles et al.,65 to probe the enzyme binding site. The 5-amino analogue
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(116) was synthesised from (-)-methyl shikimate (76) via Berchtold’s66 epoxide 
(114) (Scheme 1.35). Opening of this epoxide with sodium azide, followed by 
reduction, furnished the 5-aminoshikimate (115). Hydrolysis and enzymatic 
phosphorylation afforded (116), which was a modest competitive inhibitor of 










Scheme 1.35 Reagents: (a) Ph3P, DEAD, THF; (b) 120°C, 0.5 mmHg; (c) NaN3, 
NH4C1, MeOH, H20; (d) H2, Lindlars cat., EtOH; (e) aq. KOH, THF; (f) ATP, 
shikimate kinase.
The 5-deoxy analogue (120) was also obtained from the epoxide (114) 
(Scheme 1.36). Treatment of (114) with dilithiotetrabromonickelate provided the 
bromoshikimate (117), which was protected as the acetonide. Tri-n-butyltin hydride 
reduction, followed by deprotection, afforded the diol (118). Hydrolysis and 
enzymatic phosphorylation, as before, gave (119), which was a similar competitive 















Scheme 1.36 Reagents: (a) Li2NiBr4, THF; (b) CH2=C(OMe)Me, p-TSA, CH2C12; 







2.1 Aims and Objectives
The primary objective of this project was to synthesise analogues of 
shikimic acid bearing an additional carbon atom at the 5-position. Such 
‘5-homoshikimates’ (123) were required for testing as specific enzyme inhibitors.
The synthesis of shikimic acid from furan has been demonstrated both 
within the Bath laboratory and by other groups (Section 1.2). It was envisaged that 
this approach could be extended by replacing furan with a different heterocycle. 
Thus, the Diels-Alder reaction of a 1,2-dihydropyridine (120), (Scheme 2.1), with a 








Scheme 2.1 Planned Strategy for Synthesis of 5-Homoshikimates
Upon base mediated ring opening these would afford a single (racemic) diene (122),
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possessing the required carbon framework of the target compounds. Introduction of 
the ris-dihydroxy functionality and modification of the 5-substituent, would yield 
the desired 5-homoshikimate (123).
Additionally, further elaboration of the side chain at the 5-position could 
give access to analogues of later intermediates in the shikimate pathway, such as the 
carba analogue (124), of 5-enolpyruvylshikimic acid.
Dihydropyridines were chosen since the more obvious choice, the oxygen 
heterocycle 2//-pyran, is unknown.67 In contrast, the chemistry of dihydropyridines 
has been studied and their usefulness proven in a number of natural product 
syntheses.68
2.2 Synthesis of 5-Homogabaculine
2.2.1 Preparation of the 1,2-Dihydropyridine
This cycloaddition - ring opening strategy was first demonstrated using the 
l-methoxycarbonyl-l,2-dihydropyridine (125). This compound was prepared from 
pyridine, according to the procedure of Fowler,69 (Scheme 2.2). Treatment of 
pyridine with methyl chloroformate in the presence of sodium borohydride, at 
-78°C, afforded the 1,2-dihydropyridine (125) in 65% yield. Even though Fowler has 
shown69 that the production of the 1,4-isomer is minimised by performing the 
reaction at low temperature, a small amount of the 1,4-isomer was detected in the 




Scheme 2.2 Reagents: (a) MeOCOCl, NaBH4, MeOH, -78°C, 2 h.
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N-Alkyloxycarbonyl-l,2-dihydropyridines are considerably more stable
Nevertheless, the carbamate (125) discoloured on exposure to air and accordingly it 
was stored under a nitrogen atmosphere at low temperature. Purification was 
achieved by chromatography on a short alumina column, eluting with diethyl ether, 
immediately before use.
2.2.2 Diels-Alder Reaction
The Diels-Alder reaction of 1-methoxycarbonyl- 1,2-dihydropyridine (125) 
with methyl acrylate, has been reported by Sliwa,70 but no experimental details were 
given. In our hands, the reaction was found to proceed smoothly in refluxing toluene 
giving the mixed exo and endo adducts (126) as a colourless oil, after column 
chromatography, in 73% yield (Scheme 2.3).
Analysis of the NMR spectrum indicated that only C-7 substituted 
products were formed and the endo:exo ratio was 7:5. The regioselectivity is to be
1-heterosubstituted diene with a dienophile bearing an electron withdrawing group 
and a consideration of the orbital coefficients in the HOMO of the diene and those in 
the LUMO of the dienophile. The endo preference in cycloadditions with an acrylate 
ester, results from secondary orbital interactions which provide a small, but 
significant reduction in the energy of the transition state leading to the endo isomer.





Scheme 2.3 Reagents: (a) PhMe, reflux, 3 days.
expected from the application of frontier orbital theory71 to the cycloaddition of a
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The *H NMR spectrum of the product is complicated by conformational 
mobility between the two possible orientations for the N-methoxycarbonyl group, 
for each (endo or exo) adduct (Figure 2.1). Signals due to each conformation are 






The exo and endo adducts proved inseparable by chromatography, but this 
was unimportant since ring opening of either adduct leads to the same diene. The 
mixture was therefore carried forward and used in the next step.
2.2.3 Ring Opening of the Diels-Alder Adducts
The ring opening of 2-azabicylco[2.2.2]oct-5-ene systems may be 
considered as a reverse Michael addition and, since in the case of the furan adduct 
7-oxobicyclo[2.2.1]hept-5-ene, lithium hexamethyldisilazide was found to be the 
best base to initiate the reaction, 2 2 , 2 3 , 2 6  this was also our first choice of reagent.
Treatment of the mixed adducts (126) with this reagent (generated by the 
action of n-butyl lithium on 1,1,1,3,3,3-hexamethyldisilazane), produced the diene 







Scheme 2.4 Reagents: (a) w-BuLi, (TMS)2 NH, THF, -78 to 20°C, 20 min.
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2.2.4 Hydrolysis of the Diene (127)
Alkaline hydrolysis of the diene (127) was investigated in order to prepare 
the amino acid. Treatment of (127) with aqueous sodium hydroxide at 20°C 
produced only the carbamate acid (128) (Scheme 2.5), but under reflux conditions, 
hydrolysis of the carbamate function also occurred, giving a mixture of the amino 
acid (129) and the carbamate acid (128). Separation was achieved by first acidifying 
the reaction mixture and extracting the acid carbamate (128) into ethyl acetate. The 
aqueous phase was lyophilised and purified by ion-exchange chromatography to 
yield the amino acid (129).
(129)
37%
Scheme 2.5 Reagents: (a) aq. NaOH, THF, 20°C, 16 h; (b) aq. NaOH, THF, reflux, 
3 days.
The amino acid (129) was named 5-homogabaculine, since it is the 
5-homologue of gabaculine. Naturally occurring (-)-gabaculine (130), was first 
isolated from Streptomyces toyocaensis by Mishima et al?1 and is a potent inhibitor 









When this enzyme is inhibited an intracellular build up of y-aminobutyric acid 
occurs and this inhibition may be useful in the treatment of Parkinsons disease, 
epilepsy and Schizophrenia, since these diseases are characterised by a deficiency of 
this acid. The homologue (129), although racemic, was therefore of interest for 
biological testing.
The *H NMR spectrum of the amino acid (129) was similar to those of the 
dienes (127),(128) and later compounds: several long range and allylic couplings are 
observed and much work was undertaken, with the aid of 2D COSY experiments, in 
order to obtain the data which is summarised in Figure 2.2.
/ a = 2.0 Hz 
7b = 1.0 Hz 
Jc = 5.5 Hz 
7d = 9.5 Hz 
/ e = 4.4 Hz 
J f=  1.5 Hz 
Jg = 12.8 Hz 
/ h = 8.5 Hz 
J{ = 6 . 6  Hz 
/j = 7.0 Hz 




Figure 2.2 Coupling Constants for (129) (in D2 0).
2.3 Synthesis of 5-Homoshikimic Acid
An extension of the synthesis required the carbamate to be hydrolysed 
selectively in the presence of the methyl ester. To this end, a different 
dihydropyridine starting material was chosen, 1 -rm-butoxycarbonyl- 1 ,2 -dihydro­
pyridine.
2.3.1 Preparation of the 1,2-Dihydropyridine
The required 1,2-dihydropyridine was prepared according to the procedure 
of Sundberg et al , 7 3  These workers demonstrated that direct acylation of pyridine 
with di-rm-butyl dicarbonate or 2 -[[(rm-butoxycarbonyl)oxy]imino]-2 -phenyl- 
acetonitrile, under the reductive conditions which are satisfactory in the case of the 
acylation with methyl chloroformate, cannot be used. The more obvious reagent, 
rm-butyl chloroformate, is unavailable and so an exchange route was developed 
(Scheme 2.6).
C 0 2Ph C 0 2-t-Bu
(131) (132)
Scheme 2.6 Reagents: (a) PhOCOCl, NaBH4, MeOH, -78°C, 2 h; (b) r-BuOK, THF, 
20°C, 1 h.
Phenyl chloroformate when reacted with pyridine in the presence of sodium 
borohydride gave the crystalline dihydropyridine (131), in 59% yield. The phenoxy 
group was then displaced by treatment with 1 . 1  equivalents of potassium 
tm-butoxide in THF, to give the rm-butoxycarbonyl derivative (132). The crude 
yield of this product was 90%, however, the corresponding 1,4-dihydropyridine was
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also present as a minor impurity, due to base catalysed isomerisation of (132). 
Sundberg has reported that the use of 2.8 equivalents of potassium rm-butoxide 
gives predominantly the 1,4-isomer, whereas 1.2 equivalents leads to the 
1 ,2 -isomer. 7 3
2.3.2 Diels-Alder Reaction
The Diels-Alder cycloaddition of l-?m-butoxycarbonyl-l,2-dihydro- 
pyridine (132) with methyl acrylate was performed under the same conditions as 
used for the methyl derivative (Scheme 2.7). The mixed exo and endo adducts were 
obtained in 59% yield, the product ratio being 1:1 (as determined by NMR). No 
correction was made for the amount of 1,4-dihydropyridine impurity in the starting 
material and this is reflected in the low yield.
Although inseparable by chromatography, the isomers were separable by 
crystallisation of the endo isomer (133) from toluene. On the large scale that this 
reaction was usually done, the crystallisation was conveniently performed on the 
crude product (obtained after evaporation of excess methyl acrylate from the 
reaction mixture). The mother liquor was then chromatographed, to remove any 
1,4-dihydropyridine, yielding the exo isomer (134) as a colourless oil.
i
N C 0 2Me
C 0 2-t-Bu
59%
n^ C ° 2-.-Bu
CO„ Me
(132) (133) (134)
Scheme 2.7 Reagents: (a) PhMe, reflux, 2 days.
2.3.3 Ring-Opening and Preparation of the AVV-Disulphonyl Derivative
The mixed exo and endo adducts were ring opened, as before, by treatment 
with lithium hexamethyldisilazide to afford the diene (135) (Scheme 2.8). This
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diene has the amino function protected by the rm-butoxycarbonyl (BOC) group7 4  
and thus deprotection was now possible without hydrolysis of the methyl ester. 
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At this point it was decided to attempt to displace the amino group via 
conversion to a ‘good leaving group’. Disulphonimides (137) were first shown to be 
useful intermediates for the deamination of primary aliphatic amines by 
Baumgarten7 5  (Scheme 2.9).
SOgR Nu" S 0 2R
 ► R  ►  R ^ / N u  +  -A






The approach is analogous to the substitution of alcohols via conversion to 
the p-toluenesulphonyl derivative (tosylate). The disulphonimide ion (138) is a 
relatively weak base and can therefore be displaced by either iodide or bromide ions 
to yield the corresponding alkyl halides, as well as elimination products. 
Di-(p-nitrobenzene) sulphonimides are less prone to elimination reactions than
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di-(p-toluene) sulphonimides and thus we decided to use the former.
Accordingly the amino ester was treated with triethylamine and 
p-nitrobenzene-sulphonyl chloride (NsCl), thus providing the sulphonamide (139) 
(Scheme 2.10). Further sulphonylation using sodium hydride as the base and NsCl 
afforded the disulphonimide (140).
Scheme 2.10 Reagents: (a) NsCl, Et3 N, THF, 20°C, 40 h; (b) NsCl, NaH, DMF, 
20°C, 1.5 h.
The displacement reaction was attempted using Baumgarten’s 
conditions, 7 5 1 5 namely, heating a solution of the disulphonimide (140) in DMF at 
110°C with potassium iodide (Scheme 2.11). The only product isolated was methyl 
3-methylbenzoate (142) in 64% yield. Under the same conditions, but with omission 
of the potassium iodide, no reaction was observed by TLC analysis. Thus, it is 
probable that displacement did occur to give the iodide (141), but that under the 
reaction conditions this compound then eliminated HI and underwent rearrangement 






Scheme 2.11 Reagents (a) KI, DMF, 110°C, 16 h.
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2.3.4 Osmylation of the Diene Disulphonimide (140)
In view of the results with the diene disulphonimide (140), we decided to 
introduce the 3,4-c/s-diol functionality before trying the displacement reaction. The 
driving force of aromatisation would then be absent and substitution products would 
be more likely.
Osmium tetroxide is the most reliable reagent available for the 
c/s-hydroxylation of alkenes. 7 6  Due to the high toxicity and expense of this reagent, 
it is more convenient to use it catalytically, in this case a secondary oxidant is 
employed to oxidatively hydrolyse the intermediate osmium (VI) ester and 
regenerate the osmium tetroxide, with the reaction being complete on consumption 
of the secondary oxidant. The use of /V-methylmorpholine V-oxide, rather than 
hydrogen peroxide, for this purpose was preferred since the latter often gives rise to 
over oxidised products. 7 7
Treatment of the diol disulphonimide (140) with V-methylmorpholine 
V-oxide and a catalytic amount of osmium tetroxide afforded the three diols 















(143), 16% (144), 8 %
Scheme 2.12 Reagents: (a) 0 s 0 4  (0.05 eq.), NMO, Me2 CO, THF, H2 0 , 20°C, 24 h.
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The diol with the desired (3a, 4a, 5p) relative stereochemistry, (143), was 
isolated in 16% yield and its structure determined by examination of the *H NMR 
spectrum. When this was run in D6 -DMSO, signals due to the diol functionality 
were immediately obvious in the form of two doublets at 6  4.69 (/^oh 6 . 8  Hz) and 8  
5.11 C/ 3  o h  6.2 Hz). Other resonances were more complex, due to unresolved fine 
coupling interactions, but an assignment was made possible through a 2D COSY 
experiment. When run in D6 -acetone/D20  the spectrum was simplified allowing 
coupling constants to be measured. These are summarised in Figure 2.3.
These figures correlate reasonably well with coupling constants calculated 
from the Karplus equation. 7 8  Even though this method needs to be used with 
caution, especially when electronegative groups are present, it seems to be generally 
applicable to shikimic acid derivatives and analogues. 7 9  The geometry of the 
cyclohexene ring is essentially defined by the double bond, which forces the four 
carbon atoms (C- 6  and C-l to C-3) to be coplanar. The ring can then adopt either a 
half-chair or boat conformation, of which the former is generally favoured.
It is important to realise that rapid conformational inversion is possible at 
room temperature and the observed conformation is a statistical average of all 




Figure 2.3. Coupling Constants for (143) (in D6 -acetone/D2 0 )
52
substituents determines which conformation is favoured energetically and, providing 
the energy differences are significant, the observed conformation will approximate 
to the favoured species.
The resonance due to 4-H is especially informative in the spectra of 
shikimates and in this case a doublet of doublets was evident at 5 3.62 ( / 4  3  4.5, / 4 t 5
9.5 Hz). The 4,5-coupling is consistent with a half-chair conformation in which the 
5-substituent is in an equatorial position and 4-H and 5-H are both axial (Figure
2.4). The cis arrangement of the 3-hydroxyl and 4-hydroxyl is not in doubt since 
these groups arose from osmylation, however, this arrangement is also supported by 
the relatively small 3,4-coupling. The protons in the 6 a and 6(3 positions were also 
distinguished by their coupling constants with 5-H and these couplings are also in 
agreement with the conformation shown. The alternative half-chair and both boat 





Figure 2.4 Half-Chair Conformation of (143).
The other two diols (144) and (145) were isolated in 8 % and 10% yields 
respectively. Due to their insolubility in CDC13  or D6 -acetone, NMR spectra could 
only be obtained for D6-DMSO solutions and again, assignments were made with 
the aid of a 2D COSY experiment. The *H NMR of (144) was similar to that of the 
diastereomeric diol (143), but due to unresolved coupling, the coupling constants 
could not be measured. The resonance due to 2-H in (144) was at higher field (5
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6.53) than that in compound (143) ( 8  6.70). This difference between the (3p, 4p, 5p) 
and (3a, 4a, 5p) systems seems a general feature and was followed in the spectra of 
later compounds.
The relative stereochemistry of the 1,2-diol (145) could not be established 
by NMR. The resonances due to 3-H and 4-H were coincident, as where those 
due to both 6 a-H and 6 p-H. Therefore, coupling constants could not be determined 
and meaningful n.O.e experiments were not possible.
Although all three diols were solids, it was not possible to obtain good 
quality crystals suitable for an X-ray crystallographic determination, recrystallis­
ation of these disulphonimides consistently produced microcrystalline solids.
The overall yield for the three diols was only 34%, other products were not 
detected. It is possible that hydroxylation occurred at both double bonds to produce 
tetra-ols, which were too polar to be eluted from the column during chromatography. 
Due to the poor yield of the required diol (143), an alternative cw-hydroxylation 
method was sought.
2.3.5 * Wet’ Provost Reaction upon the Diene Disulphonimide (140)
The Prevost reaction involves the reaction between an alkene, iodine and a 
silver carboxylate (typically the acetate or benzoate) to yield the diester of a trans 
diol (Scheme 2.13).80 The mechanism involves reaction of iodine with two 
equivalents of silver acetate to afford a complex, AcOAg-AcOI, known as a 
Simonini complex. Electrophilic attack of the acyl hypoiodite to the least hindered 
face of the alkene, produces an iodonium species (146). Opening of this cation with 
acetate ion gives an iodo acetate (147), which is converted to a cyclic acetoxonium 
ion (148). Finally, further nucleophilic displacement by acetate ion affords a trans 
diacetate (149).
A useful modification of the Prevost reaction, the ‘wet* Prevost reaction or 
Woodward hydroxylation, 81 involves the addition of at least one equivalent of water
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AcO' ^  (148) (149)
Scheme 2.13 Mechanism of the Prevost Reaction.
to the reaction mixture (Scheme 2.14). The intermediate acetoxonium ion (148) 
undergoes hydrolysis under these conditions, rather than a second nucleophilic 
displacement, yielding a mixture of cis hydroxy acetates (150) and (151). 
Subsequent saponification leads to a cis diol (152) with a stereochemistry 




R OH R. .OAc




R '  ^O A c R '  -O H  R OH
(150) (151) (152)
Scheme 2.14 Mechanism of the Woodward Hydroxylation.
Thus, the Woodward hydroxylation is usually complementary to the use of
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osmium tetroxide, which gives products resulting from preferential attack from the 
least hindered face of the alkene.
In practice, the Prevost reaction or Woodward hydroxylation of more 
highly substituted alkenes, can give rise to a several products. The product ratio is 
determined by preferential attack of the acyl hypoiodite on the alkene and/or a 
preferred direction of opening of the acetoxonium ion. The possibility of carbonium 
ion intermediates can also lead to further complication.
A ‘wet’ Prevost reaction was performed on the diene disulphonimide (140), 
by treatment with iodine and silver acetate in glacial acetic acid containing an 









(153) + (154) 20%
(156)
(155) + (156) 52%
(143) 3%
Scheme 2.15 Reagents: (a) AgOAc, I2, AcOH, H2 0 , reflux, 4 h.
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A complex mixture of six products was obtained which was subjected to 
column chromatography. The epimeric diacetates (153) and (154) were obtained as 
an inseparable 1:1 mixture, in 20% yield. The major product was a 1:1 mixture of 
the hydroxy acetates (155) and (156), in 52% yield and again these were inseparable 
by chromatography. Two minor products were also isolated, the hydroxy acetate 
(157) and the previously prepared diol (143), both in 3% yield.
The structure of the products was determined by examination of the *H 
NMR spectra. In order to aid identification, the two diacetates (153) and (158) were 









Scheme 2.16 Reagents: (a) Ac2 0 , Py, DMAP, 20°C, 24 h.
On examination of the *H NMR data for the mixture of diacetates (153) and
(154), obtained from the Prevost reaction, it was obvious that one component was 
the (3a, 4a, 5p) compound (153), identical to the product obtained by acetylation of 
the diol (143). The NMR data for the most useful ring protons (2-H to 4-H), are 
summarised in Table 2.1 and support a diaxial arrangement of 4-H and 5-H (Figure
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2.5). The other diacetate showed a marked difference in the 2,3- and 3,4-coupling 
constants, but a similar 4,5-coupling constant. The larger 3,4-coupling of 7.1 Hz for 
compound (154) is consistent with (3P, 4a, 5p) stereochemistry, in which the 
molecule adopts the half-chair conformation shown in Figure 2.5.
The NMR data for the major product, a mixture of the hydroxy acetates 
(155) and (156), indicated that these have the desired (3a, 4a, 5p) stereochemistry, 
both showed coupling constants similar to those for compound (153) (Table 2.1).
Compound
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Figure 2.5 Half-Chair conformations of (153) and (154).
The final compound to be accounted for was the hydroxy acetate (157), a 
minor product of the reaction. The structure of this compound was assigned by 
comparison with the *H NMR data for the (3p, 4p, 5p) diacetate (158), obtained by 
acetylation of the diol (144) from the osmylation reaction. The spectra for both these 
compounds were less informative than for previous compounds. The resonances due 
to 2-H were broad singlets, whilst those due to 3-H and 4-H appeared as unresolved 
multiplets or broad singlets. The total width of these multiplets was small, (ca. 6  Hz) 
and thus it was reasoned that the important 2,3-, 3,4- and 4,5-couplings must also 
small (ca. 0 to 3 Hz).
The suggested half-chair conformation for (158), that accounts for this data, 
is shown in Figure 2.6. The 5-substituent is equatorial, the 4-substituent axial and 
consequently the dihedral angles between 2-H, 3-H and 4-H, all give rise to 
relatively small coupling constants.
An alternative explanation is that since the 4- and 5-substituents cannot 
both be equatorial, unlike the (3a, 4a, 5p) compounds, the half-chair conformation 
shown (Figure 2.6) is less stable. The energy difference between this and other 
possible conformations may therefore be slight, leading to time averaged signals and 
thus broad singlets. However, this would also lead to broadening of the 6 -H 






Figure 2.6 Half-Chair conformation of (158)
Overall, the reaction was therefore fairly stereoselective, producing 
products with predominantly the desired (3a, 4a, 5(3) stereochemistry. This would 
not be expected from a consideration of the ‘normal’ mechanism discussed earlier. 
The attack of the acyl hypoiodite would be expected from the a-face of the double 
bond to give the a-iodonium species (159) (Scheme 2.17). This would then lead to 




















Another possible mechanism has been suggested by Campbell and 
Sainsbury, 2 5  to account for this stereoselectivity in Prevost reactions applied to 
similar dienes. Initial Michael addition by acetate from the a-face at C-4, possibly 
mediated by the silver cation, followed by electrophilic attack of the acyl 
hypoiodite, would lead to the iodo acetate (161) (Scheme 2.18). Cyclisation would 
give the a-acetoxonium species (162) and hence, via hydrolysis, the two hydroxy 












The two diacetates isolated (153) and (154), would also arise from an 
a-acetoxonium species. A competing nucleophilic attack of acetate at C-3, rather 
than hydrolysis, would give the diacetate (154). However, since the (3a, 4(3, 5(3) 
diacetate, resulting from attack at C-4, is not observed, it is likely that the two 
diacetates arise through SN1 attack at C-3, via the allylic cation (163), rather than 

















Considering the two minor products isolated, the diol (143) would be 
produced from hydrolysis of either of the hydroxy acetates. The other minor product 
(157), the 3p-acetoxy-4p-hydroxy compound, presumably arises from initial 
Michael attack of acetate from the (3-face of the diene, or from an a-iodonium 
species. In either case the reaction would proceed via a p-acetoxonium intermediate. 
None of the corresponding 3p-hydroxy-4p-acetoxy compound was isolated, but this 
fact should not be given too much attention, in view of the small amount of (157) 
isolated.
The low yield of (157) from the reaction also testifies to the remarkable 
selectivity observed for attack to only one face of the double bond.
In summary, it is clear that the major products observed must arise from an 
a-acetoxonium species (162). This may either arise from a conventional Prevost 
mechanism, but with unexpected preferential formation of the p-iodonium species, 
or from a different mechanism involving initial Michael attack of acetate ion.
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The mixed hydroxy acetates (155) and (156) were hydrolysed using 
aqueous ammonia in methanol to afford the diol (143) (Scheme 2.20). The product 
was identical, in all respects, to a sample of the diol obtained via osmylation, thus 
confirming the assignments made for the structures of the hydroxy acetates. The 
overall yield of the diol (143) was 36%, for the two steps from the diene 












Scheme 2.20 Reagents: (a) aq. NH3, MeOH, 20°C, 23 h.
2.2.6 Displacement Reactions of the Disulphonimide (164)
With access to sufficient quantities of the diol (143) now possible, we could 
return to the attempted displacement of the disulphonimide group. There were two 
aims in mind - displacement with iodide to form a useful intermediate for later 
syntheses and with an oxygen containing nucleophile to give access to the 
tri-hydroxylated compound.
The two hydroxyl groups of (143) were first protected by formation of the 
acetonide (164) (Scheme 2.21). Treatment of this compound with potassium iodide 
in DMF at 130°C, afforded a mixture of three products, which were separated by 
column chromatography.
The desired iodide (165) was isolated as a crystalline solid in 32% yield 
and the diene (166), arising from elimination of HI from (165), as a colourless oil, in 
























Scheme 2.21 Reagents: (a) Me2 C(OMe)2, M e^O , p-TSA, 20°C, 22 h; (b) KI, 
DMF, 130°C, 21 h.
crystals of suitable quality for a successful X-ray crystallographic determination 
(Figure 2.7, full details are included in Appendix One). The results confirmed the 
relative stereochemistry assigned to these compounds on the basis of NMR data. 
The conformation of compound (165) in the crystal structure was the same as would 
be expected in solution from NMR data. The molecule exists in the now familiar 
half-chair conformation, in which the 5-iodomethyl substituent is equatorial and thus 
both 4-H and 5-H are axial, leading to a relatively large (9.2 Hz) 4,5-coupling 
constant (Figure 2.8).
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Figure 2.8 Half-Chair conformation of (165)
Full NMR data for this compound were obtained by a series of 
homonuclear decoupling experiments. The resonances due to the proton in the 6(3 
position appeared originally as a sixteen line signal (dddd). When irradiation was 
carried out at the position corresponding to 2-H, the resonance simplified to eight 
lines (ddd). Irradiation at the 3-H position produced a similar effect. In this way the
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fine allylic (2, 6 p) and homo-allylic (3, 6(3) couplings were measured. The resonance 
due to 6 a-H was less well resolved and appeared as a broadened doublet of doublets. 
Irradiation at either the 2-H or 3-H positions produced a marked sharpening of the 
6 a-H resonance, indicating similar fine couplings to this proton, which are not quite 
resolved at 270 MHz. Tabulated data is included in the experimental chapter, 
Section 3.2.
The final product obtained was the O-formyl derivative (167), isolated as a 
colourless oil, in 17% yield. The 0-formyl group was evident from the NMR data, 
giving rise to a low field doublet (J 0.5 Hz) at 5 8.10 in the ]H spectrum and a 
distinct carbonyl resonance at 5 160.8 in the 13C spectrum. Homonuclear decoupling 
experiments were also carried out on compound (167) in order to determine the fine 
allylic and homo-allylic couplings (these are tabulated in Section 3.2).
This compound was of great interest since we had unwittingly introduced a 
protected hydroxyl group at the 1 '-position and thus achieved the synthesis of the 
protected form of one of our major targets.
A mechanism for the formation of this product is illustrated in Scheme 
2.22. Nucleophilic attack of the solvent DMF, on the iodide (165), would give the 
immonium species (168). The disulphonimide starting material (164) is less likely to 
undergo this reaction. Hydrolysis of (168), during the aqueous workup, would give 
the O-formyl product (167).
COgMe
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A similar preparation of formate esters from disulphonimides has been 
described by Baumgarten. 8 2  Various simple V-alkyl-V^V-disulphonimides, when 
heated with aqueous HI in DMF, gave rise to a mixture of the corresponding 
alcohols, formate esters and elimination products.
A superior route to the iodide (165), from the disulphonimide (164), was 
developed using potassium iodide with 18-crown-6 in toluene (Scheme 2.23). 
Substitution reactions using crown ethers and potassium iodide, have been 
demonstrated for alkyl tosylates and mesylates, 8 3  the crown ether forms a complex 
with the potassium cation, thus solubilising the potassium iodide in the non-polar 
solvent. The iodide anion is not solvated and consequently much more nucleophilic 
than in polar solvents. The iodide (165) was obtained in 63% yield, and in contrast 
to the previous method, no elimination product was observed.
(170)
Scheme 2.23 Reagents: (a) KI, 18-crown-6, PhMe, reflux, 7 days; (b) NaOAc, 
DMF, 110°C, 2.5 h; (c) KOAc, 18-crown-6, PhMe, reflux, 18 h.
With a suitable route to the iodide (165) established, the other concern was
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to investigate substitution with oxygen nucleophiles. Treatment of the iodide (165) 
with sodium acetate in DMF, yielded the acetate (169), in 60% yield (Scheme 2.23). 
The reaction was complete after only 2.5 h, no elimination products were observed.
It was hoped to introduce the acetate group directly via treatment of the 
disulphonimide (164) with the 18-crown-6/potassium acetate complex (Scheme 
2.23). However, in this case the only product produced was the N-acetyl derivative
(170). A mechanism for this transformation in shown in Scheme 2.24. Initial 
nucleophilic attack at sulphur would result in sulphur-nitrogen bond cleavage and 
formation of the sulphonamide anion (171). This species is then acetylated to give 
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SO ^r SO^r ^ S O ^ r
(171)
Scheme 2.24
This sulphur-nitrogen rather than carbon-nitrogen bond cleavage in 
disulphonimides, has also been observed by Baumgarten, 7 5 c ’8 2  and the direct 
conversion of disulphonimides to alcohols or esters is not possible. This conversion 
has been described by Andersen, 8 4  who treated a disulphonimide with a mixture of 
potassium iodide and potassium acetate in HMPA, to afford the corresponding 
acetates. Potassium iodide was essential for reaction and the acetates are therefore 
formed by substitution of the intermediate iodide.
This last reaction was not attempted with our disulphonimide (164), 
however, our sequence did give access to the acetate (169) in reasonable yields, by 




The final stage in the synthesis of our target compound, 5-homoshikimic 
acid (174), was the removal of all the protecting groups from either the formate 
(167), or acetate (169) (Scheme 2.25). Both of these compounds were used to 
prepare 5-homoshikimic acid, although the route via the acetate (169) was preferred, 














Scheme 2.25 Reagents: (a) Amberlyst-15, MeOH, 20°C, 17 h; (b) 50% aq. AcOH, 
THF, 60°C, 3.5 h; (c) NaOH, H2 0 , 20°C, 5.5 h; (d) aq. NH3, MeOH, 48 h; (e) 50% 
aq. AcOH, THF, 60°C, 17 h;
Methanolysis of the 0-formyl group of compound (167), using an acidic 
ion-exchange resin and methanol, also effected incomplete cleavage of the 
isopropylidene group, affording a mixture of the acetonide alcohol (172) and the 
triol (173). The two protecting groups were more conveniently removed in a 
‘one-pot’ reaction, before purification, using aqueous glacial acetic acid to complete
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removal of the isopropylidene group. In this way the triol (173) was obtained in 64% 
yield.
Alternatively, Methanolysis of the acetate (169) was performed using 
aqueous ammonia in methanol to give the acetonide alcohol (172), in 87% yield. 
Removal of the isopropylidene group, again using aqueous glacial acetic acid, 
afforded the triol (173), in 73% yield.
This triol, methyl 5-homoshikimate, (173) was saponified using aqueous 
sodium hydroxide to yield 5-homoshikimic acid (174). An acidic ion-exchange resin 
was used to work-up this saponification and removal of the resin by filtration, 
followed by lyophilisation, gave excellent yields of the pure acid (174). This 
completed the synthesis of the 5-homologue of shikimic acid, samples of which 
were submitted for biological testing.
The resonances in the *H NMR spectrum of 5-homoshikimic acid were 
assigned with the aid o f homonuclear decoupling experiments (tabulated in Section 
3.2). The signals due to 4-H and one of the l'-H overlapped in the original spectrum, 
however, irradiation at the position corresponding to 3-H, simplified the 4-H 
resonance and allowed the couplings in the l'-H resonance to be measured.
In order to complete the *H NMR study of these 5-homoshikimate systems, 
the triacetyl derivative of methyl 5-homoshikimate was prepared (Scheme 2,26). 
Acetylation of methyl 5-homoshikimate (173) with acetic anhydride in pyridine, 
afforded the triacetate (175), in 87% yield.
All resonances in the *H NMR spectrum of this compound were distinct 
and full assignments could be made. The compound exhibited typical fine allylic 
coupling ( / 2 ,6a 1*3* 2^,6p 2.4 Hz) and homo-allylic coupling C^gp 1«2 Hz). The 
resonance due to 4-H is observed as a doublet of doublets C/ 4  5  10.8, J4 3  3.9 Hz). 
The 4,5-coupling is consistent with the expected diaxial arrangement for 4-H and 
5-H, although slightly larger than observed in the spectra of previous compounds, a 









Scheme 2.26 Reagents: (a) Ac2 0 , Py, DMAP, 20°C, 15 h.
Another compound thought suitable for biological testing, was obtained by 
deprotection of the iodide (165) (Scheme 2.27). Hydrolysis of the acetonide using 
aqueous acetic acid yielded the diol (176) which was subsequently saponified with 
aqueous sodium hydroxide to afford the acid (177). The order of reactions was also 
reversed - treatment of (165) with aqueous sodium hydroxide giving the acid (178) 
which was converted to (177). The iodo substituent was unaffected throughout these 











Scheme 2.27 Reagents: (a) 50% aq. AcOH, THF, 60°C, 39 h; (b) NaOH, H2 0 ,  
20°C, 24 h; (c) NaOH, H2 0 , 20°C, 18 h; (d) 50% aq. AcOH, THF, 60°C, 24 h.
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2.4 Improved Synthesis of 5-Homoshikimic Acid
Although the preceding work had led to a synthesis of our major target, 
5-homoshikimic acid (174), the approach was somewhat involved, requiring a total 
of thirteen to fifteen steps (depending on the route used), from pyridine. 
Considerable interest in the results of biological testing of (174), led us to 
investigate a more concise route to this compound. Starting from the previously 
prepared diene (135), available in four steps from pyridine, the three key stages of 
hydroxylation, deamination and deprotection were addressed as follows.
2.4.1 Osmylation of the Diene (135)
Treatment of the diene (135) with N-methylmorpholine N-oxide and a 
catalytic amount of osmium tetroxide afforded a mixture of the diastereomeric diols 
(179) and (180) (Scheme 2.28). The ratio of (179):(180) was determined to be 5:4 










(179) 29% (180) 39%
Scheme 2.28 Reagents: (a) 0 s 0 4  (cat.), NMO, Me2 CO, H2 0 , 20°C, 48 h.
This reaction had been tried earlier in the project, but the two diols proved 
inseparable by TLC or column chromatography and thus the alternative strategy was 
developed. On returning to this reaction, it was found that the two products could be 
separated by trituration with diethyl ether. The diol (179) was virtually insoluble in 
ether and was obtained as a colourless solid which could be recrystallised from ethyl 
acetate. In contrast, the diastereomeric diol (180) was readily soluble in ether and
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was obtained as a colourless oil. In this way, separation was possible and the 
diastereomeric diols could be obtained pure, relatively easily.
The relative stereochemistry of the two products was determined by 
consideration of the NMR spectra. When the spectrum of (179) in D6-DMSO 
was examined the resonance due to 4-H was observed as a multiplet at 5 3.39, and 
the associated coupling constants could not be determined. Using D6-DMSO as the 
solvent results in the appearance of distinct doublets for the signals due to the 
hydroxyl protons and thus it was the coupling between the 4-OH and 4-H that was 
complicating the 4-H signal. Homonuclear decoupling experiments were used to 
determine these couplings (tabulated in Section 3.2). Irradiation at the resonance 
due to 3-H, simplified the 4-H resonance to a doublet of doublets (/^oh 5.5, J4  5  8.5 
Hz). Similarly, irradiation at the resonance due to the 4-hydroxyl, produced another 
doublet of doublets (74 3  3.5, / 4 5  8.5 Hz). The relatively large 4,5-coupling is 
consistent with a trans diaxial arrangement for these two protons and thus (3a, 4a, 
5(3) stereochemistry.
Recrystallisation of (179) from ethyl acetate provided crystals suitable for 
an X-ray crystallographic determination, which duly confirmed our assignment of 
this structure (Figure 2.10, full details are included in Appendix Two). The 
molecule adopts the same half-chair conformation (Figure 2.11) in the crystal 





Figure 2.11 Half-Chair Conformation of (179)
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Figure 2.10 ORTEP Diagram of (179)
The *H NMR spectrum of the other diol, (180), was less informative, the 
resonances due to 2-H, 3-H and 4-H all appearing as broad singlets. Nevertheless, 
the spectrum showed great similarity to those of previous compounds with (3(3, 4(3, 
5(3) stereochemistry and the assignment is not in doubt.
2.4.2 Deprotection of the Diols (179) and (180)
The diols (179) and (180) are the protected forms of two novel amino acids, 
which were of interest for biological testing. Deprotection of each of these 
compounds was accomplished by first cleaving the N-tm-butoxycarbonyl group,
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through treatment with trifluoroacetic acid (Scheme 2.29). The intermediate amino 
esters were not isolated since they were highly water soluble and thus extraction was 
difficult. Instead, the crude products were treated with aqueous sodium hydroxide 
solution to effect saponification and the amino acids (181) and (182), were 









Scheme 2.29 Reagents: (a) TFA, 20°C, 5 min; (b) aq. NaOH, H2 0 , 20°C, 20 h.
2.4.3 Deamination of the diol (179)
A different deamination procedure was utilised for the diol (179), instead of 
using a disulphonimide. Our attention was drawn to the conversion of aliphatic 
amines to alcohols, via N-nitrosation of the corresponding amides, by a recent 
publication by Ganem. 8 5  As part of a synthesis of a shikimate pathway enzyme 
inhibitor, 8 6  the quinate derived trifluoroacetamide (183) was transformed into the 
acetate (184) by treatment with sodium nitrite in acetic acid and acetic anhydride 
(Scheme 2.30). The acetate was obtained in 64% yield. Elimination, rearrangement 













Scheme 2.30 Reagents: (a) NaN02, AcOH, Ac2 0 ,0°C .
The deamination of aliphatic amines via conversion into their A-nitroso- 
amides has been widely studied. 8 7  The conventional procedure involves nitrosation 
of an amide (185) to give a A-nitrosoamide (186), which on heating rearranges to a 
diazoester (187) (Scheme 2.31). This transient intermediate cannot be isolated, but 
rapidly breaks down to afford a diazonium salt (188), the cation of which can either 
react with the carboxylate counter anion to form an ester, or react with solvent to 
give a solvolysis product or undergo an elimination reaction to yield an olefin.
Rearrangement of A-nitrosotrihaloacetamides is more rapid than that of 
simple A-nitrosoacetamides and in Ganem’s procedure8 5  the reaction is complete at 
0°C; no intermediates are observed and if acetic acid is present in the solvent 






In order to apply this procedure to our compound, the diol carbamate (179) 
was converted into the trifluoroacetamide (189) (Scheme 2.32). A * one-pot’ 
procedure was used, treatment with trifluoroacetic acid cleaved the tert- 
butoxycarbonyl group and the crude product was then acylated using trifluoroacetic 
anhydride in pyridine, to afford the trifluoroacetamide (189) in 76% yield.
Nitrosation of this compound was performed according to Ganem’s 
conditions, starting at -4°C initially and allowing the reaction mixture to warm to 
10°C overnight. The acetate (190) was isolated in only 31% yield, although this was 
the major product. From TLC analysis, traces of other products were evident which 
appeared less polar than the main product, unfortunately these minor compounds 













Scheme 2.32 Reagents: (a) TFA, 20°C, 30 min; (b) TFAA, Py, DMAP, 20°C, 3 
days; (c) NaN02, AcOH, Ac2 0 , -4 to 10°C, 17 h.
The reaction was repeated several times and since no unreacted starting 
material was observed, the low yield is most likely due to hydrolysis of the methyl 
ester. Although this yield was disappointing, especially in comparison to the yields
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reported by Ganem for other compounds, it was felt that this was acceptable since 
fewer steps were involved than the previous deamination method.
2.4.4 Deprotection and Protection of the Diol Acetate (190)
To complete the synthesis of 5-homoshikimic acid by this route, a sequence 
of straightforward deprotection steps were necessary (Scheme 2.33). Methanolysis 
of the acetate (190) yielded methyl 5-homoshikimate (173), identical in all respects 
with the sample prepared by previous routes and thus providing further confirmation 
of our earlier stereochemical assignments. This compound was saponified, as before, 
to afford 5-homoshikimic acid (174). The complete route to this compound involved 
























Scheme 2.33 Reagents: (a) aq. NH3, MeOH, 20°C, 21 h; (b) M e^ O M e)*  M e^O , 
p-TSA, 20°C, 18 h; (c) NaOH, H2 0 , 20°C, 5.5 h; (d) Me2 C(OMe)2, Me2 CO, p-TSA, 
20°C, 22 h; (e) aq. NH3, MeOH, 20°C, 48 h;
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The acetate (190) was also subjected to further protection/deprotection 
reactions, in order to access the acetonide (172) which was required for some further 
studies (Section 2.5). Protection of the two hydroxyl groups yielded the previously 
prepared acetonide acetate (169), which upon methanolysis afforded the acetonide 
(172), as before.
Preparation of this acetonide (172) was also investigated via the triol (173), 
however, the overall yield was lower. This was due to the formation of the ketal
(191) as a by-product, in the conversion of the triol (173) to the acetonide (172). The 
structure of the ketal (191) was deduced from examination of the and 13C NMR 
spectra and supported by mass spectrometric data. Interestingly, the compound is 
symmetric and the lH NMR spectrum for each half should be identical. However, 
since the compound was formed from a racemic triol (173), two diastereomeric (and 
racemic) compounds are possible. This was evident from the complex nature of 
NMR spectrum and the duplication of signals in the 13C NMR spectrum.
2.4.5 Synthesis of 5-e/w-Homoshikimic acid
Since the osmium tetroxide catalysed cis-hydroxylation of the diene (135) 
produced both the (3p, 4p, 5p) diol (180) as well as the (3a, 4a, 5p) diol (179), the 
triol with (3p, 4p, 5p) stereochemistry was potentially just as accessible as 
5-homoshikimic acid. The deamination - deprotection sequence was therefore 
applied to compound (180), in order to prepare a further derivative for biological 
assessment.
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The diol (180) was first converted to the diacetate (192), by standard 
methods, in order to investigate whether this would lead to an improved yield for the 
deamination step (Scheme 2.34). This also served to purify the starting material, the 
diol (180) being non-crystalline and slightly difficult to obtain pure. The diacetate


























Scheme 2.34 Reagents: (a) Ac2 0 , Et3 N, DMAP, 20°C, 21 h; (b) TFA, 20°C, 10 min;
(c) TFA A, Py, DMAP, 20°C, 1.5 h; (d) NaN02, AcOH, Ac2 0 , -4°C to 0°C, 18 h; (e) 
aq. NH3, MeOH, 20°C, 2 days; (f) NaOH, H2 0 , 20°C, 18 h.
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Nitrosation of this trifluoroacetamide gave a complex mixture, from which 
the desired triacetate (194) could be separated by chromatography. The yield of this 
product was very poor and TLC analysis indicated several minor products at higher 
Rp than the triacetate, as well as some more intense spots at lower RF. Methanolysis 
of the triacetate (194) afforded the triol (195).
It was anticipated that the lower Rp products observed in the nitrosation 
reaction were various hydroxy acetates, produced by hydrolysis of one or more of 
the acetate groups during the reaction. This was proved by performing the 
nitrosation reaction and then carrying out the methanolysis on the crude product, 
before any chromatographic purification. The major product produced from this 
sequence of reactions was indeed the triol (195), obtained in 48% yield. As before, a 
few minor products were evident by TLC, these were not characterised. This two 
step procedure proved far more convenient than separation of the triacetate.
Saponification of the triol (195) yielded the acid (196), (±)-5-fi,p/-homo- 
shikimic acid. The *H NMR spectrum of this compound was not particularly 
informative, in contrast to that of 5-homoshikimic acid. The resonances due to 2-H,
3-H and 4-H appeared as unresolved multiplets or broadened singlets. However, the 
similarity of the spectrum to those of the previously prepared compounds with (3p, 
4p, 5p) stereochemistry was clear and it is likely that 5-cp/-homoshikimic acid 
adopts the same solution conformation (see page 20).
2.5 Synthesis of 5-FIuoromethyI Shikimate Analogues
Replacement of a hydroxyl group by a fluorine atom is a frequent ploy used 
by medicinal chemists seeking to modify biological processes. Since some of the 
homoshikimates show interesting bioactivities, we considered it important to 
prepare the 5-fluoromethyl analogues of shikimic acid.
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2.5.1 Fluorination
The conversion of oxygen-containing functional groups to fluorinated 
substituents is commonly achieved using analogues of sulphur tetrafluoride. 
Diethylaminosulphur trifluoride (DAST) 8 8  has been widely used, however, recently 
morpholinosulphur trifluoride (morph-DAST) 8 9  has been reported as an alternative. 
The latter reagent is safer to use than DAST and reportedly gives higher yields of 
fluorinated products.
Treatment of the previously described alcohol (172) with morph-DAST in 
dichloromethane afforded the fluoride (197) in 65% yield, with 23% recovered 





Scheme 2.35 Reagents: (a) morph-DAST, CH2 C12, -78°C to 20°C, 2 days; (b) PCC, 
CH2 C12, 20°C, 4 h; (c) morph-DAST, CH2 C12, 20°C, 2 days.
In order to obtain the difluoro analogue, it was first necessary to oxidise the
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alcohol to the corresponding aldehyde (198). Pyridinium chlorochromate90 was the 
reagent of choice and this effected clean oxidation to afford the aldehyde (198) in 
71% yield. A more modem reagent, tetra n-propylammonium pemithenate (TPAP)91 
was also tried, but found to be less convenient and lower yielding, at least on a small 
scale.
The structure of the aldehyde was obvious from examination of the JH 
NMR spectrum, with the aldehyde proton resonating as a fine doublet at 8 9.79 ( /  
0.5 Hz). The appearance of the resonance due to 5-H was initially puzzling: it is a 
broadened four line signal. A comprehensive series of homonuclear decoupling 
experiments, (tabulated in Section 3.2), established this resonance to be an 
overlapping doublet of doublet of doublets (/s^p 7.0, 6.0, Js,sa 5*7 Hz), with the
fine coupling to the aldehyde proton unresolved. These NMR experiments also 
confirmed the fine allylic 1»5, /6p,2 1*6 Hz) an(  ^homoallylic ( /^  1.5, J6 p,3  1.6 
Hz) coupling present.
Fluorination of the aldehyde (198) with morph-DAST, afforded the 
difluoride (199) in excellent yield. These fluorination reactions were found to 
benefit from the long reaction times (typically 2 days), premature work-up led to 
reduced yields. This was not immediately obvious by TLC analysis of the reaction 
mixture, since the disappearance of starting material was virtually instantaneous.
2.5.2 Deprotection
Deprotection of both fluorinated products was accomplished by previously 
established methods (Scheme 2.36). Cleavage of the isopropylidene group from the 
fluoride (197) using aqueous acetic acid, afforded the diol (200), which was 
subsequently saponified with aqueous sodium hydroxide, to yield the acid (201). In 











Scheme 2.36 Reagents: (a) 55% aq. AcOH, THF, 60°C, 2 days; (b) NaOH, H2 0 , 
20°C, 3 h; (c) 55% aq. AcOH, THF, 60°C, 3 days; (d) NaOH, H2 0 , 20°C, 5 h.
2.5.3 NMR Features of the Fluorinated Products
The NMR spectra of the fluorinated products were particularly interesting, 
exhibiting typical H,F- and C,F-coupling. The H,F-coupling observed in the *H 
NMR spectra of the fluoride (197) and difluoride (199), is illustrated in Figure 2.12. 
The H,F-coupling for H-5 could not be determined for the difluoride (199), this 
resonance appearing as a complex multiplet.
The presence of the fluorine atom in these structures was also evident from 
the chemical shifts of the l'-H resonances, these being further downfield than in 
earlier compounds. In the fluoride (197) the two l'-H gave rise to resonances at 6  
4.54 and 6  4.59, whereas the l'-H of the difluoride (199) produced a large triplet of 
doublets at 5 6 .0 2 .
Coupling to fluorine was also observed in the 13C NMR spectra, with 
several resonances appearing as either doublets or triplets, as appropriate (Table 














o - O ^  11971
C02Me
o J v V  (199)
i p a  I
C-l 133.1 132.4
C-2 133.7 133.3
C-3 72.9 (d, 7C F 4 Hz) 72.0 (d, / C>F 7 Hz)
C-4 71.1 70.9
C-5 38.3 (d, /c ,F 18 Hz) 41.4 (t,7C F20Hz)
C- 6 24.4 (d ,/c .F4 Hz) 19.7 ( t ,/CtF5Hz)
c - r 83.7 (d ,/c .Fl70H z) 116.0 ( t ,/CF241 Hz)
Other 25.7 (Me), 28.1 (Me)
52.1 (OMe), 109.2 (CMe2) 
166.6 (C=0)
25.5 (Me), 27.9 (Me)
52.1 (OMe), 109.5 (CMe2) 
166.2 (C=0)
Table 2.2 13C NMR Data for Compounds (197) and (199)
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2.6 Synthesis of an 5-EnoIpyruvylshikimic Acid Analogue
In order to construct analogues of later intermediates in the shikimate 
pathway, it was necessary to elaborate the 5-substituent of our 5-homoshikimates. It 
was envisaged that this could be accomplished through the reaction of the previously 
prepared iodide (165), with, formally speaking, the a-anion of a suitable acrylate
(204) (Scheme 2.37).
2.6.1 a-Acrylate Anion Equivalent Reactions
Since it has not been possible to generate an a-acrylate anion (204) 
directly, a number of synthetic equivalents have been developed. 9 2  The more recent 
a-acrylate synthons reported include: the dianion of methyl 3-nitropropanoate
(205)93; the anion of methyl 3-(dimethylamino)propanoate (206)94 and the anion of
4-methoxycarbonylthiolan-3-one (207)9 5  In each case a-alkylation, followed by 





A related reaction uses the DABCO-catalysed coupling of an aldehyde with 
an acrylic ester, to form 2-(hydroxyalkyl)acrylic esters (Scheme 2.38).96 This
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approach is not suitable for alkyl halides however, and addition transformations are 








For our attempted synthesis, Seebach’s approach, 9 3  using the dianion of 
methyl 3-nitropropanoate (205), was chosen. This reagent seemed the most 
convenient, the starting material being commercially available and a single 
elimination step being involved. Treatment of (205) with two equivalents of LDA, 
was carried out in a 2:1 mixture of THF - DMPU, according to Seebach’s procedure. 
The co-solvent DMPU is necessary in order to solubilise the dianion and was 
preferred to the alternative, but carcinogenic, solvent HMPA. Reaction of this 
dianion with the iodide (165) afforded the nitro compound (208), as a mixture of 
diastereomers, in only 20% yield (Scheme 2.39). The bulk of the material recovered 
was unreacted starting material (165).
Further attempts to optimise this reaction were unsuccessful. A slight 
turbidity of the dianion solutions was observed, however, sonication of the reaction 
mixture in an ultrasound bath, did not improve the product yield. The poor result 
was attributed to unreactivity of the iodide (165), since, although primary, this 
iodide is almost as sterically hindered as a neopentyl iodide.
Full characterisation of the nitro compound (208) was not possible due to 
the inseparable mixture of diastereomers obtained. Nonetheless, the presence of the 
side chain was evident from the IR spectrum, which contained two distinct carbonyl 
bands at 1735 (C=0, saturated ester) and 1715 (C=0, unsaturated ester) and from 
the mass spectrum which showed a molecular ion at m/z 258 (MH+, 31%).
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(165) (208) 2 0 %
C 0 2Me
(b)
86% C 0 2Me
(209)
Scheme 2.39 Reagents: (a) N0 2 (CH2 )2 C0 2 Me, 2 equiv. LDA, THF, DMPU, -78 to 
0°C, 13 h; (b) DBU, THF, 20°C, 4 h.
Treatment of (208) with the base l,8-diazabicyclo[5.4.0]undec-7-ene, 
effected a clean elimination of nitrous acid, to give the dialkene (209) in 8 6 % yield 
(Scheme 2.39). The presence of the exocyclic double bond was apparent from the 
*H NMR spectrum, which showed two broad singlets, exhibiting fine allylic 
coupling, at 5 5.56 and 6.24. Full assignment was facilitated by homonuclear 
decoupling experiments (tabulated in Section 3.2).
2.6.2 Deprotection
Deprotection of the dialkene (209) followed the same procedure as for 
previous compounds (Scheme 2.40). Removal of the isopropylidene group, using 
aqueous acetic acid, yielded the diol (2 1 0 ) and also effected cyclisation, to give a 
small amount of the bicyclic lactone (211). The two compounds were separated by 
chromatography and the diol (2 1 0 ) saponified to afford the diacid (2 1 2 ), which is the 














Scheme 2.40 Reagents: (a) 50% aq. AcOH, THF, 60°C, 36 h; (b) NaOH, H2 0 , 
20°C, 4 h.
The structure of the lactone (211) is particularly interesting since it 
provides a means of differentiation between the C-3 and C-4 hydroxyl groups. 
Phosphorylation of the 3-hydroxyl group would provide access to the carba analogue 
of 5-enolpyruvylshikimate-3-phosphate (8 ). Very similar bicyclic lactones were 








(8 ) R = H 
(70) R = P0 3 H2
Further optimisation of this route and investigation of the chemistry of the 
lactone (2 1 0 ), was precluded by the development of an alternative route, from 
(-)-shikimic acid, within the Bath group. 9 8
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2.7 A Chiral Approach - Asymmetric Diels-Alder Reaction
All of the compounds prepared so far, have been obtained in racemic form. 
The preparation of potential pharmaceutical products in homochiral form, is of the 
utmost importance and hence an asymmetric synthesis was sought.
The introduction of chirality through an asymmetric Diels-Alder reaction 
was the obvious choice, this being possible at the outset of the synthesis. High levels 
of asymmetric induction have been achieved in the Diels-Alder reaction, through the 
use of various chiral auxiliaries" attached to the diene or dienophile, or the 
employment of chiral Lewis acid catalysts. 1 0 0
In this work, the use of an acrylate bearing Oppolzer’s bornane 10,2-sultam 
chiral auxiliary, 1 0 1  was chosen. Previous studies1 0 2  in this laboratory, had 
concentrated on chiral auxiliaries developed by Evans1 0 3  and Helmchen, 1 0 4  with 
only moderate success.
2.7.1 Preparation of the Chiral Acrylate
The chiral acrylate (214) was prepared from the commercially available 
sultam (213), according to Oppolzer’s procedure1 0 5  (Scheme 2.41). The low yield of 
the N-acryloyl derivative (214), was similar to that recently reported for this 
reaction, by Kim and Lee. 1 0 6  These workers noted that reverse addition of the anion 
of (213) to acryloyl chloride, reduced polymerisation, and improved the yield, 




Scheme 2.41 Reagents: (a) NaH, CH2 =CHC02 Me, PhMe, 20°C, 4 h.
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2.7.2 Lewis-Acid Catalysed Diels-Alder Reaction
High levels of asymmetric induction in Diels-Alder reactions using chiral 
auxiliaries, usually require the use of a Lewis acid catalyst. The role of the catalyst 
is two-fold: firstly, co-ordination to the dienophile lowers the energy of the 
dienophile LUMO, hence decreasing the energy separation between the diene 
HOMO and thereby facilitating the reaction. Secondly, this co-ordination to the 
dienophile restricts rotation such that, ideally, approach of the diene from one face 
of the double bond is favoured.
A number of different Lewis acids were tried, in the reaction between the 
chiral acrylate (214) and l-rm-butoxycarbonyl-l,2-dihydropyridine (132) (Scheme 
2.42, Table 2.3). These reactions were conveniently monitored by TLC analysis, 
both starting materials being well separated from each other and also the expected 
Diels-Alder adducts. The position of the latter on the TLC plate was known by 
comparison with an authentic sample, obtained from the thermal cycloaddition 
reaction (discussed in the following section).
Zinc iodide was found to be effective in catalysing the reaction, (entries 2 
and 3), although only a small amount of the Diels-Alder adduct was formed. 
Decomposition of the 1,2-dihydropyridine (DHP) was observed and thus, even 
though this reagent was used in a two-fold excess, it is exhausted before all of the 
chiral acrylate has reacted. The isolated yield of the adduct obtained in this way was 
only 11%, although examination of the *H NMR spectrum revealed only one 










Scheme 2.42 Reagents: (a) Lewis acid and solvent as detailed in Table 2.3, all 
reactions used 0.15 mmol of (214), 0.30 mmol (132) in 3 cm3  solvent at 20°C.
Entry Lewis Acid Solvent TLC Observation
1 Znl2  (l.Oequiv.) PhMe Some adduct formation, 
decomposition of DHP
2 Znl2  (l.Oequiv.) CH2 C12 Some adduct formation, 
decomposition of DHP
3 Znl2  (3.0 equiv.) c h 2 c i 2 Some adduct formation, 
decomposition of DHP
4 ZnBr2  (l.Oequiv.) c h 2 c i 2 Trace of adduct formation, 
decomposition of DHP
5 MgBr2  (l.Oequiv.) c h 2 c i 2 Trace of adduct formation, 
rapid decomposition of DHP
6 Ti(OiPr) 4  (l.Oequiv.) c h 2 c i 2 No reaction, DHP remains
7 TiCl(OiPr) 3  (l.Oequiv.) c h 2 c i 2 No reaction, DHP remains
8 None h 2o No reaction, DHP remains
9 aq. LiC104  (2.5M) h 2o No reaction, DHP remains
Table 2.3
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The data for this adduct were identical with that for a sample obtained via 
the thermal cycloaddition, the stereochemistry of which was later deduced (detailed 
in following section).
The zinc iodide catalysed reaction was not considered synthetically useful, 
in view o f the poor yield and other reactions, using different Lewis acids, were 
similarly disappointing. Two opposing effects were noticeable - using more reactive 
Lewis acids led to rapid decomposition of the dihydropyridine (entries 4 and 5), 
whereas milder Lewis acids did not promote cycloaddition at all. The latter case was 
exemplified by the use of titanium isopropoxides (entries 6  and 7), these Lewis acids 
being milder than titanium tetrachloride which has previously been shown to effect 
rapid decomposition of the dihydropyridine. 102
These reactions were not intended to be comprehensive and merely 
illustrate the problems involved in using a dihydropyridine (132) bearing a labile 
protecting group. A more suitable dihydropyridine would be 1-methoxycarbonyl- 
1,2-dihydropyridine (125), however, this would then necessitate further 
protection/deprotection steps later in our synthesis. Further reactions were 
considered outside the scope o f this project and, in view of time constraints, our 
attention was concentrated on the thermal Diels-Alder reaction.
2.7.3 Thermal Diels-Alder Reaction
In contrast to the Lewis acid catalysed reactions, the Diels-Alder reaction 
of the chiral acrylate (214) and the dihydropyridine (132), proceeded cleanly to 
afford the mixed exo and endo adducts in 85% yield (Scheme 2.43). The mixed 
adducts were purified by column chromatography, particular care being taken to 
ensure that all fractions containing the products were collected, before analysis of 
the product ratio by NMR.
The 8  0.90-1.25 region of the ^  NMR spectrum is of particular interest, 
since it contains only the resonances due to the two methyl groups of the chiral
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auxiliary. In the spectrum of the mixed adducts, this region contained at least eight 
singlets, suggesting that all four possible diastereomers (215) to (218) were present 
(Figure 2.13). Four major peaks are observed, implying two major products, but 






















Product ratio: (215): (216) = 1:1 
(217): (218) =1:1 
Endo : Exo = 10:1
Scheme 2.43 Reagents: (a) PhMe, reflux, 2.5 days.
Recrystallisation of the mixed adducts yielded a single diastereomer, which 
was obviously an endo adduct by comparison of the NMR data with previous 
compounds. The 5 0.90-1.25 region of the spectrum for this compound, contained 
only two singlets, corresponding to two of the four major peaks in the spectrum of 
the mixed adducts (Figure 2.13).
Somewhat fortuitously, upon concentration and recrystallisation of the 















1.2 1.1 1.0 
Figure 2.13
NMR spectrum for this compound contained one major singlet and a pair of smaller 
singlets (Figure 2.13). Repeated recystallisation did not alter the spectrum for this 
product. It was anticipated that the presence of the two smaller singlets, was due to 
the existence of two possible positions for the rerf-butoxycarbonyl group attached to 
the nitrogen. Similar effects were noted for earlier adducts without the chiral 
auxiliary. In order to test this assumption the spectrum was recorded at a higher 
temperature (60°C). Coalescence of the two smaller singlets was observed, resulting 
from the increased rate of exchange at this temperature.
On the basis of these findings, it can be seen that the thermal reaction gave 
rise to predominantly endo adducts. The two possible endo adducts were formed in 
approximately 1:1 ratio and the endo:exo ratio was tentatively assigned as 10:1. The 
lack of asymmetric induction under these reaction conditions is not unexpected.
When the reaction was repeated on a larger scale, reasonable quantities of 
both endo adducts could be obtained. The two products were separated by repeated 
column chromatography and reciystallised to obtain pure materials. The 
diastereomeric excess (d.e.) was estimated to be greater than 98% from 1H NMR 
measurements.
The problem of determining the absolute stereochemistry of each endo 
adduct remained and this was achieved by first removing the chiral auxiliary. 
Methanolysis of each adduct using potassium carbonate in methanol, afforded both 
enantiomers of the previously prepared compound (134) (Scheme 2.44).
The absolute configuration of each enantiomer was assigned by comparison 
of the specific rotations with literature values for a similar compound. Both 
enantiomers of the methoxycarbonyl derivative (219), were prepared by 
Marazano1 0 7  and show very similar rotations to our compounds (Table 2.4). On this 































Scheme 2.44 Reagents: (a) K2 C03, MeOH, 20°C, 2.5 h; (b) fl-BuLi, (TMS)2 NH, 
THF, -78 to 20°C, 1 h.




















(c = 1.02, CHC13)







Having achieved what amounts to a resolution of the adduct (134), both 
enantiomers were ring opened in the same way as the racemic compound, to afford
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the two enantiomers of the diene (135). The optical rotations of these compounds 
were also instructive and could be compared to another literature compound (2 2 0 ) 
prepared by Birch2 8  (Table 2.5). Compound (220) was an intermediate in an 
asymmetric synthesis of (-)-gabaculine and both these compounds are strongly 
levorotatory, thus supporting our assignment of (135).
Specific Rotation [a ] D 2 0
CO,Me 









+2 0 0 °
(c = 0.4, CHC13)
-195°
(c = 0.4, CHCI3 )
-249°
( c = 0.1,CHC13 ) 2 8
Table 2.5
Since the racemic form of the diene (135), had previously been converted 
to 5-homoshikimic acid, preparation of both enantiomers of this compound, (and our 
other targets), was now possible. The amount of homochiral diene (135) available 
and lack of time, precluded completion of the sequence.
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2.8 Summary
The total syntheses of (±)-5-homogabaculine (129) and (±)-5-homo- 
shikimic acid (174) have been described, from readily available 1,2-dihydro- 
pyridines. Improved syntheses of the latter have been developed, also leading to a 
range of analogues (177), (181), (182) and (196). In addition, the 5-fluoromethyl 
shikimate (201) and 5-difluoromethyl shikimate (203) have been prepared. 
Stereochemical and NMR features have been rationalised throughout.
The synthesis of (212), the carba analogue of 5-enolpyruvylshikimic acid 
has been detailed and a way by which the 3-hydroxyl group may be selectively 
phosphorylated is suggested.
A key intermediate in the synthesis of these compounds has been prepared 
in homochiral form.
(177) X = I
(181) X = NH2
(182) X = NH2 
(196) X = OH
(201) X = H 









3.1 Instrumentation and Experimental Techniques
3.1.1 Solvents and Reagents
All solvents were dried and distilled before use. Petrol refers to petroleum 
ether boiling in the range 60-80°C and light petrol refers to that boiling in the range 
40-60°C. Tetrahydrofuran was pre-dried over sodium wire and then refluxed over 
sodium benzophenone ketyl under a nitrogen atmosphere until anhydrous. This was 
redistilled immediately prior to use. Osmium tetroxide was used as a solution in 
tm-butanol prepared according to the procedure of Daniels and Fischer. 1 0 8  All other 
solvents and reagents were purified using the procedures described in Purification of  
Laboratory Chemicals.109
3.1.2 Chromatography
Thin layer chromatography (TLC) was used extensively as a qualitative 
guide during reactions and for assessing the purity of compounds. Merck 
DC-alufolien Kieselgel 60 F2 5 4  sheets containing fluorescent indicator were used for 
this purpose. Visualisation of compounds was acheived by illumination under short 
wavelength (254 nm) ultraviolet light (when possible). Plates were developed by 
treatment with either a 0.5% (w/v) aqueous solution of potassium permanganate 
(followed by washing in water) or a 7% (w/v) methanolic solution of 
phosphomolybdic acid, followed by warming of the TLC plate.
Medium pressure flash column chromatography was routinely employed 
using Amicon Matrex or Merck 9385 silica gel. Columns were packed as a slurry in 
the eluting solvent and the material to be chromatographed introduced directly as a
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solution in the eluting solvent or preabsorbed onto the column support and then 
applied as a thin layer to the top of the column. A pressure gradient was developed 
using a small hand bellow.
3.1.3 General
Glassware used for moisture sensitive reactions was heated in an oven at 
120°C overnight and then allowed to cool in a desiccator over CaCl2. Flasks and 
stirrer bars were additionally flame dried under a stream of dry nitrogen prior to use.
Solvents were evaporated with a Biichi rotary evaporator using a water 
aspirator or a vacuum pump as required and a water bath temperature <40°C to 
avoid unnecessary heating.
All dilute aqueous solutions used were 2.0 M unless otherwise stated.
3.1.4 Analysis and Spectroscopy
Melting points (m.p.) were determined on commercially available 
apparatus (Electrothemal Mk in or Gallenkamp) and are uncorrected. Elemental 
micro-analyses were carried out using a Carlo Erba 1106 Elemental Analyser. 
Optical rotations were measured using a Perkin-Elmer 141 polarimeter with 
concentration (c) expressed in g/100 cm3.
Infrared spectra were recorded in the range 4000-600 cm-1 using a 
Perkin-Elmer 1310 spectrophotometer and peaks are reported (vmax) in 
wavenumbers (cm-1). Samples were prepared as liquid films, nujol mulls or 
chloroform solutions, as indicated.
Proton magnetic resonance spectra were recorded on a Jeol GX FT 270 
(270 MHz) spectrometer although, where indicated, Jeol GX FT 400 (400 MHz) or 
Varian EM-360 (60 MHz) instruments were used. Carbon-13 magnetic resonance 
spectra were recorded on a Joel GX FT 270 spectrometer operating at 67.8 MHz and 
using 90 and 135 DEPT pulse sequences to aid multiplicity determination. Chemical
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shifts (5) are expressed in parts per million downfield from internal 
tetramethylsilane. The multiplicities of the resonances are denoted by s (singlet), d 
(doublet), t (triplet), q (quartet) and m (multiplet). The abbreviation br (broadened) 
is used to indicate significant broadening, whether due to rapid exchange or 
unresolved fine coupling. Homonuclear decoupling experiments and 2D 
homonuclear shift correlated (COSY) spectra were used to confirm proton 
assignments when required.
Mass spectra were recorded using a VG Analytical 7070E instrument with 
a VG 2000 data system. Electron ionisation (E.I.) spectra were produced using an 
ionising potential of 70 eV. Chemical ionisation (C.I.) was employed using 
isobutane as the reagent gas, although where indicated, ammonia was also used.
3.2 Experimental Procedure
1-(Methoxycarbonyl)-l ,2 -dihydropyridine (125)69
A solution of methyl chloroformate (4.6 cm3, 60 mmol) in diethyl ether (10 cm3) 
was added slowly to a stirred suspension of sodium borohydride (2.34 g) in pyridine 
(4.9 cm3, 60 mmol) and methanol (30 cm3) at -78°C under a nitrogen atmosphere. 
The rate of addition was controlled to maintain the temperature below -60°C. After 
2 hours the reaction mixture was poured into ice-water (ca. 400 cm3), allowed to 
warm to 20°C and extracted with ether (4 x 80 cm3). The combined extracts were 
dried (M gS04) and concentrated under reduced pressure. Chromatography on a 
short alumina column eluted with diethyl ether yielded the title compound as a 
colourless oil (5.39 g, 65%): Rp 0.78 (1:1 petrol-ethyl acetate); vmax(liquid film) 
1705 (C=0), 1650 (C=C), 1585, 1440, 1340, 1280, 1235, 1120, 970, 770, 700 cm’1; 
5h(60 MHz, CDC13) 3.75 (3H, s, OMe), 4.30 (2H, dd, /  2, 3 Hz, 2 x 2-H), 4.80-6.00 
(3H, m, 3-H, 4-H, 5-H), 6.70 (1H, m, 6-H).
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2,7-Di-(methoxycarbonyl)-2-azabicyclo[22.2]oct-5-ene (126)
A solution of the dihydropyridine (125) (2.90 g, 20.9 mmol) and methyl acrylate 
(3.76 cm3, 41.8 mmol) in toluene (10 cm3) was heated to reflux under a nitrogen 
atmosphere. After 3 days the solvent and excess methyl acrylate was evaporated 
under reduced pressure. Column chromatography (petrol-ethyl acetate 4:1 to 1:1) 
yielded the title compound, a mixture of exo and endo adducts, as a colourless oil 
(3.45 g, 73%): Rp 0.58 (1:1 petrol-ethyl acetate); vmax(liquid film) 1710 br (C=0), 
1440, 1390, 1345, 1305, 1280, 1195, 1115 cm'1; 5H(CDC13) 1.57 (1H, m, 8cxo-H), 
1.86 (2H, m, 2 x 8endo-H), 2.10 (1H, d, / gem 12.0 Hz, 8exo-H), 2.57 (1H, m, 7exo-H), 
2.82 (2H, m, 4cxo-H, 4 ^ - H ) ,  2.96 (2H, m, 3exo-H, 3.07 (1H, m, 7endo-H),
3.27 (1H, d, / gem 10.0 Hz, 3cndo-H), 3.38 (1H, dd, / gem 10.0, J3A 2.0 Hz, 3CX0-H), 
3.64 (3H, s, OMe), 3.66 (3H, s, OMe), 3.69 (3H, s, OMe), 3.70 (3H, s, OMe), 4.96 
(1H, m, l exo-H), 5.10 (1H, m, W H ) ,  6.34 (1H, m, 5endo-H), 6.46 (3H, m, 5exo-H, 
6exo-H, 6endo-H); m/z (E.I.) 225 (M+, 225.0994 Cn H15N 0 4 requires 225.1000, 2%), 
194(7), 139(100), 124(38).
Methyl 5-[N-( methoxycarbonyl)aminomethyl]cyclohexa-lj3-diene-l -carboxylate 
(127)
A solution of 1,1,1,3,3,3-hexamethyldisilazane (1.78 cm3, 8.44 mmol) in dry THF (8 
cm3) was cooled to -78°C under a nitrogen atmosphere and a solution of n-butyl 
lithium in hexanes (1.6 M, 8.44 mmol) was added slowly. After 30 min a solution of 
the adducts (126) (1.81 g, 8.04 mmol) in THF (20 cm3) was added dropwise via 
cannular. The reaction mixture was stirred for 20 min at this temperature, allowed to 
warm to 20°C and quenched with saturated aqueous ammonium chloride solution 
(20 cm3). The mixture was extracted with dichloromethane (3 x 50 cm3). The 
combined extracts were dried (M gS04) and concentrated under reduced pressure.
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Column chromatography (petrol-ethyl acetate 2:1) yielded the title compound as a 
colourless solid (1.46 g, 81%): m.p. 51-52°C (from petrol-ethyl acetate); Rp 0.55 
(1:1 petrol-ethyl acetate); (Found: C, 58.7; H, 6.8; N, 6.1. C11H 1 5N0 4  requires C, 
58.7; H, 6.7; N, 6.2%); v ^ n u jo l)  3320 (NH), 1690 (C=0), 1530, 1430, 1265, 
1250,1225,1180,1085 cm'1; 5H(CDC13) 2.37 (1H, ddd, / gem 14.8, J6^  8.4, / 6Pt2 1.3 
Hz, 6p-H), 2.59 (1H, ddd partially obscured by 5-H, Jgem 14.8, 6.4, J^a,2 1-3
Hz, 6a-H), 2.62 (1H, m, 5-H), 3.12 (1H, m, l'-H), 3.28 (1H, m, l'-H), 3.67 (3H, s, 
OMe), 3.76 (3H, s, OMe), 4.97 (1H, br s, NH), 6.03 (1H, dd, / 43 9.5, J4<5 3.0 Hz,
4-H), 6.13 (1H, ddd, / 3f4 9.5, JX1 5.0, / 3>5 1.5 Hz, 3-H), 6.99 (1H, dt, J%3 5.0, / 2>6a
1.3, / 2>6p 1.3 Hz, 2-H); 5c(CDC13) 24.7 (C-6), 34.2 (C-5), 43.7 (C-l'), 51.6 (OMe), 
52.1 (OMe), 124.8 (C-3), 126.5 (C-l), 132.6 (C-4), 134.6 (C-2), 157.1 (C=0), 167.6 
(C=0); m/z (C.I.) 226 (MH+, 33%), 194 (100), 166 (19), 137 (26).
5-[N-( methoxycarbonyl)aminomethyl]cyclohexa-lj3-diene-l-carboxylic acid (128)
A solution o f the ester carbamate (127) (250 mg, 1.11 mmol) in THF (50 cm3) was 
treated with aqueous sodium hydroxide solution (1.0 M, 3.33 cm3). Water (11 cm3) 
was added to give a homogeneous solution which was stirred at 20°C for 16 h. The 
solution was acidified with 1.0 M hydrochloric acid and extracted with ethyl acetate 
(3 x 50 cm3). The combined extracts were dried (MgS04) and concentrated under 
reduced pressure to yield the title compound as a colourless powder (153 mg, 65%): 
m.p. 139-140°C (from chloroform); (Found: C, 57,2; H, 6.2; N, 6.6. C10H13NO4 
requires C, 56.9; H, 6.2; N, 6.6%); vmax(nujol) 3320 (NH), 1680 br (C=0), 1620 
(C=C), 1530, 1440, 1370, 1280, 1230 c m 1; 5H(D6-DMSO) 2.12 (1H, m, 6p-H), 2.46 
(2H, m, 5-H, 6<x-H), 3.01 (2H, m, 2 x l'-H), 3.53 (3H, s, OMe), 6.03 (1H, dd, / 43
9.3, / 4f5 2.4 Hz, 4-H), 6.12 (1H, dd, / 3>4 9.3, / 3>2 4.8 Hz, 3-H), 6.88 (1H, d, / 2>3 4.8 
Hz, 2-H), 7.30 (1H, br t, J  5.7 Hz, NH), 12.28 (1H, br s, C 02H); 8c (D6-DMSO) 24.7 
(C-6), 34.2 (C-5), 43.3 (C-l'), 51.4 (OMe), 124.4 (C-3), 127.4 (C-l), 131.9 (C-4),
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135.3 (C-2), 157.0 (C=0), 168.1 (C=0); m/z (C l.) 212 (MH+, 6%), 194 (100), 180 
(19), 166 (49), 162 (61), 137 (22), 123 (58).
5-(Aminomethyl)cyclohexa-ly3-diene-l-carboxylic acid (129)
A solution of the ester carbamate (127) (400 mg, 1.78 mmol) in THF (75 cm3) was 
treated with aqueous sodium hydroxide solution (1.0 M, 3.55 cm3) and water (17 
cm3). The reaction mixture was heated to reflux under a nitrogen atmosphere for 3 
days, acidified with dilute aqueous hydrochloric acid and extracted with ethyl 
acetate (3 x 50 cm3). The combined organic extracts were dried (M gS04) and 
concentrated under reduced pressure to yield the previously prepared acid (128) (210 
mg, 56%). The aqueous phase was lyophilised to leave a white solid which was 
added to the top o f a column of ion-exchange resin (Dowex 50/8-100, previously 
regenerated with dilute aqueous hydrochloric acid and packed as an aqueous slurry). 
The column was eluted with water to remove impurities and the product removed 
from the column by elution with dilute aqueous ammonia solution. Evaporation 
under reduced pressure and lyophilisation yielded the title compound as a 
cream-coloured solid (101 mg, 37%): Rp 0.70 (reverse phase silica, water); 8H(D20 )
2.34 (1H, ddd, / gem 17.5, J6p,5 8.5, Jm  1.0 Hz, 6p-H), 2.56 (1H, ddd, / gem 17.5, 
h o^ 5 8.5, J6<Xt2 2.0 Hz, 6a-H), 2.71 (1H, m, 5-H), 2.93 (1H, dd, Jgem 12.8, Jx\ 5 7.0 
Hz, l'-H), 3.01 (1H, dd, 7gem 12.8, 6.6 Hz, l'-H), 5.95 (1H, dd, / 4t3 9.5, J4t5 4.4
Hz, 4-H), 6.23 (1H, ddd, J3A 9.5, JX2 5.5, / 3,5 1.5 Hz, 3-H), 6.69 (1H, br d, J2%3 5.5 
Hz, 2-H); 8c (D20 )  25.3 (C-6), 31.2 (C-5), 41.4 (C-l'), 126.0 (C-3), 128.1 (C-4),




Phenylchloroformate (18.75 cm3, 150 mmol) was added dropwise to a stirred 
suspension o f sodium borohydride (6.24 g) in pyridine (12.13 cm3, 150 mmol) and 
methanol (120 cm3) at -78°C. The rate of addition was controlled so as to maintain 
the temperature below -60°C. After 2 hours the reaction mixture was poured into 
ice-water (ca. 400 cm3), allowed to warm to 20°C and extracted with ether (300, 2 x 
200 cm3). The combined extracts were dried (MgS04) and concentrated under 
reduced pressure. Recrystallisation from ethanol yielded the title compound as 
colourless needles (17.9 g, 59%): m.p. 65-66°C (from ethanol) (lit.73 65-67°C); Rp 
0.60 (petrol-ethyl acetate 4:1); (Found: C, 71.9; H, 5.5; N, 6.9. Calc, for C^H^NC^ 
C, 71.6; H, 5.5; N, 7.0%); vmax(nujol) 1705 (C=0), 1380, 1355, 1325, 1200, 1065, 
740, 700 cm'1; m/z (E.I.) 201 (M+, 46%), 200 (49), 156 (12), 124 (27), 108 (22), 94 
(7), 80 (100).
1 -(t-Butoxycarbonyl)-l2 -dihydropyridine (132)73
Potassium rm-butoxide (11.3 g, 101 mmol) in THF (170 cm3) was added dropwise 
to a stirred solution of the dihydropyridine (131) (18.4 g, 91.5 mmol) in THF (200 
cm3) at 20°C under a nitrogen atmosphere. After 1 h the reaction mixture was 
poured into water (500 cm3) and extracted with diethyl ether (3 x 300 cm3). The 
combined extracts were washed with aqueous sodium hydroxide solution (0.5 M, 2 x 
200 cm3), dried (M gS04) and concentrated under reduced pressure to yield the title 
compound as a yellow oil (15.0 g, 90%). TLC indicated the title compound Rp 0.70 
(petrol-ethyl acetate 4:1) plus a minor amount of the 1,4-isomer Rp 0.75. The 
product was used immediately as it tended to decompose on standing: 8H(60 MHz, 
CDC13) 1.49 (9H, s, CMe3), 4.32 (2H, dd, /  4, 2 Hz, 2 x 2-H), 5.10-5.85 (3H, m, 
3-H, 4-H, 5-H), 6.63 (1H, br d, /  7 Hz, 6-H); m/z (E.I) 181 (M+, 42%), 125 (100).
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2-(t-Butoxycarbonyl)-7-(methoxycarbonyl)-2-azabicyclo[2.22]oct-5-ene (133/134)
A solution of the dihydropyridine (132) (15.0 g, 82.8 mmol) and methyl acrylate 
(14.9 cm3, 165 mmol) in toluene (40 cm3) was heated to reflux under a nitrogen 
atmosphere. After 2 days the solvent and excess methyl acrylate was evaporated 
under reduced pressure to leave an oil-solid mixture. Repeated recrystallisation from 
toluene yielded the endo isomer (133) as a colourless crystalline solid (6.58 g, 30%). 
Column chromatography (petrol-ethyl acetate 9:1) of the remaining material yielded 
the exo isomer (134) as a colourless oil (6.52 g, 29%).
endo isomer (133): m.p. 113-114°C (from toluene); Rp 0.50 (petrol-ethyl acetate 
4:1); (Found: C, 63.0; H, 8.0; N, 5.3. C14H21N 0 4 requires C, 62.9; H, 7.9; N, 5.2%); 
vmax(CHCl3) 1725 (C=0), 1665 (C=C), 1395, 1370, 1350, 1300, 1280, 1160, 1115 
cm-1; 6h(CDC13) 1.46 (9H, s, CMe3), 1.85 (2H, m, 2 x 8-H), 2.80 (1H, m, 4-H), 2.90 
(1H, d, 7gem 10.3 Hz, 3-H), 3.06 (1H, m, 7-H), 3.22 (1H, dd, Jgem 10.3, / 3>4 2.2 Hz, 
3-H), 3.65 (3H, s, OMe), 5.06 (1H, br s, 1-H), 6.34 (1H, m, 5-H), 6.43 (1H, m, 6-H); 
m/z (CL, NH3) 285 (MNH4+, 2%), 268 (MH+, 3), 229 (26), 212 (30), 168 (51), 81 
(100).
exo isomer (134): Rp 0.50 (petrol-ethyl acetate 4:1); vmax(CHCl3 ) 1725 (C=0), 1665 
(C=C), 1390,1345, 1305, 1160,1115 c m 1; 8H(CDC13) 1.43 (9H, 2 x s, CMe3), 1.50 
(1H, m, 8-H), 2.10 (1H, m, 8-H), 2.54 (1H, m, 7-H), 2.77 (1H, m, 4-H), 2.93 (1H, m, 
3-H), 3.34 (1H, m, 3-H), 3.70 (3H, 2 x s, OMe), 4.94 (1H, m, 1-H), 6.44 (2H, m, 
5-H, 6-H); m/z (C.I.) 268 (MH+, 4%), 252 (4), 212 (100), 181 (24).
Methyl 5-[N-(t-butoxycarbonyl)aminomcthyl]cyclohexa-lr$-diene-1-carboxylate 
(135)
A solution of 1,1,1,3,3,3-hexamethyldisilazane (7.30 cm3, 34.6 mmol) in dry THF 
(35 cm3) at -78°C was treated with a solution of n-butyl lithium in hexanes (1.6 M,
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34.6 mmol) under a nitrogen atmosphere. After 20 min a solution of the adducts 
(133 + 134) (8.40 g, 31.5 mmol) in THF (90 cm3) was added dropwise via cannular. 
The reaction mixture was stirred for 10 min at this temperature, allowed to warm to 
20°C and quenched with saturated aqueous ammonium chloride solution (100 cm3). 
The mixture was extracted with dichloromethane (600, 2 x 200 cm3). The combined 
extracts were dried (MgS04) and concentrated under reduced pressure. Column 
chromatography (petrol-ethyl acetate 4:1) yielded the title compound as a colourless 
solid (7.00 g, 83%): m.p. 69-70°C (from petrol-ethyl acetate); RF 0.30 (petrol-ethyl 
acetate 4:1); (Found: C, 62.8; H, 8.0; N, 5.1. C14H21N 0 4 requires C, 62.9; H, 7.9; N, 
5.2%); vmax(CHCl3) 3450 (NH), 1695 (C=0), 1640 (C=C), 1420, 1360, 1230, 1150, 
1080 cm’1; 5H(CDC13) 1.44 (9H, s, CMe3), 2.34 (1H, ddd, / gem 19.5, / 6p>5 13.5, / 6Pf2
1.5 Hz, 6p-H), 2.58 (1H, ddd partially obscured by 5-H, / gem 19.5, 8.5, 1*5
Hz, 6<x-H), 2.60 (1H, m, 5-H), 3.06 (1H, m, l'-H), 3.23 (1H, m, l'-H), 3.76 (3H, s, 
OMe), 4.72 (1H, br s , N-H), 6.03 (1H, dd, / 4>3 9.5, / 4>5 3.0 Hz, 4-H), 6.12 (1H, ddd, 
h,A 9-5, / 3>2 5.0, / 3,5 1.5 Hz, 3-H), 6.99 (1H, dt, 5.0, J2>6a 1.5, / 2>6p 1.5 Hz, 2-H); 
8c (CDC13) 14.1 (CMe3\  24.7 (C-6), 28.3 (CMe3), 34.3 (C-5), 43.2 (C-l'), 51.6 
(OMe), 124.6 (C-3), 126.5 (C-l), 132.6 (C-4), 134.8 (C-2), 155.9 (C=0), 167.5 
(C=0); m/z (C.I) 268 (MH+, 2%), 233 (3), 212 (41), 180 (18), 168 (100), 137 (70).
Methyl 5-(aminomethyl)cyclohexa-lJ-diene-l-carboxylate (136)
The BOC protected amine (135) (28.8 g, 0.11 mol) was added portion-wise to 
trifluoroacetic acid (100 cm3). After stirring for 5 mins, excess TFA was evaporated 
under reduced pressure to leave a yellow oil. Sodium hydroxide (1.0 M, ca. 400 
cm3) was added cautiously until the solution was alkaline to litmus. The solution 
was extracted with ethyl acetate (2 x 500 cm3), dried (M gS04) and evaporated to 
give the title compound as a yellow oil (15.7 g, 85%): Rp 0.80 (dichloromethane - 
methanol - aqueous ammonia 20:8:1); vmax(liquid film) 1700 (C=0), 1630 (C=C),
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1565, 1430, 1265, 1200, 1090, 715 c m 1; 5H(CDC13) 2.35 (1H, m, 6p-H), 2.51 (1H, 
m, 5-H), 2.60 (1H, m, 6<x-H), 2.77 (2H, m, 2 x l'-H), 3.73 (3H, s, OMe), 4.29 (2H, 
br s, NH2), 6.02 (1H, dd, / 4>3 9.5, J4t5 3.0 Hz, 4-H), 6.11 (1H, dd, / 3>4 9.5, JX1 5.3 
Hz, 3-H), 6.96 (1H, d, / 2t3 5.3 Hz, 2-H); 5c (CDC13) 24.8 (C-6), 37.1 (C-5), 45.1 
(C-l'), 51.6 (OMe), 124.3 (C-3), 126.1 (C-l), 132.8 (C-4), 135.8 (C-2), 167.8 
(C=0); m/z (C.I) 168 (MH+,100%), 151 (22), 137 (38), 105 (12), 91 (20).
Methyl 5-[N-(p-nitrobenzenesulphonyl)aminomethyl]cyclohexa-l y3-diene-l- 
carboxylate (139)
A solution of the amine (136) (15.7 g, 93.9 mmol) in dry THF (250 cm3) was treated 
with p-nitrobenzenesulphonyl chloride (22.9 g, 0.103 mol) and triethylamine (14.4 
cm3, 0.103 mol). After stirring for 40 h at 20°C the reaction mixture was poured into 
water (500 cm3) and extracted with ethyl acetate (3 x 500 cm3). The combined 
extracts were dried (MgS04) and evaporated under reduced pressure to give a dark 
brown oil. Column chromatography (petrol-ethyl acetate 4:1 to 1:1) yielded the title 
compound as a pale yellow solid (20.7 g, 63%): m.p. 130-132°C (from petrol-ethyl 
acetate); Rp 0.30 (petrol-ethyl acetate 7:3); (Found: C, 51.1; H, 4.6; N, 7.9. 
Ci5H16N20 6S requires C, 51.1; H, 4.6; N, 7.95%); vmax(CHCl3) 1695 (C=0), 1350 
(SOJ, 1300,1260,1160 (S02), 1085 cm*1; 5H(D6-acetone) 2.31 (1H, ddd,/gem 16.9, 
/ 6pt5 10.9, / 6p>2 1.7 Hz, 6p-H), 2.53 (1H, ddd, / gem 16.9, / 6o,5 8.4, JM  1.5 Hz, 
6<x-H), 2.62 (1H, m, 5-H), 3.03 (2H, m, l'-H), 3.70 (3H, s, OMe), 6.06 (1H, ddd, / 4f3
9.5, / 4>5 3.5, / 4f2 1.5 Hz, 4-H), 6.12 (1H, ddd, J3A 9.5, / 3>2 5.1, J3t5 1.5 Hz, 3-H), 6.93 
(1H, m, 2-H), 7.01 (1H, br t, J 6.2 Hz, N-H), 8.12 (2H, d, J  9.0 Hz, Ar-H), 8.42 (2H, 
d, J  9.0 Hz, Ar-H); 5c (CDC13) 24.5 (C-6), 33.8 (C-5), 45.6 (C-l'), 51.8 (OMe),
124.4 and 128.2 (aromatic CH), 125.4 (C-3), 126.2 (C-l), 132.5 (C-4), 133.1 (C-2),
145.8 and 150.0 (aromatic C), 167.5 (C=0); m/z (C.I) 353 (MH+,9%), 321 (100), 




Sodium hydride (0.28 g, 11.6 mmol) was added slowly to a stirred solution of the 
sulphonamide (139) (3.15 g, 8.94 mmol) in dry DMF (50 cm3) over 7 min. The 
resultant black solution was stirred at 20°C for 1 h and then p-nitrobenzene- 
sulphonyl chloride (2.57 g, 11.6 mmol) added. After 1.5 h water (200 cm3) was 
added and the mixture extracted with ethyl acetate (3 x 200 cm3). The combined 
extracts were washed with brine (100 cm3), dried (M gS04) and evaporated under 
reduced pressure to leave a dark brown oil. Column chromatography petrol-ethyl 
acetate 4:1 to 1:1) yielded the title compound as a pale yellow solid (3.37 g, 70%): 
m.p. 178-179°C (from petrol-ethyl acetate); Rp 0.50 (petrol-ethyl acetate 7:3); 
(Found: C, 46.9; H, 3.4; N, 7.6. C2 iH19N3 O10S2  requires C, 46.9; H, 3.6; N, 7.8%); 
vmax(CHCl3) 1700 (C=0), 1350 (S 0 2), 1310, 1270, 1170 (SO2 ), 1085 cm'1; 
5h(CDC13) 2.39 (2H, m, 6-H), 2.92 (1H, m, 5-H), 3.73 (2H, m partially obscured by 
OMe, 2 x l'-H), 3.75 (3H, s, OMe), 5.88 (1H, dd, / 43 9.3, / 4>5 4.4 Hz, 4-H), 6.16 
(1H, ddd, / 3>4 9.3, J3t2 5.2, / 33 1.6 Hz, 3-H), 7.01 (1H, d, J%3 5.2 Hz, 2-H), 8.28 (4H, 
d, J  9.0 Hz, Ar-H), 8.45 (4H, d, /  9.0 Hz, Ar-H); 8c (CDC13) 24.3 (C-6), 32.7 (C-5),
51.0 (C-l'), 51.8 (OMe), 124.4 and 129.9 (aromatic CH), 126.0 (C-3), 126.6 (C-l),
131.4 (C-4), 132.1 (C-2), 144.5 and 150.9 (aromatic C), 166.7 (C=0); m/z (C.I., 
NH3) 555 (MNH4+, 100%), 538 (MH+, 18), 523 (15), 493 (31).
Reaction of diene disulphonimide (140) with potassium iodide
The diene disulphonimide (140) (195 mg, 0.36 mmol) and potassium iodide (132 
mg, 0.80 mmol) were suspended in DMF (2 cm3) and heated at 110°C under a 
nitrogen atmosphere for 16 h. TLC on silica gel indicated one major product plus a 
trace of unreacted starting material. The reaction mixture was diluted with water (35
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cm3) and extracted with ether (3 x 30 cm3). The combined extracts were dried 
(MgS04) and evaporated to leave a brown oil. Column chromatography (petrol-ethyl 
acetate 9:1 to 17:3) gave recovered starting material (3.5 mg, 2%) and methyl 
3-methylbenzoate (142) (35 mg, 64%) as a colourless oil: 5H(60 MHz, CDCI3 ) 2.50 
(3H, s, Me), 3.98 (3H, s, OMe), 7.20-8.00 (4H, m, Ar-H); m/z (C.I.) 151 (MH+, 
100%), 119 (54), 91 (34).
Osmium tetroxide catalysed cw-hydroxylation of diene disulphonimide (140)
N-methylmorpholine N-oxide, (0.62 g, 5.29 mmol) in acetone (10 cm3) and water (25 
cm3) was treated with a 0.5% (w/v) solution of osmium tetoxide in rm-butanol (11.1 
cm3, 0.05 equiv). The diene disulphonimide (140) (2.37 g, 4.41 mmol) in THF (50 
cm3) was added slowly and the reaction mixture stirred at 20°C for 24 h. TLC 
(petrol-ethyl acetate 1 :1 ) indicated three close running products and baseline 
material. THF and acetone were evaporated under reduced pressure and the reaction 
mixture diluted with water (400 cm3), acidified with 2M hydrochloric acid and 
carefully extracted with ethyl acetate (1000 cm3, 2 x 500 cm3). The combined 
extracts were dried (M gS04) and preabsorbed onto silica gel. Column 
chromatography (petrol-ethyl acetate 54:46) yielded:
Methyl 1 2 -dihydroxy-5$-[NfJ-di(p-nitrobenzenesulphonyl)aminomethyl]cyclohex-
3-ene-l-carboxylate (145) (0.25 g, 10%): m.p. 217-218°C (from ethyl acetate); RF 
0.32 (petrol-ethyl acetate 1:1); (Found: C, 44.0; H, 3.7; N, 7.2. C2 iH2 iN3 0 12 S2  
requires C, 44.1; H, 3.7; N, 7.35%); vmax(nujol) 1735 (C=0), 1540, 1360 (S02), 
1310, 1170 (S 0 2), 800 c m 1; 5H(D6 -DMSO) 1.52-1.72 (2H, m, 2 x 6 -H), 2.84 (1H, 
m, 5-H), 3.65 (3H, s, OMe), 3.74 (1H, m, l'-H), 4.00 (1H, m, l'-H), 4.30 (1H, m,
2-H), 4.91 (1H, s, 1-OH), 5.03 (1H, d, / 2>o h  7.9 Hz, 2-OH), 5.51 (2H, m, 3-H, 4-H), 
8.21 (4H, d, J  9.2 Hz, Ar-H), 8.47 (4H, d, J  9.2 Hz, Ar-H); 5 c (D6 -E>MSO) 3 2 . 4  
(C-5), 34.9 (C-6), 52.1 (OMe), 53.8 (C-l'), 69.1 (C-2), 74.8 (C-l), 124.9 and 129.8
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(aromatic CH), 126.8 (C-4), 130.9 (C-3), 143.5 and 150.9 (aromatic C), 175.2 
(C=0); m/z (C.I) 554 (MH+-H20 , 4%), 536 (MH+-2H20 , 46%), 504 (100), 402 (52), 
349 (60), 319 (70).
Methyl 3$,4$-dihydroxy-5$-[N,N-di(p-nitrobenzenesulphonyl)aminomethyl]cyclo- 
hex-1-ene-l-carboxylate (144) (0.20 g, 8%): m.p. 212-213°C (from ethyl acetate); 
Rp 0.25 (petrol-ethyl acetate 1:1); (Found: C, 43.7; H, 3.7; N, 7.2. C21H21N30 12S2 
requires C, 44.1; H, 3.7; N, 7.35%); vmax(nujol) 3420 (OH), 1685 (C=0), 1350 
(S02), 1310, 1175 (SOi), 1145, 1090, 860, 810, 750 cm'1; 5H(D6-DMSO) 1.90 (2H, 
m, 6-H), 2.23 (1H, m, 5-H), 3.63 (3H, s, OMe), 3.65 (1H, m partially obscured by 
OMe, 4-H), 3.98 (2H, m, l'-H), 4.16 (1H, m, 3-H), 4.73 (1H, d, / 4?0h  3.3 Hz, 4-OH), 
5.17 (1H, d, / 3f0H 6.4 Hz, 3-OH), 6.53 (1H, s, 2-H), 8.26 (4H, d, /  8.9 Hz, Ar-H),
8.49 (4H, d, J  8.9 Hz, Ar-H); 5c(D6-DMSO) 23.4 (C-6), 37.1 (C-5), 51.6 (OMe),
52.1 (C-l'), 66.3 (C-4), 68.5 (C-3), 124.9 and 129.8 (aromatic CH), 128.4 (C-l),
140.7 (C-2), 143.5 and 150.9 (aromatic C), 166.2 (C=0); m/z (C.I) 536 (MH+-2H20 ,  
11%), 504 (22), 388 (100).
Methyl 3a,4a-dihydroxy-5$-[Nfl-di(p-nitrobenzenesulphonyl)aminomethyl]cyclo- 
hex-1-ene-l-carboxylate (143) (0.40g, 16%): m.p. 198-199°C (from petrol-ethyl 
acetate); Rp 0.21 (petrol-ethyl acetate 1:1); (Found: C, 44.0; H, 3.7; N, 7.3. 
C2iH2iN3Oi2S2 requires C, 44.1; H, 3.7; N, 7.35%); vmax(nujol) 3480 (OH), 3360 
(OH), 1715 (C=0), 1520, 1350 (SOj), 1245, 1165 (SOj), 795, 740 cm'1; 
5h(D6-DMSO) 1.88 (1H, dd, Jgem 17.8, / 6M 9.0 Hz, 6p-H), 2.18 (1H, dd, / gem 17.8, 
J6aLt5 4.8 Hz, 6<x-H), 2.37 (1H, m, 5-H), 3.43 (1H, m, 4-H), 3.62 (3H, s, OMe), 3.85 
(1H, m, l'-H), 4.10 (1H, m, 3-H), 4.14 (1H, m, l'-H), 4.69 (1H, d, / 4t0H 6.8 Hz,
4-OH), 5.11 (1H, d, / 3>oh 6.2 Hz, 3-OH), 6.70 (1H, m, 2-H), 8.23 (4H, d, J  9.0 Hz, 
Ar-H), 8.48 (4H, d, J  9.0 Hz, Ar-H); 8c (D6-DMSO) 26.8 (C-6), 34.6 (C-5), 51.7 
(OMe), 52.5 (C-l'), 64.7 (C-4), 70.2 (C-3), 124.9 and 129.8 (aromatic CH), 129.4 
(C-l), 138.4 (C-2), 143.5 and 150.9 (aromatic C), 166.5 (C=0); m/z (C.I) 536 
(MH+-2H20 , 6%), 504 (12), 388 (100).
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‘Wet’ Prevost reaction upon diene disulphonimide (140)
A mixture of silver acetate (0.31 g, 1.86 mmol) and iodine (0.24 g, 0.93 mmol) in 
glacial acetic acid (20 cm3) was stirred at 20°C until all the iodine was consumed. 
The diene disulphonimide (140) (0.50 g, 0.93 mmol) was added and the reaction 
mixture heated to reflux under a nitrogen atmosphere for 2 h. Water (0.2 cm3) was 
added and heating continued for a further 2 h. The reaction mixture was allowed to 
cool, filtered and concentrated under reduced pressure (azeotroping with toluene). 
TLC indicated four products which were separated by column chromatography 
(petrol-ethyl acetate 7:3 then 1:1) to yield:
Methyl 3a,4oi~diacetoxy-5^-[NJ^-di(p-nitrobenzenesulphonyl)aminomethyl]cyclo- 
hex-1-ene-l-carboxylate (153) and methyl 3$,4a-diacetoxy-5$-[N,N-di(p-nitro- 
benzenesulphonyl)aminomethyl]cyclohex-l -ene-l-carboxylate (154) as an 
inseparable mixture, pale yellow solid (124 mg, 20%): Rp 0.78 (petrol - ethyl acetate 
1:1).
Diacetate (153): 5H(CDC13) 1.99 (3H, s, Me), 2.10 (1H, m, 6|3-H), 2.12 (3H, s, Me),
2.53 (1H, dd, 7gem 18.4, JM  5.4 Hz, 6a-H), 2.73 (1H, m, 5-H), 3.75 (3H, s, OMe),
3.76 (1H, dd, / gem 15.0, 8.2 Hz, l'-H), 3.89 (1H, dd, / gem 15.0, 6.0 Hz,
l'-H), 4.97 (1H, dd, / 4>5 10.1, / 43 4.0 Hz, 4-H), 5.67 (1H, dd, / 3>2 5.0, J3A 4.0 Hz,
3-H), 6.74 (1H, d m, 5.0 Hz, 2-H), 8.32 (4H, d, /  9.0 Hz, Ar-H), 8.45 (4H, d, /
9.0 Hz, Ar-H);
Diacetate (154): 8H(CDC13) 2.05 (3H, s, Me), 2.06 (3H, s, Me), 2.10-2.60 (3H, m,
5-H, 2 x 6-H), 3.73 (3H, s, OMe), 3.70-3.83 (2H, m, 2 x l'-H), 5.04 (1H, dd, J4t5
10.2, / 43 7.1 Hz, 4-H), 5.56 (1H, d m, / 3 4 7.1 Hz, 3-H), 6.62 (1H, t, / 2,3 2.0, / 2>6 2.0 
Hz, 2-H), 8.30 (4H, d, J 9.0 Hz, Ar-H), 8.45 (4H, d, J  9.0 Hz, Ar-H).
Methyl 3$-acetoxy-4$-hydroxy-5$-[NJV-di(p-nitrobenzenesulphonyl)aminomethyl]- 
cyclohex-1-ene-l-carboxylate (157) as a pale yellow solid (19 mg, 3%): Rp 0.59 
(petrol-ethyl acetate 1:1); 8H(D6DMSO) 2.00 (2H, m, 2 x 6-H), 2.06 (3H, s, Me),
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2.35 (1H, m, 5-H), 3.65 (3H, s, OMe), 3.81 (1H, m, 4-H), 3.90 (1H, dd, / gem 15.0,
7.5 Hz, l'-H), 4.09 (1H, dd, / gem 15.0, 6 . 8  Hz, l'-H), 5.24 (2H, br s, 4-OH,
3-H), 6.45 (1H, br s, 2-H), 8.29 (4H, d, J  9.0 Hz, Ar-H), 8.49 (4H, d, J  9.0 Hz, 
Ar-H).
Methyl 3a-acetoxy-4a.-hydroxy-5$-[Nfl-di(p-nitrobenzenesulphonyl)aminomethyl]- 
cyclohex-1-ene-l-carboxylate (155) and methyl 4a-acetoxy-3a-hydroxy-5(3-[NJV- 
di(p-nitrobenzenesulphonyl)aminomethyl]cyclohex-l-ene-l-carboxylate (156) as an 
inseparable mixture, pale yellow solid (294 mg, 52%): Rp 0.51 (petrol-ethyl acetate 
1:1); m/z (E.I.) 613 (M+, 3%), 571 (2), 553 (3), 367 (4), 317 (12), 186 (32), 153 (45), 
122 (35), 43 (100).
Hydroxy acetate (155): 6H(CDC13) 1.95-2.21 (1H, m, 6 p-H), 2.16 (3H, s, Me),
2.40-2.59 (2H, m, 5-H, 6 a-H), 3.70-3.92 (2H, m, 2 x l'-H), 3.73 (3H, s, OMe), 4.18 
(1H, dd, J4t5  11.0, J4t3  4.4 Hz, 4-H), 5.45 (1H, dd, JX2 4.6, JX4 4.4 Hz, 3-H), 6.79 
(1H, dd, J%3 4.6, / 2 ,6 p 1*6 Hz, 2-H), 8.33 (4H, d, J  9.2 Hz, Ar-H), 8.45 (4H, d, J  9.2 
Hz, Ar-H).
Hydroxy acetate (156): 5H(CDC13) 1.95-2.21 (1H, m, 6 p-H), 2.02 (3H, s, Me),
2.40-2.59 (1H, m, 6 a-H), 2.82 (1H, m, 5-H), 3.70-3.92 (2H, m, 2 x l'-H), 3.74 (3H, 
s, OMe), 4.53 (1H, dd, / 3 t2  4.5, JX4 4.0 Hz, 3-H), 4.87 (1H, dd, J4 5 10.0, / 4 3  4.0 Hz,
4-H), 6.84 (1H, d m, 4.5 Hz, 2-H), 8.32 (4H, d, J  9.2 Hz, Ar-H), 8.44 (4H, d, J
9.2 Hz, Ar-H).
3oL,4oL-dihydroxy-5$-[NJV-di(p-nitrobenzenesulphonyl)aminomethyl]cycloh£X-l- 
ene-l-carboxylate (143) as a pale yellow solid (15 mg, 3%): Rp 0.21 (petrol-ethyl 
acetate 1 :1 ), identical with the sample prepared via the osmium tetroxide route.
Methyl 3 a,4a-dihydroxy-5$-[N,N-di(p-nitrobenzenesulphonyl)aminomethyl]- 
cyclohex-1 -ene-1 -carboxylate (143)
A solution of the mixed hydroxy-acetates (155 + 156) (3.00 g, 4.89 mmol) in
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methanol (140 cm3) was treated with dilute aqueous ammonia solution and stirred at 
20°C under a nitrogen atmosphere for 23 h. Methanol was evaporated under reduced 
pressure and the resultant slurry was lyophilised to leave a pale yellow solid. 
Recrystallisation from ethyl acetate yielded the title compound as a cream coloured 
solid (1.94 g, 69%), identical with the sample prepared via the osmium tetroxide 
route.
General procedure for acetylation of the diols
A solution of the diol in pyridine (4 cm3) was treated with acetic anhydride (0.5 
cm3), DMAP (catalytic) and stirred at 20°C for 24 h. The reaction mixture was 
poured into chloroform (30 cm3) and washed with dilute aqueous hydrochloric acid 
(4 x 25 cm3) and water (25 cm3). The organic phase was dried (MgS04) and 
concentrated under reduced pressure (azeotroping with toluene). Column 
chromatography (petrol-ethyl acetate 7:3) yielded the diacetate.
Methyl 3a,4a-diacetoxy-5$-[N,N-di(p-nitrobenzenesulphonyl)aminomethyl]- 
cyclo-hex-1 -ene-1 -carboxylate (153)
Acetylation of the diol (143) (64.5 mg, 0.11 mmol) using the general procedure 
described above gave the title compound as a pale yellow solid (60 mg, 81%): m.p. 
214-215°C (dec.) (from petrol-ethyl acetate); Rp 0.78 (petrol-ethyl acetate 1:1); 
(Found C, 45.8; H, 3.8; N, 6.3. C25H25N3014S2 requires C, 45.8; H, 3.8; N, 6.4%); 
Vax(nujol) 1730 (C=0), 1705 (C=0), 1525, 1375 (S 02), 1340, 1255, 1240, 1170 
(S 02), 730 cm'1; 5H(CDC13) 1.99 (3H, s, Me), 2.10 (1H, m, 6(3-H), 2.12 (3H, s, Me),
2.53 (1H, dd, Jgem 18.4, 5.4 Hz, 6<x-H), 2.73 (1H, m, 5-H), 3.75 (3H, s, OMe),
3.76 (1H, dd, / gem 15.0, Jx\ 5 8.2 Hz, l'-H), 3.89 (1H, dd, / gem 15.0, JY\ S 6.0 Hz, 
l'-H), 4.97 (1H, dd, / 4>5 10.1, / 4 3 4.0 Hz, 4-H), 5.67 (1H, dd, / 2i3 5.0, J3A 4.0 Hz,
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3-H), 6.74 (1H, d m, Jx 3  5.0 Hz, 2-H), 8.32 (4H, d, /  9.0 Hz, Ar-H), 8.45 (4H, d, /
9.0 Hz, Ar-H); 5c(CDC13) 20.8 (2 x Me), 27.6 (C-6 ), 33.1 (C-5), 51.1 (C-l'), 52.3 
(OMe), 64.8 (C-4), 70.5 (C-3), 124.4 and 130.1 (aromatic CH), 132.0 (C-2), 133.0 
(C-l), 144.1 and 151.0 (aromatic C), 165.8 (C=0), 169.8 (C=0), 170.0 (C=0); m/z 
(C.I., NH3) 673 (MNH4 +, 81%), 488 (100), 428 (28).
Methyl 3$,4$-diacetoxy-5$-[N,N-di(p-nitrobenzenesulphonyl)aminomethyl]- 
cyclohex-1 -ene-1 -carboxylate (158)
Acetylation of the diol (144) (55.5 mg, 0.10 mmol) using the general procedure 
described above gave the title compound as a pale yellow solid (55 mg, 8 6 %): m.p. 
187-188°C (dec.) (from petrol-ethyl acetate); Rp 0.77 (petrol-ethyl acetate 1:1); 
(Found C, 46.0; H, 3.85; N, 6.3. C^H^NjO^Sj requires C, 45.8; H, 3.8; N, 6.4%); 
Vmax(nujol) 1755 (C=0), 1700 (C=0), 1525, 1375 (SO2), 1340, 1215, 1160 (SOJ, 
730 cm'1; 6H(CDC13) 2.02 (3H, s, Me), 2.08 (3H, s, Me), 2.21 (1H, m, 6 P-H), 2.39 
(1H, br dd, Jgem 17.5, 5.5 Hz, 6 <x-H), 2.51 (1H, m, 5-H), 3.63 (1H, dd, 7gem
15.0, 6.1 Hz, l'-H), 3.78 (3H, s, OMe), 3.93 (1H, dd, Jgem 15.0, J x\ 5  8.2 Hz,
l'-H), 5.23 (1H, m, 4-H), 5.33 (1H, m, 3-H), 6.60 (1H, br s, 2-H), 8.32 (4H, d, /  9.1 
Hz, Ar-H), 8.48 (4H, d, /  9.1 Hz, Ar-H); 5c(CDC13) 20.6 (Me), 20.7 (Me), 24.8 
(C-6 ), 35.7 (C-5), 49.9 (C-l'), 52.1 (OMe), 65.3 (C-4), 6 8 . 8  (C-3), 124.6 and 130.0 
(aromatic CH), 131.3 (C-2), 134.3 (C-l), 143.8 and 151.0 (aromatic C), 165.7 
(C=0), 169.8 (C=0), 170.5 (C=0).
Methyl 3cL,4a-isopropylidenedioxy-5$-[Nfl-di(p-nitrobenzenesulphonyl)amino- 
methyl]cyclohex-1 -ene-1 -carboxylate (164)
The diol disulphonimide (143) (2.80 g, 4.90 mmol) was suspended in 2,2-di- 
methoxypropane (10 cm3) and acetone (10 cm3). A catalytic amount of p-TSA was
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added and the reaction mixture stirred at 20°C under a nitrogen atmosphere for 22 h. 
The suspension cleared and then a fine white precipitate formed. Evaporation under 
reduced pressure and trituration with acetone yielded the title compound as a white 
powder (2.80 g, 94%): m.p. 220-220.5°C (from ethyl acetate); Rp 0.72 (petrol-ethyl 
acetate 1:1); (Found : C, 47.1; H, 4.2; N, 6.9. C24H25N30 12S2 requires C, 47.1; H, 
4.1; N, 6.9%); vmax(nujol) 1715 (C=0), 1520, 1390, 1350 (SO2 ), 1240, 1165 (SO2 ), 
800,740 cm’1; 8H(D6-DMSO) 1.30 (3H, s, Me), 1.38 (3H, s, Me), 1.85 (1H, dd, / gem
16.5, / 6Pf5 9.0 Hz, 6p-H), 2.11 (1H, m, 5-H), 2.20 (1H, dd, / gem 16.5, / 6ot,5 3.7 Hz, 
6a-H), 3.64 (3H, s, OMe), 4.02 (3H, m, 4-H, 2 x l'-H), 4.68 (1H, m, 3-H), 6.79 (1H, 
m, 2-H), 8.21 (4H, d, J  9.0 Hz, Ar-H), 8.49 (4H, d, J  9.0 Hz, Ar-H); m/z (C.I., NH3) 
629 (MNH4+, 100%), 612 (MH+, 5), 596 (16), 571 (15), 444 (50), 386 (35), 369 (10).
Reaction of acetonide disulphoimide (164) with potassium iodide
The acetonide disulphonimide (164) (309 mg, 0.51 mmol) and dry potassium iodide 
(419 mg, 2.53 mmol) were suspended in dry DMF (4 cm3) and heated at 130°C 
under a nitrogen atmosphere for 21 h. The reaction mixture was poured into water 
(50 cm3) and extracted with ethyl acetate (3 x 50 cm3). The combined extracts were 
washed with aqueous sodium thiosulphate solution (2% w/v, 25 cm3), dried 
(M gS04) and concentrated under reduced pressure. TLC on silica gel (petrol-ethyl 
acetate 4:1) indicated three products and baseline material. Column chromatography 
(petrol-ethyl acetate 17:3 to 4:1) gave:
Methyl 3a,4a-isopropylidenedioxy-5-methylenecyclohex-l -ene-1 -carboxylate (166) 
as a colourless oil (12.5 mg, 11%): Rp 0.49 (petrol-ethyl acetate 4:1); vmax(CHCl3) 
1715 (C=0), 1660 (C=C), 1375, 1305, 1230, 1160, 1100, 1075, 1040, 910 c m 1; 
5H(CDC13) 1.38 (3H, s, Me), 1.41 (3H, s, Me), 3.04 (1H, d, 7gem 19.0 Hz, 6-H), 3.17 
(1H, dm, / gem 19.0 Hz, 6-H), 3.78 (3H, s, OMe), 4.63 (1H, d, / 4f3 5.2 Hz, 4-H), 4.70 
(1H, m, 3-H), 5.14 (1H, m, l'-H), 5.26 (1H, m, l'-H), 6.74 (1H, m, 2-H); 8c (CDCl3)
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26.6 (Me), 28.0 (Me), 28.6 (C-6), 52.0 (OMe), 74.3 (C-4), 76.9 (C-3), 109.6 (CMe^,
115.7 (C-l'), 130.6 (C-l), 135.3 (C-2), 139.9 (C-5), 166.8 (C=0); m/z (E.I.) 209 
(M+-CH3, 209.0799 Cn H130 4 requires 209.0812, 75%), 167 (22), 149 (100), 135 
(22), 107 (25).
Methyl 3(x,4a-isopropylidenedioxy-5$-( iodome thy l)cy clo hex-1 -ene-1 -carboxylate
(165) as colourless crystals (56.5 mg, 32%): m.p. 69-71°C (from light petrol); Rp 
0.44 (petrol-ethyl acetate 4:1); (Found: C, 40.8; H, 4.9. C12H17I0 4 requires C, 40.9; 
H, 4.9%); vmax(CHCl3) 1710 (C=0), 1655 (C=C), 1430, 1370, 1220, 1160, 1095, 
1045 cm'1; 5H(CDC13) 1.40 (3H, s, Me), 1.44 (3H, s, Me), 1.56 (1H, m, 5-H), 2.05 
(1H, ddt, / gem 17.7, J6p,5 10.3, 76p,3 2.2, % 2 2.2 Hz, 6(1-H), 2.69 (1H, br dd, 7gem 
17.7, /6<x.5 4.4 Hz, 6a-H), 3.34 (1H, dd, / gem 10.1, 6.4 Hz, l'-H), 3.47 (1H, dd,
/ gem 10.1, J X'%5 3.7 Hz, l'-H), 3.78 (3H, s, OMe), 4.01 (1H, dd, J4J5 9.2, / 4 3 6.2 Hz,
4-H), 4.63 (1H, ddd, J3A 6.2, JX2 3.9, / 3>6p 2.2 Hz, 3-H), 6.94 (1H, ddd, / 2t3 3.9, / 2>6p
2.2, JXSa 0.7 Hz, 2-H); 5c (CDC13) 10.2 (C-l'), 25.8 (Me), 28.2 (Me), 29.0 (C-6),
38.6 (C-5), 52.1 (OMe), 71.3 (C-4), 76.7 (C-3), 109.5 (CMe^, 133.4 (C-l), 133.5 
(C-2), 166.5 (C=0); m/z (E.I.) 352 (M+, 2%), 337 (66), 149 (33).
Homonuclear decoupling experiment data for (165):
Signal Irradiated
(Chemical shift, 5) 2-H 3-H
Observed Resonance 
4-H l'-H l'-H 6oc-H 6p-H
Original resonance ddd ddd dd dd dd brdd dddd
2-H (6.94) dd dd dd dd dd ddd
3-H (4.63) dd d dd dd dd ddd
5-H (4.63) ddd ddd d d d brd ddd
Methyl 3 a,4a-isopropylidenedioxy-5$-( O-formylhydroxymethyl)cyclohex-l -ene-1 -
carboxylate (167) as a colourless oil (24 mg, 17%): Rp 0.25 (petrol-ethyl acetate
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4:1); vmaj,(CHCl3) 1715-1725 (C=0), 1375, 1230, 1160, 1095, 1050 cm’1; 
5H(CDC13) 1.40 (3H, s, Me), 1.44 (3H, s, Me), 2.05 (2H, m, 5-H, 6 p-H), 2.68 (1H, br 
dd, Jgem 21.0, Jsajs 9.0 Hz, 6 a-H), 3.78 (3H, s, OMe), 4.10 (1H, dd, 8.5, / 4 i3  6.0 
Hz, 4-H), 4.20 (1H, dd, Jgem 11.0, Jx'^ 5.5 Hz, l'-H), 4.38 (1H, dd, Jgem 11.0, Jx\ 5
3.5 Hz, l'-H), 4.63 (1H, ddd, / 3>4 6.0, / 3 i2  3.5, Jm  1.5 Hz, 3-H), 6.95 (1H, ddd, J23
3.5, Ju p 2.0, Jx6a 1.0 Hz, 2-H), 8.10 (1H, d, J  0.5 Hz, CHO); 8 c (C D a 3) 25.0 (C-6 ),
25.8 (Me), 28.1 (Me), 36.7 (C-5), 52.1 (OMe), 63.9 (C-l'), 71.1 (C-4), 73.9 (C-3),
109.4 (CMej), 133.0 (C-l), 133.7 (C-2), 160.8 (CHO), 166.6 (C=0); m/z (E.I) 270 
(M+, 0.4%), 255 (39), 181 (17), 167 (16), 149(100), 135 (11).
Homonuclear decoupling experiment data for (167):
Signal Iradiated Observed Resonance
(Chemical shift, 6 ) 2-H 3-H 4-H l'-H l'-H 6 a-H
Original resonance ddd ddd dd dd dd brdd
6 cc-H (2.68) dd ddd dd dd dd
6 p-H & 5-H (4.28) dd dd d d d d
1.0 Hz
Methyl 3a,4a-isopropylidenedioxy-5$-( iodomethyl)cyclohex-l -ene-1 -carboxylate 
(165)
A suspension of 18-crown-6 (0.57 g, 2.16 mmol) and diy potassium iodide (0.65 g, 
3.93 mmol) in toluene (130 cm3) was stirred at 20°C for 10 mins. The 
disulphonimide (164) was added and the reaction mixture heated to reflux under a 
nitrogen atmosphere. After 3 days additional potassium iodide (0.50 g, 3.01 mmol) 
and 18-crown-6 (0.50 g, 1.89 mmol) were added. After a total of 7 days, toluene was 
evaporated under reduced pressure, ethyl acetate was added and the suspension was
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filtered and concentrated under reduced pressure. Column chromatography 
(petrol-ethyl acetate 4:1) yielded the title compound as colourless crystals (435 mg, 
63%), identical with the sample described above.
Methyl 3a,4a-isopropylidenedioxy-5$-[N-acetyl-N-(p-nitrobenzenesulphonyl)- 
aminomethyl]cyclohex-l-ene-1 -carboxylate (170)
A suspension o f 18-crown-6 (96 mg, 0.36 mmol) and dry potassium acetate (64 mg, 
0.65 mmol) in toluene (20 cm3) was stirred at 20°C for 10 mins. The disulphonimide 
(164) was added and the reaction mixture heated to reflux. After 7 h additional 
potassium acetate (32 mg, 0.32 mmol) and 18-crown-6 (47 mg, 0.18 mmol) were 
added. After a total o f 18 h toluene was evaporated under reduced pressure. Column 
chromatography (petrol-ethyl acetate 7:3 to 11:9) yielded the title compound as a 
pale yellow solid (92 mg, 60%): m.p. 159-160°C (from petrol-ethyl acetate); Rp 0.70 
(petrol-ethyl acetate 1:1); (Found: C, 51.1; H, 5.1; N, 5.9. C2 0 H2 4 N2 O9 S requires C, 
51.3; H, 5.2; N, 6.0%); vmax(CHCl3) 1715 (C=0), 1370, 1350 (SO2 ), 1220, 1170 
(SO2), 1090, 1055 cm-1; SH(CDC13) 1.40 (3H, s, Me), 1.47 (3H, s, Me), 2.00 (1H, 
ddt, / gem 17.5, J6p,5 9.9, Jm  2.0, % ,  2.0 Hz, 6 p-H), 2.25 (1H, m, 5-H), 2.36 (3H, s. 
Me), 2.70 (1H, dd, / gem 17.5, Jta^ 4.3 Hz, 6 <x-H), 3.78 (3H, s, Me), 3.87 (1H, dd, 
/ gem 14.6, >5 8 . 6  Hz, l'-H), 4.04 (1H, dd, Ji£  9.2, %  6.2 Hz, 4-H) 4.09 (1H, dd,
Jgtm 14.6, y , ' t5 5.9 Hz, l'-H), 4.67 (1H, m, 3-H), 6.97 (1H, m, 2-H), 8.10 (2H, d, J
8 . 8  Hz, Ar-H), 8.40 (2H, d, J  8 . 8  Hz, Ar-H); 5c (CDC13) 24.9 (Me), 25.5 (C-6 ), 25.8 
(Me), 27.9 (C-5), 37.8 (Me), 48.8 (C-l'), 52.1 (OMe), 71.2 (C-4), 75.6 (C-3), 109.5 
(CMej), 124.4 and 129.0 (aromatic CH), 132.8 (C-l), 133.8 (C-2), 145.0 and 150.6 
(aromatic C), 166.5 (C=0), 170.2 (C=0); m/z (C.I., NH3) 486 (MNH4+, 22%), 453 
(M+-CH3 , 5), 444 (16), 439 (7), 411 (6 8 ), 381 (100).
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Methyl 3ct,4a-isopropylidenedioxy-5$-(acetoxymethyl)cycloclohex-l-ene-1 - 
carboxylate (169)
(a) A solution of the iodide (165) (116 mg, 0.33 mmol) in dry DMF (5 cm3) was 
treated with sodium acetate and heated to 110°C under an argon atmosphere for 2.5 
h. The reaction mixture was poured into water (50 cm3) and extracted with diethyl 
ether (4 x 25 cm3). The combined extracts were dried (M gS04) and concentrated 
under reduced pressure. Column chromatography (petrol-ethyl acetate 4:1) yielded 
the title compound as a colourless oil (59 mg, 63%): Rp 0.80 (petrol-ethyl acetate 
1:1); vmax(CHCl3) 1710 (C=0), 1645 (C=C), 1430, 1380, 1370, 1220, 1160, 1050 
cm'1; 6H(CDC13) 1.36 (3H, s, Me), 1.40 (3H, s, Me), 2.02 (2H, m, 5-H, 6(3-H), 2.03 
(3H, s, Me), 2.61 (1H, dd, / gem 21.0, J ^ 5 8.0 Hz, 6 <x-H), 3.74 (3H, s, OMe), 4.04 
(1H, dd, / gem 11.0, J\r$  6.0 Hz, l'-H), 4.07 (1H, dd, J4t5 8.5 , / 4>3 6.0 Hz, 4-H), 4.24 
(1H, dd, / gem 11.0, Jx \ 5  4.0 Hz, l'-H), 4.58 (1H, m, 3-H), 6.89 (1H, m, 2-H); 
6c (CDC13) 20.8 (Me), 24.8 (C-6 ), 25.7 (Me), 28.0 (Me), 36.5 (C-5), 52.0 (OMe),
64.3 (C-l'), 71.0 (C-4), 73.9 (C-3), 109.2 (CMe2), 132.8 (C-l), 133.7 (C-2), 166.6 
(C=0), 170.8 (C=0); m/z (C.I.) 285 (MH+, 1%), 269 (36), 227 (20), 195 (21), 167 
(100), 149 (67).
(b) The diol (190) (80 mg, 0.33 mmol) and p-TSA (catalytic) were dissolved in 
acetone (3 cm3) and 2,2-dimethoxypropane (3 cm3). The reaction mixture was 
stirred at 20°C under a nitrogen atmosphere for 18 h after which solvents were 
evaporated under reduced pressure. Column chromatography (petrol-ethyl acetate 
3:1) yielded the title compound as a colourless oil ( 8 8  mg, 94 %), identical with the 
sample described above.
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Methyl 3a,4a-isopropylidenedioxy-5$-(hydroxymethyl)cyclohex-l-ene-1 - 
carboxylate (172)
(a) A solution of the acetate (169) (85 mg, 0.30 mmol) in methanol (4 cm3) was 
treated with aqueous ammonia solution ( 1  cm3) and stirred at 20°C under a nitrogen 
atmosphere for 48 h. The solvents were evaporated under reduced pressure. Column 
chromatography (petrol - ethyl acetate 1 :1 ) yielded the title compound as a 
colourless oil which crystallised on standing (63.5 mg, 87%): m.p. 52-53°C (from 
petrol-diethyl ether); RF 0.40 (petrol-ethyl acetate 1:1); (Found: C, 59.3; H, 7.6. 
Ci2 H i8 0 5  requires C, 59.5; H, 7.5%); vmax(CHCl3) 3500 (OH), 1710 (C=0), 1655 
(C=C), 1435, 1375, 1250, 1160, 1100, 1040, 910 cm’1; 5H(CDC13) 1.40 (3H, s, Me),
1.47 (3H, s, Me), 1.96 (1H, m, 5-H), 1.98 (1H, m, 6 p-H), 2.13 (1H, br s, OH), 2.60 
(1H, dd, 7gem 22.0, JM  9.0 Hz, 6 a-H), 3.75 (2H, m, 2 x l'-H), 3.77 (3H, s, OMe), 
4.16 (1H, dd, J4t5  8.5, / 4>3 6.0 Hz, 4-H), 4.62 (1H, ddd, J3A 6.0, J3t2 3.5, / 3>6p 1.0 Hz, 
3-H), 6.94 (1H, m, 2-H), 5c (CDC13) 24.8 (C-6 ), 25.8 (Me), 28.0 (Me), 39.0 (C-5),
52.1 (OMe), 64.9 (C-l'), 71.4 (C-4), 76.4 (C-3), 109.4 (CMe2 ), 133.5 (C-l,C-2),
166.7 (C=0); m/z (E.I.) 242 (M+, 1%), 227 (65), 211 (4), 195 (3), 167 (22), 153 (45), 
137 (100).
(b) The triol (173) (60 mg, 0.30 mmol) and p-TSA (catalytic) were dissolved in 
acetone (3 cm3) and 2,2-dimethoxypropane (3 cm3). The reaction mixture was 
stirred at 20°C under a nitrogen atmosphere for 22 h after which the solvents were 
evaporated under reduced pressure. Column chromatography (petrol-ethyl acetate 
4:1 then 1:1) yielded the title compound as a colourless oil which crystallised on 
standing (60.5 mg, 84%), identical with the sample described above and the ketal 
(191) as a colourless oil (12.5 mg, 8 %): Rp 0.80 (petrol-ethyl acetate 1:1); 
6h(CDC13) 1.33 (3H, s, Me), 1.39 (3H, s, Me), 1.42 (3H, s, Me), 1.95-2.20 (2H, m,
5-H, 6 p-H), 2.64 (1H, m, 6 <x-H), 3.35-3.57 (2H, m, l'-H), 3.76 (3H, s, OMe), 4.15 
(1H, m, 4-H), 4.58 (1H, m, 3-H), 6.87 (1H, m, 2-H); 8c (CDC13) 24.8 (Me), 26.0
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(Me), 28.2 (Me), 37.3 (C-5), 52.0 (OMe), 60.5 and 60.7 (C-l'), 71.1 (C-4), 74.0 and
74.1 (C-3), 99.8 (CMei), 108.8 (CMe^, 132.9 (C-l), 133.8 and 133.9 (C-2), 167.0 
(C=0).
Methyl 3 a,4oL-dihydroxy-5$-(hydroxymethyl)cyclohex-l -ene-1 -carboxylate (173)
(a) The acetonide formate (167) (38 mg, 0.14 mmol) was dissolved in dry methanol 
(3 cm3), Amberlyst-15 ion exchange resin was added and the reaction mixture 
stirred at 20°C for 17 h. The resin was filtered off and the methanol evaporated 
under reduced pressure. The residue was dissolved in glacial acetic acid (1 cm3), 
water (1 cm3) and THF (1 cm3) and heated at 60°C under an argon atmosphere for
3.5 h. Removal of the solvents under reduced pressure and column chromatography 
(ethyl acetate) yielded the title compound as a white powder (18 mg, 64%): m.p. 
115-115.5°C (from ethyl acetate); RF 0.25 (ethyl acetate); (Found: C, 53.3; H, 7.1. 
C9H 1 4 0 5  requires C, 53.5; H, 7.0%); vmax(nujol) 3250 br (OH), 1715 (C=0), 1655 
(C=C), 1425,1270,1245, 1115, 1070,1040 cm'1; 6H(D2 0 )  2.11 (2H, m, 5-H, 6 p-H), 
2.55 (1H, m, 6 a-H), 3.64 (1H, dd, 7gem 12.0, J ^ 5 6.0 Hz, l'-H), 3.73 (2H, m, 4-H, 
l'-H), 3.75 (3H, s, OMe), 4.28 (1H, dd, JX2 4.5, J3A 4.5 Hz, 3-H), 6.83 (1H, dd, J2%3
4.5, J2,6p 1.5 Hz, 2-H); 8C(D2 0 )  25.4 (C-6 ), 35.9 (C-5), 51.9 (OMe), 61.7 (C-l'),
64.8 (C-4), 68.7 (C-3), 131.4 (C-l), 135.9 (C-2), 168.9 (C=0); m/z (C.I., NH3) 220 
(MNH4+, 100%), 202 (M+, 22), 185 (33), 170 (5), 153 (15).
(b) A solution of the acetonide (172) (40 mg, 0.17 mmol) in glacial acetic acid (1.5 
cm3), water (1.5 cm3) and THF (1.5 cm3) was heated to 50-60°C under an argon 
atmosphere for 17 h. Evaporation of the solvents under reduced pressure and column 
chromatography (ethyl acetate) yielded the title compound as a white powder (23.5 
mg, 70%), identical with the sample described above.
(c) A solution of the acetate (190) (30 mg, 0.12 mmol) in methanol (3 cm3) was 
treated with aqueous ammonia solution ( 1  cm3) and stirred at 20°C under a nitrogen
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atmosphere for 21 h. The solvents were evaporated under reduced pressure. Column 
chromatography (ethyl acetate) yielded the title compound as a white powder ( 2 1  
mg, 84%), identical with the sample described above.
3 a,4a-Dihydroxy-5 p -(hydroxymethyl)cyclohex-l -ene-1 -carboxylic acid (174)
A solution of the triol (173) (34 mg, 0.17 mmol) in water (3 cm3) was treated with 
aqueous sodium hydroxide solution (1.0 M, 0.17 cm3) and stirred at 20°C under an 
argon atmosphere for 5.5 h. The solution was acidified by the addition of IR-120 
ion-exchange resin. The resin was filtered off and washed with water. The combined 
aqueous phases were lyophilised to yield the title compound as a white powder (32 
mg, quantitative): Rp 0.83 (reverse phase silica, water); vmax(nujol) 3410 (OH), 3370 
(OH), 3280 (OH), 1685 (C=0), 1645 (C=C), 1410, 1295, 1265, 1120, 1095, 1075, 
1025, 1005 cm'1; 8H(D2 0 )  2.09 (2H, m, 5-H, 60-H), 2.53 (1H, dd, Jgem 22.0, JM
9.0 Hz, 6 <x-H), 3.64 (1H, dd, / gem 11.2, J ^ 5 6.0 Hz, l'-H), 3.74 (2H, m, 4-H, l'-H),
4.28 (1H, dd, Jx 4  4.5, JX2 4.5 Hz, 3-H), 6.79 (1H, dd, JZ3 4.5, J2t6p 2.0 Hz, 2-H); 
5c (D2 0 ), 25.8 (C-6 ), 36.2 (C-5), 62.0 (C-l'), 65.1 (C-4), 69.0 (C-3), 132.4 (C-l),
135.6 (C-2), 170.9 (C=0); m/z (C.I., NH3) 206 (MNH4+, 100%), 190 (21), 188(12). 
Homonuclear decoupling experiment data for (174):
Signal Irradiated Observed Resonance
(Chemical shift, 5) 2-H 3-H 4-H l'-H l'-H
Original resonance dd dd m m dd
3-H (4.28) d d dd dd
2.0 Hz 9.0 Hz 11.0 Hz
4.2 Hz
4-H, l'-H (3.74) dd d m
6P-H,5-H (2.09) d dd m d d
4.5 Hz 11.0 Hz 11.0 Hz
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Methyl 3a,4a-diacetoxy-5$-(acetoxymethyl)cyclohex-l-ene-1-carboxylate (175)
A solution of the triol (173) (12 mg, 0.06 mmol) in pyridine (1 cm3) was treated with 
acetic anhydride (0.5 cm3) and DMAP (catalytic) and stirred at 20°C for 15 h. The 
reaction mixture was poured into ethyl acetate ( 1 0  cm3) and washed with dilute 
aqueous hydrochloric acid (3 x 10 cm3) and water (10 cm3). The organic phase was 
dried (M gS04) and concentrated under reduced pressure (azeotroping with toluene) 
to yield the title compound as a colourless oil (17 mg, 87%): Rp 0.74 (petrol-ethyl 
acetate 1:1); 5H(CDC13) 2.04 (3H, s, Me), 2.06 (3H, s, Me), 2.09 (3H, s, Me), 2.33 
(1H, dddd, / gem 18.0, / 6p>5  9.9, J6p,2  2.4, Je% 3 1.2 Hz, 6|3-H), 2.49 (1H, m, 5-H), 2.75 
(1H, br dd, 7gem 18.0, 5.2 Hz, 6 <x-H), 3.78 (3H, s, OMe), 4.09 (1H, dd, / gem
11.2, Ji't$ 3.8 Hz, l'-H), 4.20 (1H, dd, / gem 11.2, 5.5 Hz, l'-H), 5.04 (1H, dd,
/ 4>5 10.8,74 3  3.9 Hz, 4-H), 5.65 (1H, br dd, JX15.3, / 3 ,4  3.9 Hz, 3-H), 6.78 (1H, ddd, 
h *  5.3, J2t6p 2.4, 1.3 Hz, 2-H); 8c (CDC13) 20.8 (3 x Me), 27.3 (C-6 ), 32.5
(C-5), 52.2 (OMe), 63.2 (C-l'), 64.9 (C-4), 69.0 (C-3), 131.8 (C-2), 134.3 (C-l),
166.3 (C=0), 170.1 (C=0), 170.9 (2 x C=0).
Methyl 3a,4a-dihydroxy-5$-(iodomethyl)cyclohex-l-ene-1 -carboxylate (176)
A solution of the acetonide (165) (51 mg, 0.14 mmol) in THF (2.5 cm3), glacial 
acetic acid (2 cm3) and water (2 cm3) was heated at 60°C under a nitrogen 
atmosphere for 39 h. The solvents were evaporated under reduced pressure. Column 
chromatography (petrol-ethyl acetate 1 :1 ) yielded the title compound as a colourless 
gum (36 mg, 80%): RF 0.36 (petrol-ethyl acetate 1:1); vmax(CHCl3) 3550 (OH), 
3390 (OH), 1715 (C=0), 1655 (C=C), 1435, 1250, 1090,1070, 910 c m 1; 8H(CDC13) 
1.72 (1H, m, 5-H), 2.17 (1H, dddd, Jgcm 18.3, / 6p>5 10.3, J6p>2 2.6, / 6p<3 1.4 Hz, 
6 p-H), 2.30 (2H, br s, 2 x OH), 2.68 (1H, br dd, / gem 18.3, J ^ 5 5.1 Hz, 6 cc-H), 3.47 
(2H, m, 2 x l'-H), 3.61 (1H, dd, / 4>5 10.3, / 4>3 4.2 Hz, 4-H), 3.77 (3H, s, OMe), 4.33
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(1H, m, 3-H), 6 . 8 8  (1H, ddd, Jx 3  5.1, / 2f6p 2.6, J1M  1.1 Hz, 2-H); 8c (CDC13) 11.7 
(C-l'), 30.9 (C-6 ), 35.8 (C-5), 52.2 (OMe), 65.4 (C-4), 71.9 (C-3), 132.8 (C-l),
135.4 (C-2), 166.8 (C=0); m/z (C.I., NH3) 330 (MNH4+, 100%), 312 (M+, 10), 204 
(59), 202 (51), 186 (18), 169 (15), 153 (8 ).
Homonuclear decoupling experiment data for (176):
Signal Irradiated 
(Chemical shift, 8 ) 2-H
Observed Resonance 
3-H 4-H 6 <x-H 6 p-H
Original resonance ddd m dd brdd dddd
2-H (6 .8 8 ) brd dd dd ddd
3-H (4.33) brd d brdd ddd
6 ot-H (2.68) dd brd dd ddd
3a,4a-dihydroxy-5$-(iodomethyl)cyclohex-l -ene-1 -carboxylic acid (177)
(a) A solution of the methyl ester (176) (30 mg, 0.096 mmol) in THF (2 cm3) was 
treated with aqueous sodium hydroxide solution (1.0 M, 0.10 cm3). Water (ca . 1 
cm3) was added to give a homogeneous solution which was stirred at 20°C under a 
nitrogen atmosphere for 24 h. The solution was acidified by adding Amberlite 
IRA-120 (+) ion-exchange resin, filtered and the resin washed with water. The 
combined aqueous phases were lyophilsed to yield the tide compound as an 
off-white flocculent solid (29 mg, quantitative): Rp 0.62 (ethyl acetate - acetic acid 
99:1), 5h(D2 0 )  1.73 (1H, m, 5-H), 2.17 (1H, dddd, / gem 18.0, / 6p>5 10.0, / 6p>2 2.0, 
J6p3  1.2 Hz, 6 P-H), 2.59 (1H, br dd, / gem 18.0, 5.0 Hz, 6 a-H), 3.43 (1H, dd,
/ gem 10.2, / j ' 5  5.6 Hz, l'-H), 3.48 (1H, dd, / gem 10.2, Jx\ 5 3.9 Hz, l'-H), 3.64 (1H, 
dd, J4f5 10.1, / 4 t3  4.1 Hz, 4-H), 4.31 (1H, m, 3-H), 6.85 (1H, ddd, / 2 ,3  4 .5 ,/ 2f6p 2.0,
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/ 2,6<x 0.8 Hz, 2-H); 5C(D2 0 )  11.7 (C-l'), 30.1 (C-6 ), 34.4 (C-5), 64.7 (C-4), 71.2 
(C-3), 131.7 (C-l), 136.1 (C-2), 170.0 (C=0); m/z (CL, NH3) 316 (MNH4+, 25%), 
298 (M+, 1), 188 (100), 172 (20), 152 (20).
(b) The acetonide (178) (14 mg, 0.041 mmol) was treated with glacial acetic acid 
(1.2 cm3) and water (1 cm3). THF (1 cm3) was added to give a homogeneous 
solution which was heated at 60°C under a nitrogen atmosphere for 24 h. The 
solvents were evaporated under reduced pressure and the residue dissolved in water 
( 1  cm3) and lyophilised to yield the title compound as a pale brown solid ( 1 2  mg, 
98%), identical with the sample described above.
3a,4a-Isopropylidenedioxy-5$-(iodomethyl)cyclohex-l-ene-1-carboxylic acid 
(178)
A solution o f the methyl ester (165) (51 mg, 0.14 mmol) in THF (2.5 cm3) was 
treated with aqueous sodium hydroxide solution (1.0 M, 0.15 cm3). Water (ca. 1.2 
cm3) was added to give a homogeneous solution which was stirred at 20°C under a 
nitrogen atmosphere for 18 h. THF was evaporated under reduced pressure and the 
remaining aqueous solution diluted with water (15 cm3) and washed with diethyl 
ether (5 cm3). The aqueous solution was acidified by adding Amberlite IRA-120 (+) 
ion-exchange resin, filtered and lyophilised to yield the title compound as a cream 
solid (35 mg, 71%): Rp 0.82 (ethyl acetate-acetic acid 99:1); vmax(nujol) 1680 
(C=0), 1640 (C=C), 1290, 1250, 1215, 1065, 935 cm'1; 5H(CD3OD) 1.47 (3H, s, 
Me), 1.50 (3H, s, Me), 1.62 (1H, m, 5-H), 2.09 (1H, ddt, / gem 17.5, / 6p?5 10.1, / 6p>2
2.0, / 6p>3 2.0 Hz, 6 p-H), 2.75 (1H, dd, / gem 17.5, J6oLt5 4.0 Hz, 6 oc-H), 3.41 (1H, dd, 
/ gem 10.0,7 ^ 5  7.0 Hz, l'-H), 3.61 (1H, dd, / gem 10.0, 3.5 Hz, l'-H), 4.11 (1H,
dd, J4 5 9.0, / 4>3 6.1 Hz, 4-H), 4.79 (1H, m, 3-H), 6.96 (1H, m, 2-H); 5c (CD3OD)
10.1 (C-l'), 26.2 (Me), 28.7 (Me), 30.1 (C-6 ), 40.9 (C-5), 73.0 (C-4), 78.3 (C-3),
110.8 (CMe^, 134.8 (C-2); m/z (C.I., NH3) 356 (MNH4+, 50%), 339 (MH+, 50), 323
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(100), 298 (20), 281 (15), 263 (19), 213 (35).
Osmium tetroxide catalysed cis-hydroxylation of the diene (135)
A solution of the diene (135) (7.00 g, 26.2 mmol) in acetone (100 cm3) was treated 
with a solution of osmium tetroxide in rm-butanol (0.5% w/v, 1.0 cm3), 
N-methylmorpholine N-oxide (3.37 g, 28.8 mmol) and water (1.0 cm3). The reaction 
mixture was stirred at 20°C for 48 h and then concentrated under reduced pressure to 
yield a black oil-solid mixture. Trituration with diethyl ether and recrystallisation 
from ethyl acetate yielded Methyl 3a,4a-dihydroxy-5$-[N-(t-butoxycarbonyl)- 
aminomethyl]cyclohex-l-ene-1-carboxylate (179) as a colourless solid (2.25 g, ' 
29%): m.p. 181-182°C (from ethyl acetate); Rp 0.28 (petrol-ethyl acetate 1 :1 ); 
(Found: C, 56.0; H, 7.8; N, 4.65. C14H2 3 N 0 6  requires C, 55.8; H, 7.7; N, 4.65%); 
Vmax(nujol) 3400 (OH), 3280 (OH), 1705 (C=0), 1670 (C=C), 1530, 1285, 1255, 
1165, 1100 cm-1; 5H(D6 -DMSO) 1.38 (9H, s, CA/e3), 1.86 (1H, b rd d ,/gem 18.0, J6Pt5
8.5 Hz, 6 p-H), 1.96 (1H, m, 5-H), 2.38 (1H, br dd, Jgcm 18.0, J6(Xn5 4.0 Hz, 6 cc-H), 
2.84 (1H, ddd, / gem 14.0, J x' t5  8.0, 5.5 Hz, l'-H), 3.12 (1H, dt, / gem 14.0,
5.5, JX'%N H  5.5 Hz, l'-H), 3.39 (1H, m ,  4-H), 4.06 (1H, m ,  3-H), 4.52 (1H, d, J0liA
5.5 Hz, 4-OH), 4.89 (1H, d, / O H ,3 6.0 Hz, 3-OH), 6 . 6 6  (1H, br d, / 2 3  4.0 Hz, 2-H), 
6.80 (1H, br t, J  5.5 Hz, NH); 5c (D6-DMSO) 26.7 (C-6 ), 28.4 (CMe3), 35.8 (C-5),
41.6 (C-l'), 51.8 (OMe), 65.0 (C-4), 69.6 (C-3), 77.7 (CMe3), 130.0 (C-l), 138.6 
(C-2), 156.1 (C=0), 166.9 (C=0); m/z (C.I.) 302 (MH+, 1%), 268 (3), 246 (12), 228 
(100), 184 (35), 152 (28).
The remaining material was purified by column chromatography (petrol-ethyl 
acetate 1:1) to yield Methyl 3$,4$-dihydroxy-5$-[N-(t-butoxy-carbonyl)amino- 
methyl]cyclohex-l-ene-1-carboxylate (180) as a colourless oil (3.08 g, 39%): Rp 
0.28 (petrol-ethyl acetate 1:1); (Found: C, 56.2; H, 7.6; N, 4.7. C14H23NOg requires 
C, 55.8; H, 7.7; N, 4.65%); vmax(liquid film) 3380 (OH), 1700 (C=0), 1520, 1435,
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1365, 1270, 1250, 1165, 755 cm'1; 5H(D6 -DMSO) 1.38 (9H, s, CMe3\  1.82 (2H, m,
5-H, 6 -H), 2.15 (1H, d m, / gem 16.0 Hz, 6 <x-H), 2.99 (2H, m, 2 x l'-H), 3.67 (3H, s, 
OMe), 3.70 (3H, br s, 4-H), 4.12 (1H, br s, 3-H), 4.39 (1H, br s, 4-OH), 5.00 (1H, br 
s, 3-OH), 6.53 (1H, br s, 2-H), 6.83 (1H, br t, J  5.5 Hz, NH); 5c (D6 -DMSO) 24.1 
(C-6 ), 28.2 (CMe3), 37.0 (C-5), 42.5 (C-l'), 51.5 (OMe), 66.9 (C-4), 6 8 . 8  (C-3), 77.5 
(CMe3 ), 129.1 (C-l), 140.8 (C-2), 155.8 (C=0), 166.5 (C=0); m/z (C.I.) 302 (MH+, 
28%), 284 (5), 268 (5), 246 (95), 228 (90), 202 (100), 184 (50).
Homonuclear decoupling experiment data for (179):
Signal Irradiated Observed Resonance
(Chemical shift, 5) 2-H 3-OH 4-H l'-H l'-H
Original resonance brd d m ddd ddd
3-H (4.06) brs s dd
5.5,8.5 Hz
ddd ddd
4-OH (4.52) brd d dd
35 , 8 J  Hz
ddd ddd
N-H (2.68) brd d m dd dd
3a,4a-Dihydroxy-5$-(aminomethyl)cyclohex-l-ene-l-carboxylic acid  (181)
The ester carbamate (179) (61 mg, 0.20 mmol) was treated with trifluoroacetic acid 
(4 cm3), the solution stirred at 20°C for 5 min and then concentrated under reduced 
pressure. The residue was dissolved in water (4 cm3) and a 1.0 M aqueous sodium 
hydroxide solution was added dropwise until the solution was alkaline and then a 
further 0.3 cm3  was added. The solution was stirred at 20°C under an argon 
atmosphere for 20 h. Amberlite IR 120 (+) ion exchange resin was added and the 
mixture filtered. The resin was washed with water (3 x 10 cm3), the washings 
discarded and the product washed from the resin with dilute aqueous ammonia
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solution ( 3 x 8  cm3). Lyophilisation yielded the title compound as an off-white 
powder (30.5 mg, 80%): Rp 0.55 (reverse phase silica, water); 8h(D20 )  2.02 (1H, dd 
m, / gem 17.0, / 6P i5  11.0 Hz, 6 p-H), 2.15 (1H, m, 5-H), 2.59 (1H, dd, / gem 17.0, J6aj5
4.5 Hz, 6 <x-H), 3.03 (1H, dd, / gem 13.0, J x \ 5  6.0 Hz, l'-H), 3.24 (1H, dd, 7gem 13.0, 
/ j ' 5  7.0 Hz, l'-H), 3.72 (1H, dd, / 4 t5  10.8, / 4>3 4.0 Hz, 4-H), 4.25 (1H, dd, J3A 4.0, 
JX1 5.0 Hz, 3-H), 6.49 (1H, m, 2-H); 5C(D2 0 )  28.7 (C-6 ), 32.2 (C-5), 42.0 (C-l'),
65.2 (C-4), 71.8 (C-3), 129.6 (C-2), 137.3 (C-l), 175.0 (C=0); m/z (C.I., NH3) 188 
(MH+, 100%), 172 (35), 170 (23), 152 (44), 126 (25), 108 (14).
3$,4$-Dihydroxy-5$-(aminomethyl)cyclohex-l-ene-1 -carboxylic acid  (182)
The ester carbamate (180) (93 mg, 0.31 mmol) was treated with trifluoroacetic acid 
(5 cm3), the solution stirred at 20°C for 10 min and then concentrated under reduced 
pressure. The residue was dissolved in water (5 cm3) and a 1.0 M aqueous sodium 
hydroxide solution was added dropwise until the solution was alkaline and then a 
further 0.4 cm3  was added. The solution was stirred at 20°C under an argon 
atmosphere for 20 h. Amberlite IR 120 (+) ion exchange resin was added and the 
mixture filtered. The resin was washed with water (3 x 10 cm3), the washings 
discarded and the product washed from the resin with dilute aqueous ammonia 
solution ( 3 x 9  cm3). Lyophilisation yielded the title compound as an off-white 
powder (34 mg, 58%): RF 0.55 (reverse phase silica, water); 8H(D2 0 )  2.14 (2H, m,
5-H, 6 p-H), 2.41 (1H, d m, / gem 16.0 Hz, 6 <x-H), 3.13 (1H, dd, / gem 13.0, 6 . 8
Hz, l'-H), 3.24 (1H, dd, / gem 13.0, Jx\ 5 6.0 Hz, l'-H), 4.04 (1H, m, 4-H), 4.44 (1H, 
m, 3-H), 6.35 (1H, br s, 2-H); 5C(D2 0 )  24.1 (C-6 ), 35.0 (C-5), 41.3 (C-l'), 67.3 
(C-4), 68.2 (C-3), 132.3 (C-2), 135.1 (C-l), 175.0 (C=0); m/z (C.I., NH3) 188 
(MH+, 100%), 170 (62), 154 (40), 126 (6 8 ), 108 (28).
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Methyl 3 a ,4 a-dihydroxy-5 $-[N-( trifluoroacetyl)aminomethyl]cyclohex-l -ene-1 - 
carboxylate (189)
The carbamate (179) (3.85 g, 12.8 mmol) was added slowly to trifluoroacetic acid 
(45 cm3). After stirring at 20°C for 30 min the reaction mixture was concentrated 
under reduced pressure and taken up in pyridine (50 cm3). The solution was treated 
with trifluoroacetic anhydride (9.60 cm3, 68.0 mmol), DMAP (catalytic) and stirred 
at 20°C for 3 days. The reaction mixture was then concentrated under reduced 
pressure and poured into water (100 cm3). Dilute aqueous hydrochloric acid (200 
cm3) was added and the mixture extracted with ethyl acetate (3 x 150 cm3). The 
combined extracts were dried (Na2 S 0 4) and concentrated under reduced pressure. 
Column chromatography (petrol-ethyl acetate 1:3) yielded the title compound as a 
colourless crystalline solid (2.90 g, 76%): m.p. 116-117°C (from petrol-ethyl 
acetate); Rp 0.33 (petrol-ethyl acetate 1:3); (Found: C, 44.5; H, 4.8; N, 4.65. 
C11H 14F3 N0 5  requires C, 44.4; H, 4.75; N, 4.7%); vmax(nujol) 3400 (OH), 3310 
(OH), 1735 (C=0), 1705 (C=0), 1655 (C=C), 1260, 1235, 1205, 1175 cm'1; 
5H(D6 -Acetone) 2.00 (1H, dddd, / gem 18.0, / 6p 5  9.5, / 6p>2 2.4, / 6p 3  1.2 Hz, 6 p-H),
2.20 (1H, m, 5-H), 2.58 (1H, br dd, / gem 18.0, Je^5 5.0 Hz, 6 oc-H), 3.45 (1H, m, 
l'-H), 3.60 (2H, m, 4-H, l'-H), 3.71 (3H, s, OMe), 3.90 (2H, br s, 2 x OH), 4.26 (1H, 
br t, J3A 4.5, / 3 f2  4.5 Hz, 3-H), 6.82 (1H, ddd, / 2 3  4.5, / 2>6p 2.4, J%(>a 1.0 Hz, 2-H),
8.50 (1H, br s, NH); 5c (D6-Acetone) 27.7 (C-6 ), 35.3 (C-5), 41.8 (C-l'), 51.4 
(OMe), 65.5 (C-4), 71.1 (C-3), 116.5 (q, / C,F 268 Hz, CF3), 131.3 (C-l), 137.2 (C-2),
157.4 (C=0), 166.9 (C=0); m/z (C.I., NH3) 315 (MNH4+, 100%), 297 (M+, 38), 280 
(16), 264(17), 248(11).
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Homonuclear decoupling experiment data for (189):
/
Signal Irradiated Observed Resonance
(Chemical shift, 5) 2-H 3-H 6 <x-H 6 p-H
Original resonance ddd brdd brdd dddd
3-H (4.26) dd ddd
18.0,5.0,1.0 Hz
ddd




A solution of the trifluoroacetamide (189) (0.38 g, 1.28 mmol) in acetic anhydride 
(100 cm3) and glacial acetic acid (50 cm3), was cooled to -4°C under a nitrogen 
atmosphere. Sodium nitrite (0.88 g, 12.8 mmol) was added, and the reaction mixture 
was stirred at -4 to 10°C for 17 h. The solution was concentrated under reduced 
pressure and poured into water (50 cm3). Saturated brine (50 cm3) was added and 
the mixture extracted with ethyl acetate (3 x 100 cm3). The combined extracts were 
dried (Na2 S 0 4) and concentrated under reduced pressure (azeotroping with toluene). 
Column chromatography (petrol-ethyl acetate 1:3) yielded the title compound as a 
yellow oil (98 mg, 31%): RF 0.43 (petrol-ethyl acetate 1:3); vmax(CHCl3) 3450 
(OH), 1710 (C=0), 1655 (C=C), 1365, 1230, 1070, 955, 910 c m 1; 5H(CDC13) 2.10 
(3H, s, Me), 2.18 (2H, m, 5-H, 6|3-H), 2.64 (1H, m, 6 a-H), 2.73 (1H, br s, OH), 3.21 
(1H, br s, OH), 3.58 (1H, dd, J4t5 9.5, / 4>3 4.5 Hz, 4-H), 3.77 (3H, s, OMe), 4.15 (1H, 
dd, / gem 11.4, 5  3.4 Hz, l'-H), 4.34 (1H, dd, / 3>2 5.0, J3A 4.5 Hz, 3-H), 4.43 (1H,
dd, / gem 11.4, J X' %5 4.4 Hz, l'-H), 6.90 (1H, ddd, / 2 3  5.0, / 2>6p 2.0, J2M  1.0 Hz, 2-H); 
5c(CDC13) 20.8 (Me), 27.0 (C-6 ), 34.6 (C-5), 52.0 (OMe), 64.7 (C-l'), 65.3 (C-4),
69.2 (C-3), 132.2 (C-l), 135.8 (C-2), 167.0 (C=0), 171.8 (C=0); m/z (C.I.) 245
132
(MH+, 1%), 227 (10), 211 (5), 195 (12), 167 (100), 151 (20), 137 (15).
Methyl 3$,4$-diacetoxy-5$-[N-(t-butoxycarbonyl)aminomethyl]cyclohex-l-ene-
l-carboxylate (192)
A solution of the diol (180) (9.90 g, 32.9 mmol) in dichloromethane (100 cm3) was 
treated with triethylamine (11.5 cm3, 82.3 mmol), acetic anhydride (7.76 cm3, 82.3 
mmol) and DMAP (catalytic). The reaction mixture was stirred at 20°C under a 
nitrogen atmosphere for 21 h. The solution was diluted with dichloromethane (100 
cm3), washed with dilute aqueous hydrochloric acid ( 2  x 1 0 0  cm3), saturated 
aqueous sodium bicarbonate solution (100 cm3), dried (M gS04) and concentrated 
under reduced pressure. Column chromatography (petrol-ethyl acetate 7:3) yielded 
the title compound as a colourless oil which crystalised on standing (9.00 g, 71%): 
m.p. 94-96°C (from petrol-ethyl acetate); Rp 0.70 (petrol-ethyl acetate 1:1); (Found: 
C, 56.1; H, 7.1; N, 3.6. C1 8H2 7 N 0 8 requires C, 56.1; H, 7.1; N, 3.6%); vmax(CHCl3) 
3420 (NH), 1710 br (C=0), 1425, 1365, 1155, 1085, 1015, 930 cm*1; 8H(CDC13)
1.44 (9H, s, CMc3), 2.06 (3H, s, Me), 2.08 (2H, m, 5-H, 6 P-H), 2.09 (3H, s, Me), 
2.47 (1H, d m, / gem 17.0 Hz, 6 <x-H), 2.85 (1H, m, l'-H), 3.28 (1H, m, l'-H), 3.78 
(3H, s, OMe), 4.95 (1H, br t, J  6.0 Hz, NH), 5.45 (1H, m, 4-H), 5.57 (1H, m, 3-H), 
6.64 (1H, m, 2-H); 5c (CDC13) 20.7 (2 x Me), 24.4 (C-6 ), 28.3 (CMe3), 36.4 (C-5),
41.2 (C-l'), 52.0 (OMe), 66.3 (C-4), 69.3 (C-3), 79.5 (CMe3), 132.0 (C-l), 134.4 
(C-2), 155.8 (C=0), 166.2 (C=0), 170.0 (C=0), 171.1 (C=0); m/z (C.I.) 386 (MH+, 
1%), 368 (1), 330 (55), 286 (50), 270 (20), 252 (10), 226 (100).
Methyl 3 p,4p -diacetoxy-5 p -[N-(trifluoroacetyl)aminomethyl]cyclohex-l -ene-1 - 
carboxylate (193)
The carbamate (192) (1.05 g, 2.72 mmol) was added portionwise to trifluoroacetic
acid (10 cm3). After stirring for 10 min at 20°C the reaction mixture was 
concentrated under reduced pressure, taken up in pyridine ( 8  cm3). Trifluoroacetic 
anhydride (0.37 cm3, 3.90 mmol) and DMAP (catalytic) were added and the reaction 
mixture stirred at 20°C for 1.5 h. After diluting with ethyl acetate (200 cm3), the 
solution was washed with dilute aqueous hydrochloric acid ( 2  x 1 0 0  cm3), saturated 
aqueous sodium bicarbonate solution (100 cm3), dried (MgSC^) and concentrated 
under reduced pressure. Column chromatography (petrol-ethyl acetate 7:3) yielded 
the title compound as a colourless solid (1.01 g, 97%): m.p. 117-118°C (from 
petrol-ethyl acetate); Rp 0.70 (petrol-ethyl acetate 1:1); (Found : C, 47.0; H, 4.6; N, 
3.6. C15H 1 8F3 N0 7  requires C, 47.25; H, 4.8; N, 3.7%); vmax(nujol) 3280 (NH), 1710 
(C=0), 1270, 1230, 1150, 1050, 1025 c m 1; 8H(CDC13) 2.08 (3H, s, Me), 2.12 (1H, 
m, 6|3-H), 2.13 (3H, s, Me), 2.30 (1H, m, 5-H), 2.54 (1H, br dd, Jgem 17.5, / 6a> 5 5.5 
Hz, 6 a-H), 3.00 (1H, m, l'-H), 3.61 (1H, m, l'-H), 3.79 (3H, s, OMe), 5.37 (1H, m,
4-H), 5.58 (1H, m, 3-H), 6.67 (1H, br s, 2-H), 7.32 (1H, br t, J  6.0 Hz, NH); m/z 
(C.I.) 382 (MH+, 3%), 322 (100), 262 (15), 230 (29).
Methyl 3$,4$-diacetoxy-5$-(acetoxymethyl)cyclohex-l-ene-1-carboxylate (194)
A solution of the trifluoroacetamide (193) (5.00 g, 13.1 mmol) in glacial acetic acid 
(120 cm3) and acetic anhydride (240 cm3) was cooled to -4°C under a nitrogen 
atmosphere. Sodium nitrite (9.06 g, 131 mmol) was added and the solution was 
stirred at 0°C for 18 h. The reaction mixture was concentrated under reduced 
pressure and partitioned between ethyl acetate (400 cm3) and water (150 cm3). The 
aqueous phase was extracted with ethyl acetate ( 2  x 2 0 0  cm3) and the combined 
organic extracts dried (Na2 S 0 4), concentrated under reduced pressure and 
azeotroped with toluene. Column chromatography (petrol-ethyl acetate 4:1 to 7:3) 
yielded the title compound as a colourless oil (0.48 g, 11%): Rp 0.43 (petrol-ethyl 
acetate 7:3); vmax(liquid film) 1740 (C=0), 1650 (C=C), 1430, 1370, 1240, 1150,
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1090, 1040 cm-1; SH(CDC13) 2.05 (3H, s, Me), 2.07 (3H, s, Me), 2.08 (3H, s, Me), 
2.18 (1H, m, 6 p-H), 2.33 (1H, m, 5-H), 2.50 (1H, br dd, / gem 17.5, / ^  5.5 Hz, 
6 a-H), 3.79 (3H, s, OMe), 3.97 (1H, dd, / gem 11.2, 6.3 Hz, l'-H), 4.03 (1H, dd,
/ gem 11.2, J i' j  8.2 Hz, l'-H), 5.51 (1H, m, 4-H), 5.60 (1H, m, 3-H), 6.65 (1H, br s,
2-H); 6c(CDC13) 20.7 (2 x Me), 20.8 (Me), 23.4 (C-6 ), 52.0 (OMe), 63.4 (C-l'), 65.4 
(C-4), 68.9 (C-3), 131.7 (C-l), 134.4 (C-2), 166.1 (C=0), 170.0 (C=0), 170.4 
(C=0), 170.8 (C=0), m/z (C.I.) 329 (MH+, 3%), 269 (100), 227 (6 ), 211(6), 209 (4), 
195 (3).
M ethyl 3$,4$-dihydroxy-5$-(hydroxymethyl)cyclohex-l-ene-l-carboxylate (195)
(a) A solution of the triacetate (194) (420 mg, 1.28 mmol) in methanol (25 cm3) was 
treated with aqueous ammonia solution ( 8  cm3) and stirred at 20°C for 2 days. The 
solvents were evaporated under reduced pressure. Column chromatography (ethyl 
acetate) yielded the title compound as a colourless powder (152 mg, 59%): m.p. 
127-128°C (from ethyl acetate); Rp 0.28 (ethyl acetate); (Found : C, 53.6; H, 6.7. 
C9 H1 4 0 5  requires C, 53.5; H, 7.0%); vmax(nujol) 3320 (OH), 3220 (OH), 1710 
(C=0), 1640 (C=C), 1255, 1235, 1150, 1110, 1055, 1035, 970 cm'1; 5H(D2 0 )  1.97 
(2H, m, 5-H, 6 p-H), 2.35 (1H, br d, 6 <x-H), 3.58 (1H, dd, / gem 11.0, 6.0 Hz, 
l'-H), 3.70 (1H, dd, / gem 11.0, Jx\ 5 1 2  Hz, l'-H), 3.76 (3H, s, OMe), 4.08 (1H, m,
4-H), 4.42 (1H, m, 3-H), 6 . 6 8  (1H, br s, 2-H); 8C(D20 )  22.2 (C-6 ), 38.3 (C-5), 52.0 
(OMe), 62.1 (C-l'), 66.2 (C-4), 68.7 (C-3), 130.0 (C-l), 138.8 (C-2), 168.8 (C=0); 
m/z (C.I.) 185 (M+-OH, 70%), 167 (39), 153 (100), 137 (62).
(b) A solution of the trifluoroacetamide (193) (0.70 g, 1.84 mmol) in glacial acetic 
acid (70 cm3) and acetic anhydride (140 cm3) was cooled to -4°C under a nitrogen 
atmosphere. Sodium nitrite (1.27 g, 18.4 mmol) was added and the solution was 
stirred at -4 to 10°C for 18 h. The reaction mixture was concentrated under reduced 
pressure and poured into water (50 cm3). Brine (50 cm3) was added and the mixture
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extracted with ethyl acetate (3 x 100 cm3). The combined organic phases were dried 
(Na2 S 0 4) and concentrated under reduced pressure (azeotroping with toluene) to 
leave a yellow oil (0.70 g). This crude product was dissolved in methanol (40 cm3) 
and treated with dilute aqueous ammonia solution. After stirring at 20°C for 19 h the 
reaction mixture was concentrated under reduced pressure. Column chromatography 
(ethyl acetate) yielded the title compound as a pale yellow solid (0.18 g, 48%), 
identical with the sample described above.
3$,4$-Dihydroxy-5$-(hydroxymethyl)cyclohex-l-ene-1 -carboxylic acid (196)
A solution of the methyl ester (195) (81 mg, 0.40 mmol) in water ( 8  cm3) was 
treated with aqueous sodium hydroxide solution (1.0 M, 0.42 cm3) and stirred at 
20°C under a nitrogen atmosphere for 18 h. The solution was acidified by adding 
Amberiite IR 120 (+) ion exchange resin and filtered. The resin was washed with 
water ( 3 x 5  cm3) and the combined filtrate and washings lyophilised to yield the 
title compound as an off-white solid (75 mg, quantitative): m.p. 192-193°C (from 
acetonitrile); RF 0.72 (reverse phase silica , water); 6H(D2 0 )  1.94 (2H, m, 5-H, 
6 p-H), 2.31 (1H, br d, / gem 16.0 Hz, 6 cx-H), 3.57 (1H, dd, / gem 11.0, 6.0 Hz,
l'-H), 3.69 (1H, dd, / gem 11.0, 7.5 Hz, l'-H), 4.06 (1H, m, 4-H), 4.41 (1H, m,
3-H), 6.65 (1H, br s, 2-H); 5C(D2 0 )  22.2 (C-6 ), 38.3 (C-5), 62.1 (C-10, 66.2 (C-4),
68.7 (C-3), 130.6 (C-l), 138.5 (C-2), 170.4 (C=0); m/z (C.I.) 189 (MH+, 5%), 171 
(46), 153 (100), 137 (49).
M  ethyl 3 a,4a-isopropylidenedioxy-5$-(fluoromethyl)cyclohex-l -ene-1 - 
carboxylate (197)
A polythene reaction vessel fitted with a septum cap was charged with 
dichloromethane (4 cm3) and morpholino-DAST (0.14 cm3, 1.14 mmol) under a
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nitrogen atmosphere and cooled to -78°C. A solution of the alcohol (172) (275 mg, 
1.14 mmol) in dichloromethane (2 cm3) was added via cannular and the solution 
stirred for 30 min before warming to 20°C and stirring for a further 2 days. Silica gel 
was added and the dichloromethane evaporated under reduced pressure. The 
pre-absorbed product was added to the top of a silica gel column and eluted with 
petrol-ethyl acetate (9:1) to yield the title compound as a colourless oil (180 mg, 
65%): Rp 0.50 (petrol-ethyl acetate 4:1); vmax(CHCl3) 1715 (C=0), 1645 (C=C), 
1430, 1370, 1220, 1160, 1090, 1050 cm’1; 8H(CDC13) 1.41 (3H, s, Me), 1.44 (3H, s, 
Me), 1.99 (1H, d m, J5j  25.6 Hz, 5-H), 2.15 (1H, ddt, / gem 17.3, / 6P t5 9.7, / 6p>2 1.9, 
/ 6 p 3  1.9 Hz, 6 p-H), 2.70 (1H, br dd, 7gem 17.3, / 6 a ,5  4.1 Hz, 6 a-H), 3.78 (3H, s, 
OMe), 4.16 (1H, dd, / 4>5 9.0, / 4 t3  6.0 Hz, 4-H), 4.54 (1H, ddd, Jx'%F 49.0, / gem 9.5, 
Jx\ 5  4.0 Hz, l'-H), 4.59 (1H, ddd, F 49 .0 ,7gem 9.5, Jx^  5.1 Hz, l'-H), 4.65 (1H, 
m, 3-H), 6.94 (1H, ddd, Jx 3  3.5, Jm  1.9, / 2 .6 a 1.0 Hz, 2-H); 5c (CDC13) 24.4 (d, / 6>F 
4 Hz, C-6 ), 25.7 (Me), 28.1 (Me), 38.3 (d, / 5>F 18 Hz, C-5), 52.1 (OMe), 71.1 (C-4), 
72.9 (d, / 3>F 4 Hz, C-3), 83.7 (d, Jx^  170 Hz, C -l'), 109.2 (CMe^, 133.1 (C-l), 
133.7 (C-2), 166.6 (C=0); m/z (E.I.) 244 (M+, 1%), 229 (M+-CH3, 229.0867 
C12H 17F 0 4  requires 229.0876,55%), 187 (16), 169 (28).
Further elution with petrol-ethyl acetate (4:6) yielded the unreacted alcohol (172) 
(65 mg, 23%).
Methyl 3 a ,4 a-isopropylidenedioxy-5$-formylcyclohex-1-ene-1-carboxylate (198)
A solution of the alcohol (172) (260 mg, 1.07 mmol) in dichloromethane (12 cm3) 
was treated with pyridinium chlorochromate (0.35 g, 1.61 mmol) and stirred at 20°C 
for 4 h. The reaction mixture was added directly to the top of a silica gel column and 
eluted with petrol-ethyl acetate (7:3) to yield the title compound as a colourless oil 
(182 mg, 71%): RF 0.55 (petrol-ethyl acetate 7:3); vmax(liquid film) 1715 (C=0), 
1650 (C=C), 1435, 1370, 1250, 1165, 1100, 1060, 1020, 860 c m 1; 6H(CDC13) 1.42
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(3H, s, Me), 1.43 (3H, s, Me), 2.49 (1H, ddt, 7gem 18.0, / 6P f5 7.0, / 6 p .2  1.6, / 6 p 3  1.6 
Hz, 6 p-H), 2.75 (1H, ddt, / gem 18.0, 5.7, JM  1.5, 1.5 Hz, 6 ct-H), 2.93
(1H, ddd, / 5>6p 7.0, J5A 6.3, J5M  5.7 Hz, 5-H), 3.78 (3H, s, OMe), 4.51 (1H, dd, / 4>5 
6.3, / 4 3  6.3 Hz, 4-H), 4.72 ( 1 H, m, 3 -H), 6.89 ( 1 H, ddd, 3.5, / 2>6p 1.6, J1M  1-5 
Hz, 2-H), 9.79 (1H, d, J  0.5 Hz, CHO); 5c (CDC13) 20.5 (C-6 ), 25.7 (Me), 27.7 (Me), 
49.6 (C-5), 52.0 (OMe), 70.6 (C-4), 71.8 (C-3), 109.2 (CMe^, 130.4 (C-l), 134.8 
(C-2), 166.2 (C=0), 201.3 (CHO); m/z (E.I.) 241 (MH+, 1%), 225 (M+-CH3, 
225.0768 Cu H1 30 5  requires 225.0763, 21), 156 (100).
Homonuclear decoupling experiment data for (198):
Signal Iradiated
(Chemical shift, 5) 2-H
Observed Resonance 
3-H 4-H 5-H 6 <x-H 6 p-H
Original resonance ddd m dd ddd ddt ddt
2-H (6.89) d m 
63 Hz
dd ddd ddd ddd
3-H (4.72) dd m ddd ddd ddd





5-H (2.93) ddd m d dt dt
6 <x-H (2.75) dd m
simplifies
dd m m





A polythene reaction vessel fitted with a septum cap was charged with 
dichloromethane (10 cm3) and morpholino-DAST (0.11 cm3, 0.91 mmol) under a
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nitrogen atmosphere. A solution of the aldehyde (198) (182 mg, 0.76 mmol) in 
dichloromethane (4 cm3) was added via cannular and the reaction mixture stirred at 
20°C for 2 days. Silica gel was added and the dichloromethane evaporated under 
reduced pressure. The pre-absorbed product was added to the top of a silica gel 
column and eluted with petrol-ethyl acetate (9:1) to yield the title compound as a 
colourless oil (181 mg, 91%): RF 0.74 (petrol-ethyl acetate 7:3); vmax(CHCl3 ) 1715 
(C=0), 1645 (C=C), 1430,1370,1230,1060,910 cm’1; 6H(CDC13) 1.41 (3H, s, Me), 
1.46 (3H, s, Me), 2.14 (2H, m, 5-H, 60-H), 2.78 (1H, m, 6 a-H), 3.79 (3H, s, OMe),
4.20 (1H, dd, J4 t3  6.2, J4 5 9.0 Hz, 4-H), 4.66 (1H, m, 3-H), 6.02 (1H, td, F 56.0 
Hz, J X’ %5  2.0 Hz, l'-H), 6.97 (1H, ddd, / 2>3 3.5, Jm  2.0, / 2>6a 1-0 Hz, 2-H); 
6c (CDC13) 19.7 (t, J6tF 5 Hz, 6 -H), 25.5 (Me), 27.9 (Me), 41.4 (t, / 5tF 20 Hz, 5-H), 
52.1 (OMe), 70.9 (C-4), 72.0 (d, / 3>F 7 Hz, 3-H), 109.5 (CMe^, 116.0 (t, 241
Hz, l'-H), 132.4 (C-l), 133.3 (C-2), 166.2 (C=0); m/z (E.I.) 248 (M+-CH2, 
248.0853 Cn H1 4F2 0 4  requires 248.0860, 3%), 247 (M+-CH3, 39), 231 (3), 205 (5), 
187 (20) (C.I.) 263 (MH+, 100%), 247 (42), 205 (63), 187 (12).
Methyl 3a,4a-dihydroxy-5$-(fluoromethyl)cyclohex-l -ene-1 -carboxylate (200)
A solution of the acetonide (197) (175 mg, 0.72 mmol) in THF (5 cm3), glacial 
acetic acid (5 cm3) and water (4 cm3) was heated to 50-60°C under a nitrogen 
atmosphere for 2 days. The solution was concentrated under reduced pressure and 
chromatographed (petrol-ethyl acetate 1:3) to yield the title compound as a 
colourless oil which crystalised on standing (142 mg, 97%): m.p. 78-79°C (from 
petrol-ethyl acetate); RF 0.25 (petrol-ethyl acetate 1:1); (Found : C, 52.95; H, 6.45. 
C9H 1 3F 0 4  requires C, 52.9; H, 6.4%); vmax(CHCl3) 3550 (OH), 3400 (OH), 1715 
(C=0), 1650 (C=C), 1430, 1250, 1090, 1070, 965, 935, 905 cm'1; 6H(CDC13) 
2.06-2.32 (2H, m, 6 p-H), 2.47 (2H, br s, 2 x OH), 2.67 (1H, m, 6 a-H), 3.77 (3H, s, 
OMe), 3.78 (1H, m, 4-H), 4.33 (1H, dd, J3A 4.0, / 3 2  5.0 Hz, 3-H), 4.55 (1H, ddd,
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/ ! '  F 47.0, / gem 9.0, J x' t5  3.8 Hz, l'-H), 4.72 (1H, ddd, jy ,F 47.0, / gem 9.0, ^ ' , 5  4.0 
Hz, l'-H), 6.91 (1H, ddd, JX3 5.0, / 2f6p 2.0, / 2 ,6a 1.0 Hz, 2-H); 6c (CDC13) 26.2 (d, 
/ 6>F 7 Hz, C-6 ), 36.0 (d, / 5fF 18 Hz, C-5), 52.1 (OMe), 65.5 (C-4), 69.0 (d, / 3>F 4 Hz, 
C-3), 84.1 (d, / j ' tF 168 Hz, C-l'), 132.8 (C-l), 135.4 (C-2), 166.9 (C=0); m/z (E.I.) 
204 (M+, 2%), 189 (1), 172 (12), 152 (24), 128 (21), 96 (100).
3 a,4 a-Dihydroxy-5$-(fluoromethyl)cyclohex-l -ene-1 -carboxylic acid  (201)
A solution of the methyl ester (200) ( 6 8  mg, 0.33 mmol) in THF (5 cm3) was treated 
with aqueous sodium hydroxide solution (1.0 M, 0.35 cm3). Water (ca . 4 cm3) was 
added to give a homogeneous solution, which was stirred at 20°C under a nitrogen 
atmosphere for 3 h. Amberlite IR 120 (+) ion exchange resin was added and the 
mixture filtered. The resin was washed with water and the combined filtrate and 
washings were concentrated under reduced pressure and lyophilised to yield the title 
compound as an off-white solid (59 mg, 93%): RF 0.50 (reverse phase silica, water); 
Vmax(nujol) 3300 (OH), 3140 (OH), 1685 (C=0), 1650 (C=C), 1270, 1240, 1070, 
1050, 950 cm’1; 6H(D2 0 )  2.17 (2H, m, 5-H, 6 p-H), 2.54 (1H, m, 6 <x-H), 3.75 (1H, 
dd, JAt5 10.3, / 4 f3  4.0 Hz, 4-H), 4.27 (1H, dd, J3A 4.0, JX2 5.0 Hz, 3-H), 4.55 (1H, 
ddd, / j ' tF 47.0 ,7gem 9.3, Jx\ 5 3.2 Hz, l'-H), 4.66 (1H, ddd, Jx\ v 47.0, / gem 9.3,
4.2 Hz, l'-H), 6.70 (1H, d m, / 2>3 5.0 Hz, 2-H); 5C(D2 0 )  26.0 (d, / 6>F 4 Hz, 6 -H),
34.8 (d, / 5fF 18 Hz, 5-H), 64.9 (C-4), 68.2 (d, / 3>F 4 Hz, 3-H), 84.3 (d, 163 Hz,
l'-H), 133.7 (C-l), 134.0 (C-2), 171.8 (C=0); m/z (E.I.) 190 (M+, 190.0643 
C8Hn F 0 4  requires 190.0641,1%), 172 (19), 152 (30), 114 (38), 96 (100).
Methyl 3a,4a-dihydroxy-5$-(difluoromethyl)cyclohex-l-ene-1 -carboxylate (202)
A solution of the acetonide (199) (178 mg, 0.68 mmol) in THF (5 cm3), glacial 
acetic acid (5 cm3) and water (4 cm3) was heated at 60°C under a nitrogen
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atmosphere for 3 days. The solution was concentrated under reduced pressure. 
Column chromatography (petrol-ethyl acetate 4:6) yielded the title compound as a 
colourless oil which crystallised on standing (148 mg, 98%): m.p. 100-101°C (from 
petrol-ethyl acetate); Rp 0.32 (petrol-ethyl acetate 1:1); (Found: C, 48.4; H, 5.5. 
C9 H12F2 0 4  requires C, 48.65; H, 5.4%); vmax(nujol) 3260 (OH), 1700 (C=0), 1640 
(C=C), 1255, 1145, 1125, 1100, 1090, 1025, 955, 945 c m 1; 8 H(D6 -acetone, D2 0 )  
2.26 (1H, dddd, / gem 17.6, 76Pt5 10.5, % 2  2.5, / 6P -3 1.0 Hz, 6 p-H), 2.46 (1H, m,
5-H), 2.61 (1H, br dd, Jgcm 17.6, 5.3 Hz, 6 a-H), 3.72 (1H, dd, / 4>5 10.4, / 4  3  4.0
Hz, 4-H), 3.77 (3H, s, OMe), 4.30 (1H, m, 3-H), 6.26 (1H, td, J x\ F 57.0, J t\ 5 2.2 Hz, 
l'-H), 6.89 ( 1 H, ddd, Jv  5.2, 2.5, J2,6a 11 Hz, 2-H); 8c(CDC13  + D6 -acetone)
21.2 (t, 7 6  F 5 Hz, C-6 ), 38.6 (t, / 5>F 20 Hz, C-5), 51.7 (OMe), 64.7 (C-4), 67.7 (d, 
/ 3iF 9 Hz, C-3), 116.3 (t, 7,' p 240 Hz, l'-H), 131.3 (C-l), 135.3 (C-2), 166.4 (C=0); 
m/z (E.I.) 222 (M+, 3%), 190 (15), 170 (28), 128 (24), 96 (100).
3a,4a-Dihydroxy-5$-(difluoromethyl)cyclohex-l-ene-1 -carboxylic acid (203)
A solution of the methyl ester (202) (26 mg, 0.12 mmol) in water (3 cm3) was 
treated with aqueous sodium hydroxide solution (1.0 M, 0.12 cm3,) and stirred at 
20°C for 5 h. Amberlite IR-120 (+) ion exchange resin was added and the mixture 
filtered. The resin was washed with water ( 3 x 3  cm3) and the combined filtrate and 
washings were lyophilised to yield the title compound as a white solid ( 2 1  mg, 
8 6 %): Rp 0.35 (reverse phase silica, water); vmax(nujol) 3350 (OH), 3240 (OH), 
1680 (C=0), 1630 (C=C), 1260, 1230, 1135, 1095, 1020, 990 cm*1; 6H(400 MHz, 
D2 0 )  2.28 (1H, br dd, 7gem 17.5, 76Pt5 10.1 Hz, 6 p-H), 2.40 (1H, m, 5-H), 2.60 (1H, 
dd, / gem 17.5, 5  5.2 Hz, 6 a-H), 3.86 (1H, dd, / 4  5 10.6, J4  3  4.1 Hz, 4-H), 4.29
(1H, m, 3-H), 6.14 (1H, td, Jx'%F 57.0, JY't5 2.3 Hz, l'-H), 6.84 (1H, d m, J2 3 4.1 Hz,
2-H); 5c (D20 )  21.6 (t, / 6,F 5 Hz, C-6 ), 37.8 (t, / 5>F 20 Hz, C-5), 64.9 (C-4), 67.7 (d, 
/ 3>F 7 Hz, C-3), 117.0 (t, J^jp 239 Hz, l'-H), 131.6 (C-l), 135.6 (C-2), 170.4 (C=0);
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m/z (C.I., NH3) 226 (MNH4+, 100%), 210 (8 8 ), 208 (M+, 13), 182 (23); (E.I.) 190 
(M+-H20 , 190.0432 C8H8F2 0 3 requires 190.0442,18%).
M ethyl 3a,4a-isopropylidenedioxy-5$-[2-methoxycarbonyl-l-nitroprop-3-yl]- 
cyclohex-1 -ene-1 -carboxylate (208)
A solution of diisopropylamine (0.39 cm3, 2.75 mmol) in THF (4 cm3) and DMPU 
(2 cm3) was cooled to -35°C under a nitrogen atmosphere. A solution of w-butyl 
lithium in hexanes (1.6 M, 2.75 mmol) was added, the reaction mixture stirred for 10 
mins, cooled to -78°C and stirred for a further 20 mins. Methyl 3-nitropropanoate 
(0.13 cm3, 1.25 mmol) was added and the solution stirred for a further 1 h. A 
solution of the iodide (165) (200 mg, 0.57 mmol) in THF (1 cm3) and DMPU (0.5 
cm3) was added dropwise via cannular. After stirring at -78°C for 5 h, the solution 
was allowed to warm to 0°C and stirred for a further 8  h. The reaction mixture was 
poured into saturated aqueous ammonium chloride solution ( 2  cm3), diluted with 
water (10 cm3) and extracted with ethyl acetate (3 x 30 cm3). The combined extracts 
were dried (M gS04) and concentrated under reduced pressure. Column 
chromatography (petrol-ethyl acetate 17:3 then 7:3) yielded starting material (165) 
( 1 2 0  mg, 60%) and the title compound as a yellow oil (40 mg, 2 0 %): Rp 0.33 
(petrol-ethyl acetate 7:3); vmax(CHCl3) 1735 (C=0), 1715 (C=0), 1560, 1440, 1375, 
1240 and 1050 cm’1; m/z (C.I.) 258 (MH+, 31%), 342 (M+-CH3, 100), 300 (82), 268 
(65), 250 (61).
Methyl 3a,4a-isopropylidenedioxy-5f>-[2-methoxycarbonyIprop-l-en-3-yl]- 
cyclohex-1 -ene-1 -carboxylate (209)
A solution of the nitro compound (208) (40 mg, 0.11 mmol) in THF (2 cm3) was 
treated with l,8-diazabicyclo[5.4.0]undec-7-ene (0.20 cm3, 0.13 mmol). The
solution was stirred at 20°C for 4 h, filtered and concentrated under reduced 
pressure. Column chromatography (petrol-ethyl acetate 4:1) yielded the title 
compound as a colourless oil (30 mg, 8 6 %): Rp 0.58 (petrol-ethyl acetate 7:3); 
vmax(CHCl3) 1710 (C=0), 1440, 1375, 1310, 1230, 1145, 1100, 1050 c m 1; 
5 h(CDC13) 1.39 (3H, s, Me), 1.43 (3H, s, Me), 1.91 (1H, ddt, 7gem 17.5, J6^  7.0, 
y6 fl,2  1.6, y6p3 1.6 Hz, 6(5-H), 2.11 (2H, m, 5-H, 3'-H), 2.53 (1H, dd m, 7gem 17.5, 
J f ^  4.0 Hz, 6 a-H), 2.71 (1H, dd, Jgem 18.0, y3 ' >5 9.0 Hz, 3'-H), 3.75 (3H, s, Me), 
3.76 (3H, s, Me), 3.98 (1H, dd, / 4 -5  7.0, J42 5.5 Hz, 4-H), 4.59 (1H, m, 3-H), 5.56 
(1H, br s, l'-H), 6.24 (1H, d, 1.3 Hz, l'-H), 6 . 8 8  (1H, m, 2-H); 8 c(CDCl3) 25.8 
(C-6 ), 26.2 (Me), 28.1 (Me), 33.8 (0-30, 35.6 (C-5), 51.9 (OMe), 52.0 (OMe), 71.1 
(C-4), 77.2 (C-3), 109.1 (CMe^, 127.0 (C-l'), 132.5 (C-l), 134.0 (C-2), 138.2 
(C-2'), 167.0 (C=0), 167.3 (C=0); m/z (E.I.) 310 (M+, 310.1429 C1 6H2 20 6  requires 
410.1414,1%), 295 (35), 221 (52), 203 (100), 189 (22), 171 (22).
Homonuclear decoupling experiment data for (209):
Signal irradiated Observed resonance
(Chemical shift, 8 ) 2-H 3-H 4-H 6 <x-H 6 p-H
Original resonance m m dd dd m dddd
2-H (6 .8 8 ) d
5.5 Hz
dd br dd ddd
3-H (4.59) dd d
7.0 Hz
ddd ddd
Methyl 3a,4a-hydroxy-5$-[2-methoxycarbonylprop-l -en-3-yl]cyclohex-l -ene-1 - 
carboxylate (2 1 0 )
A solution of the acetonide (209) (30 mg, 0.097 mmol) in THF (1 cm3), glacial 
acetic acid (1 cm3) and water (1 cm3) was heated to 50-60°C under a nitrogen
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atmosphere for 36 h. The reaction mixture was poured into saturated aqueous 
sodium bicarbonate solution (3 cm3) and extracted with dichloromethane (10, 2 x 5  
cm3). The combined extracts were dried (Na2 S 0 4) and concentrated under reduced 
pressure. Column chromatography (petrol-ethyl acetate 1:1 to 3:7) yielded the title 
compound as a colourless solid (12 mg, 47%): Rp 0.40 (petrol-ethyl acetate 1:3); 
vma*(CHCl3) 3520 (OH), 3400 (OH), 1710 (C=0), 1660 (C=C), 1630 (C=C), 1440, 
1330, 1220, 1150, 1090, 960 c m 1; 8H(CDC13) 1.93 (1H, dddd, 7gem 18.0, / 6 f, -5 9.0, 
/ 6p>2 2 .1 ,76f, 3  1.3 Hz, 6 p-H), 2.15 (1H, m, 5-H), 2.29 (1H, dd, / gem 13.7, / 3 ' >5 8.1 Hz, 
3'-H), 2.54 (1H, br dd, / gcm 18.0, 5.0 Hz, 6 a-H), 2.72 (1H, ddd, 7gem 13.7, / 3' 5
4.0, J3' f  0.9 Hz, 3'-H), 2.82 (1H, br s, OH), 3.39 (1H, br s, OH), 3.50 (1H, dd, 74>5
10.0, J43 4.2 Hz, 4-H), 3.74 (3H, s, Me), 3.77 (3H, s, Me), 4.32 (1H, br t, J3A 4.2, 
/ 3 -2  4.2 Hz, 3-H), 5.68 (1H, d, Jx\ 3> 0.9 Hz, l'-H), 6.29 (1H, d, J  1.3 Hz, l'-H), 6.87 
(1H, ddd, 4.2, Jm  2.1, JXia 1.0 Hz, 2-H); 8c (CDC13) 28.5 (C-6 ), 33.5 (C-3'),
34.5 (C-5), 52.0 (OMe), 52.2 (OMe), 65.8 (C-4), 71.6 (C-3), 128.2 (C-l'), 132.6 
(C-l), 135.9 (C-2), 137.6 (C-2'), 167.1 (C=0), 168.2 (C=0); m/z (C.I., NH3) 288 
(MNH4+, 82%), 271 (MH+, 25), 253 (100), 238 (25), 221 (82).
and the lactone (211) as a colourless solid (3.5 mg, 15%): Rp 0.49 (petrol-ethyl 
acetate 1:3); vmax(CHCl3) 3550 (OH), 3350 (OH), 1710 (C=0), 1655 (C=C), 1635 
(C=C), 1335, 1275, 1160, 1110, 1050, 955 c m 1; 6H(CDC13) 2.01 (1H, dddd, 7 gem
18.0, y6 p -5  9.5, / 6P -2 2 .5 ,76 p,3  1.2 Hz, 6|3-H), 2.26-2.48 (2H, m, 5-H, 3'-H), 2.62 (1H, 
d, / o h .3  3.3 Hz, 3-OH), 2.79-2.92 (2H, m, 3'-H, 6 a-H), 3.78 (3H, s, OMe), 4.23 (1H, 
dd, J45 11.0, / 4 ,3  3.8 Hz, 4-H), 4.50 (1H, m, 3-H), 5.66 (1H, m, l'-H), 6.48 (1H, m, 
l'-H), 6.95 (1H, dd, Jx3  5.5, Jm  2.5 Hz, 2-H); 5c(CDC13) 27.8 (C-5), 30.7 (C-6 ),
34.2 (C-3'), 52.2 (OMe), 63.5 (C-4), 82.3 (C-3), 129.1 (C-l'), 132.9 (C-l), 133.0 
(C-2'), 134.2 (C-2), 164.8 (C=0), 166.4 (C=0); m/z (C.I., NH3) 256 (MNH4+, 
100%), 239 (MH+, 42), 21 (12), 207 (9).
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3a,4a-Dihydroxy-5$-[2-carboxyprop-l -en-3-yl]cyclohex-l -ene-1 -carboxylic acid 
(212)
A solution of the diester (210) (11 mg, 0.041 mmol) in water (1 cm3) and THF (0.5 
cm3) was treated with aqueous sodium hydroxide solution (1.0 M, 0.09 cm3) and 
stirred at 20°C under a nitrogen atmosphere for 4 h. The solution was acidified by 
adding Amberlite IRA-120 (+) ion exchange resin and filtered. The resin was 
washed with water and the combined filtrate and washings were lyophilised to yield 
the title compound as a cream solid (8.5 mg, 8 6 %): Rp 0.47 (ethyl acetate - acetic 
acid 98:2); 6H(D20 )  1.93 (1H, dd m, / gem 18.0, J6^5 7.0 Hz, 6 p-H), 2.14 (2H, m, 
3'-H, 5-H), 2.42 (1H, dd m, / gem 18.0, / 6P f5 3.5 Hz, 6 <x-H), 2.68 (1H, dd, Jgem 19.0, 
J3' j  9.0 Hz, 3'-H), 3.66 (1H, dd, / 4<5 8.2, / 4>3 4.0 Hz, 4-H), 4.32 (1H, dd, J3A 4.0, / 2f3  
4.0 Hz, 3-H), 5.74 (1H, s, l'-H), 6.24 (1H, s, l'-H), 6.80 (1H, m, 2-H); 8C(D2 0 )  26.9 
(C-3'), 32.9 (C-6 ), 33.6 (C-5), 65.1 (C-4), 71.2 (C-3), 128.0 (C-l'), 131.5 (C-l),
136.5 (C-2), 137.7 (C-2'), 171.0 (C=0); m/z (-ve FAB) 241 (M-H', 5%), 223 (6 ), 
138 (9), 122 (10).
Thermal Diels-Alder Reaction Using Chiral Auxiliary
A solution of the dihydropyridine (132) (5.38 g, 29.7 mmol) and the N-aciyloyl 
sultam (214) (4.00 g, 14.9 mmol) in toluene (100 cm3) was heated to reflux, under a 
nitrogen atmosphere, for 2.5 days. Toluene was evaporated under reduced pressure 
to leave a yellow oil. Column chromatography (petrol-ethyl acetate 4:1 then 7:3) 
yielded the mixed adducts (5.72 g, 85%) as a colourless solid. The *H NMR 
spectrum indicated two endo adducts as the major products, in 1 : 1  ratio, and a minor 
amount of the endo adducts present, with a endoiexo ratio of approximately 1 0 :1 . 
Repeated column chromatography and recrystallisations from petrol-ethyl acetate 
yielded the pure endo adducts:
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Endo A (215) (0.96 g, 14%): m.p. 238-240°C (dec.) (from petrol-ethyl acetate); RF
0.55 (petrol-ethyl acetate 7:3); (Found: C, 61.4; H, 7.75; N, 6.3. C2 3 H3 4 N2 SO5  
requires C, 61.3; H, 7.6; N, 6.2%); vmax(CHCl3) 1680 (C=0), 1390, 1360, 1330, 
1160,1125,1110 cm'1; 5H(CDC13) 0.96 (3H, s, Me), 1.11 (3H, s, Me), 1.44 and 1.47 
(9H, 2 x s, CMe^, 0.90-1.60 (8 H, m, 2 x 8 -H, 2 x 3'-H, 2 x 5'-H, 2 x 6 '-H), 2.26 
(1H, m, 4'-H), 2.77 (1H, m, 4-H), 2.93 (1H, m, 3-H), 3.23 (1H, m, 3-H), 3.45 (2H, 
m, 2 x lO'-H), 3.60 (1H, m, 7-H), 3.84 (1H, dd, J  7.2, 5.2 Hz, 2'-H), 4.89 and 5.04 
(1H, 2 x m, 1-H), 6.30-6.60 (2H, m, 5-H, 6 -H); m/z (CL) 451 (MH+, 3%), 435 (4), 
395 (100), 377 (3), 351(28).
Endo B (216) (1.04 g, 16%): m.p. 230-232°C (dec.) (from petrol-ethyl acetate); Rp
0.50 (petrol-ethyl acetate 7:3); (Found: C, 61.1; H, 7.7; N, 6.2. C2 3 H3 4 N2 SO5  
requires C, 61.3; H, 7.6; N, 6.2%); vmax(CHCl3) 1680 (C=0), 1400, 1365, 1340, 
1160, 1130,1120 cm'1; 8H(CDC13) 0.96 and 0.99 (3H, 2 x s, Me), 1.20 (3H, s, Me),
1.44 and 1.47 (9H, 2 x s, CMe3), 1.25-2.07 (9H, m, 2 x 8 -H, 2 x 3'-H, 4'-H, 2 x 5'-H, 
2 x 6 '-H), 2.88 (2H, m, 3-H, 4-H), 3.22 (1H, m, 3-H), 3.46 (2H, m, 2 x lO'-H), 3.66 
(1H, m, 7-H), 3.83 (1H, m, 2'-H), 4.98 and 5.12 (1H, 2 x m, 1-H), 6.12-6.56 (2H, m,
5-H, 6 -H); m/z (CL) 451 (MH+, 7%), 435 (5), 395 (100), 377 (4), 351 (22).
(-)-2-( t-Butoxycarbonyl)-7-endo-( metlioxycarbonyl)-2-azabicyclo[2.2.2]oct-5-ene 
(-M134)
A solution of the endo adduct (215) (0.96 g, 2.13 mmol) in methanol (65 cm3) was 
treated with potassium carbonate (0.96 g) and stirred at 20°C for 2.5 h. The reaction 
mixture was poured into water ( 2 0 0  cm3), saturated brine added ( 1 0 0  cm3) and 
extracted with dichloromethane (500, 2 x 200 cm3). The combined extracts were 
dried (M gS04) and concentrated under reduced pressure. Column chromatography 
(petrol-ethyl acetate 4:1) yielded the title compound as a colourless solid (0.40 g, 
70%): [a ] D 2 0  -106° (c 1.02 in CHC13), spectral data identical to the racemic
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compound (134) previously described. Continued elution (petrol-ethyl acetate 1:1) 
yielded the chiral auxiliary (213) as a colourless solid (0.35 g, 76%).
(+)-2-(t-Butoxycarbonyl)-7-endo-( methoxycarbonyl)-2-azabicyclo[2.2.2]oct-5-ene 
(+M134)
The title compound was prepared from the endo adduct (216) using a similar 
procedure to that detailed above. The product was isolated as a colourless solid (0.45 
g, 73%): [a ] D 2 0  +104° (c 1.01 in CHC13), spectral data identical to the racemic 
compound (134) previously described. The chiral auxiliary (213) was recovered as a 
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X-ray Crystallographic Data for (165)
(165)
Compound (165) was crystallised from light petrol.
Crystal Data: C12H170 4I, triclinic, a = 5.660(2), b = 8.252(4), c = 15.014(3)A, a  = 
97.32(3), fi = 95.59(2), y = 94.34(3)°, U = 689.4A3, space group PI, Z = 2, D c = 
1.687gcm"3, F(000) = 344. Data were measured at room temperature on a Hilger and 
Watts Y290 four-circle diffractometer in the range 2<0<24°. 2298 reflections were 
collected of which 1704 were unique with I>3a(I). Data were corrected for Lorentz 
and polarization effects but not for absorption. The structure was solved by 
Patterson methods and refined using the SHELX1 suite of programs. In the final 
least squares cycles the iodine and oxygen atoms were allowed to vibrate 
anisotropically. All other atoms were treated isotropically. Hydrogen atoms were 
included at calculated positions. Final residuals after 7 cycles of full-matrix least 
squares were R = R W = 0.0787 for unit weights. Maximum final shift/esd was 0.002, 
and the maximum and minimum residual densities were 0.84 and -0.80 eA"  ^
respectively. Final fractional atomic coordinates and isotopic thermal parameters, 
hydrogen atom positions, anisotropic thermal parameters, bond distances and bond 
angles are given below (Tables 1 to 7). The asymmetric unit is shown in Figure 1, 
along with the labelling scheme used.
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1. (a) Sheldrick G.M., SHELX8 6 , a computer program for crystal structure
determination, University of Goetingen, 1986.
(b) Sheldrick G.M., SHELX76, a computer program for crystal structure 
determination, University of Cambridge, 1976.
Figure 1
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Table 1 Fractional atomic coordinates and thermal parameters (A) for (165)
Atom X y z U i s o  o r  Ueq  ^* * -k
1 1 0 . 1 9 4 7 5  (2) - 0 . 7 4 3 1 6  (1) 0 . 0 2 7 0 2  (1) 0 . 0 7 0 1  (1) k  * *
01 - 0 . 3 6 7 8 7  (22) - 0 . 2 0 3 7 8  (12) 0 . 3 3 7 7 5 ( 6 ) 0 . 0 7 3 2  (7) * * *
02 0 . 1 5 5 4 1  (16) - 0 . 6 5 0 9 9  (10) 0 . 4 1 2 7 1  (5) 0 . 0 4 6 1  (5) k -k k
03 0 . 3 0 6 5 5  (19) - 0 . 7 8 4 5 9  (11) 0 . 2 9 1 9 3 ( 5 ) 0 . 0 6 0 5  (6) k k k
04 - 0 . 4 0 7 3 4  (21) - 0 . 2 6 8 0 3  (12) 0 . 1 8 7 3 9  (6) 0 . 0 7 2 0  (7) * * *
Cl - 0 . 1 4 9 7  (22) - 0 . 4 1 2 0  (14) 0 . 2 7 0 5  (8) 0 . 0 4 2  (3)
C2 - 0 . 0 0 2 8  (23) - 0 . 4 2 2 1  (15) 0 . 3 4 8 3 ( 9 ) 0 . 0 4 8  (3)
C3 0 . 1 9 1 2  (22) - 0 . 5 3 3 7  (14) 0 . 3 5 1 3  (8) 0 . 0 4 1  (3)
C4 0 . 2 0 8 6  (21) - 0 . 6 4 2 9  (14) 0 . 2 6 3 1  (8) 0 . 0 4 1  (3)
C5 - 0 . 0 3 0 0  (22) - 0 . 6 8 3 7  (14) 0 . 2 0 6 0  (8) 0 . 0 4 1  (3)
C6 - 0 . 1 3 6 0 ( 2 3 ) - 0 . 5 2 4 9  (15) 0 . 1 8 3 9  (8) 0 . 0 4 6  (3)
Cl 0 . 3 0 2 1  (22) - 0 . 7 8 0 0 ( 1 5 ) 0 . 3 8 8 7  (8) 0 . 0 4 3  (3)
C8 0 . 5 5 0 5  (28) - 0 . 7 4 4 0  (19) 0 . 4 3 5 4  (10) 0 . 0 6 4  (4)
C9 0 . 1 8 8 0  (30) - 0 . 9 3 5 5  (19) 0 . 4 0 8 4  (11) 0 . 0 6 9  (4)
CIO - 0 . 3 1 1 5 ( 2 3 ) - 0 . 2 8 3 6 ( 1 5 ) 0 . 2 7 1 4  (9) 0 . 0 4 6  (3)
C l l - 0 . 5 8 0 2  (32) - 0 . 1 4 6 5  (20) 0 . 1 7 9 7  (11) 0 . 0 7 4  (4)
C12 - 0 . 0 3 3 7  (25) - 0 . 8 1 4 0  (16) 0 . 1 2 6 2  (9) 0 . 0 5 1  (3)
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Table 2 Fractional atomic coordinates for the hydrogen atoms
Atom X y z
H31 0 . 3 4 7 5 - 0 . 4 4 8 6 0 . 3 7 1 3
H41 0 . 3 1 8 1 - 0 . 5 8 3 3 0 . 2 1 9 6
H51 - 0 . 1 4 8 1 - 0 . 7 4 2 4 0 . 2 4 7 0
H61 - 0 . 3 1 3 1 - 0 . 5 5 3 3 0 . 1 4 8 9
H62 - 0 . 0 2 3 0 - 0 . 4 6 5 5 0 . 1 4 1 4
H81 0 . 5 4 7 5 - 0 . 7 4 1 1 0 . 5 0 7 4
H82 0 . 6 2 1 6 - 0 . 6 2 5 9 0 . 4 2 1 2
H83 0 . 6 6 1 5 - 0 . 8 3 7 2 0 . 4 1 0 9
H91 0 . 2 9 5 6 - 1 . 0 3 5 2 0 . 3 9 1 2
H92 0 . 0 1 7 1 - 0 . 9 5 8 2 0 . 3 6 8 0
H93 0 . 1 6 2 1 - 0 . 9 2 6 6 0 . 4 7 9 1
H i l l - 0 . 6 4 3 2 - 0 . 1 4 7 6 0 . 1 0 9 3
HI 12 - 0 . 4 9 1 1 - 0 . 0 2 7 5 0 . 2 0 6 5
H113 - 0 . 7 2 9 5 - 0 . 1 7 1 9 0 . 2 1 6 9
H121 0 . 0 2 6 0 - 0 . 9 2 3 6 0 . 1 5 0 1
H122 - 0 . 2 1 3 9 - 0 . 8 3 9 3 0 . 0 9 3 8
Table 3 Anisotropic thermal parameters (A)
Atom U l l U22 U33 U23 U13 U12
11 0 . 0 9 6 ( 1 ) 0 . 0 8 0  (1) 0 . 0 3 4  (1) - 0 . 0 0 5  (1) 0 . 0 1 2  (1) 0 . 0 2 8  (1)
01 0 . 1 0 0  (8) 0 . 0 6 9  (7) 0 . 0 5 1  (6) - 0 . 0 0 5  (5) 0 . 0 1 3  (6) 0 . 0 4 4  (6)
02 0 . 0 6 2 ( 5 ) 0 . 0 4 5  (5) 0 . 0 3 1  (4) 0 . 0 0 5  (3) 0 . 0 1 0  (4) 0 . 0 1 7  (4)
03 0 . 0 8 6 ( 7 ) 0 . 0 6 4  (6) 0 . 0 3 2  (5) 0 . 0 0 4  (4) 0 . 0 0 8  (5) 0 . 0 4 5  (6)
04 0 . 0 9 3  (8) 0 . 0 7 3  (7) 0 . 0 5 0  (6)  
159
0 . 0 0 8  (5) 0 . 0 0 5  (6) 0 . 0 5 1  (6)
Table 4 Bond lengths (A)
11 -C12 2 . 1 7 1 ( 1 3 ) 01 -CIO 1 .206 (14)
02 -C3 1 .436  (14) 02 -Cl 1 .430 (14)
03 -C4 1 . 429  (14) 03 -Cl 1 .450 (14)
04 -CIO 1 . 3 4 9 ( 1 5 ) 04 - C l l 1 .460 (18)
Cl -C2 1 .381  (17) Cl -C6 1 .513 (16)
Cl -CIO 1 .452  (16) C2 -C3 1 .486 (17)
C3 -C4 1 .521  (16) C4 -C5 1 .518 (16)
C5 -C6 1 . 54 3  (16) C5 -C12 1 .501 (17)
C7 -C8 1 .500  (20) Cl -C9 1 .470 (19)
Table 5 Bond angles (°)
C7 - 0 2 -C3 1 0 6 . 2 ( 9 ) Cl - 0 3 -C4 1 0 9 . 8 (8)
C l l - 0 4 -CIO 117 (1) C6 - C l -C2 122 (1)
CIO - C l -C2 119 (1) CIO - C l -C6 120 (1)
C3 -C2 - C l 123 (1) C2 -C3 - 0 2 112 (1)
C4 -C3 - 0 2 1 0 2 . 4  (9) C4 -C3 -C2 115 (1)
C3 -C4 - 0 3 1 0 3 . 3  (9) C5 -C4 - 0 3 113 (1)
C5 -C4 -C3 1 1 3 ( 1 ) C6 -C5 -C4 110 (1)
C12 -C5 -C4 115 (1) C12 -C5 -C6 114 (1)
C5 -C6 - C l 110 (1) 03 -Cl - 0 2 1 0 4 . 2 (9)
C8 -Cl - 0 2 112 (1) C8 -Cl - 0 3 110 (1)
C9 -Cl - 0 2 109 (1) C9 -Cl - 0 3 110 (1)
C9 -Cl -C8 112 (1) 04 -CIO - 0 1 122 (1)
Cl -CIO - 0 1 126 (1) Cl -CIO - 0 4 112 (1)
















Table 6 Intermolecular distances (A)




0 1  . . .H91 2 . 5 7  1 1 . 0 - 1 . 0 0 . 0
0 1  . . .H92 2 . 8 2  1 0 . 0 - 1 . 0 0 . 0
0 1  . . .H81 2 . 7 0  - 1 0 . 0 - 1 . 0 1 . 0
0 1  . . .H93 2 . 9 2  - 1 0 . 0 - 1 . 0 1 . 0
03 . . .H112 2 . 6 4  1 - 1 . 0 1 . 0 0 . 0
C2 . . .H82 2 . 9 9  1 1 . 0 0 . 0 0 . 0
H31 . . .CIO 2 . 9 2  1 - 1 . 0 0 . 0 0 . 0
C9 . . .H93 2 . 9 8  - 1 0 . 0 - 2 . 0 1 . 0
Table 7 Intramolecular distances (A)
. H121 2 . 7 2 1 1  . . . H1 2 2 2 .
. 04 2 . 2 4 0 1  . . . Cl 2 .
. C2 2 . 8 5 0 1  . . . C l l 2 .
. HI 12 2 . 6 6 0 1  . . . H113 2 .
. 0 3 2 . 2 7 0 2  . . . C2 2 .
. H31 2 . 1 2 0 2  . . . C4 2 .
.H51 2 . 8 6 0 2  . . . C8 2 .
.H81 2 . 7 2 0 2  . . .H82 2 .
. C9 2 . 3 6 0 2  . . .H92 2 .
. H93 2 . 6 0 03 . . . C3 2 .
.H31 2 . 8 6 03 . . .H41 2 .
. C5 2 . 4 5 03 . . . H51 2 .
. C8 2 . 4 1 03 . . .H82 2 .
















03 . . . H91 2 . 7 0 03 . . . H92 2 .
03 . . . C1 2 2 . 9 7 03 . . . H1 2 1 2 .
04 . . . Cl 2 . 3 2 04 . . . C6 2 .
04 . . . H61 2 . 4 6 04 . . . H62 2 .
04 . . . H i l l 2 . 0 8 04 . . .H112 2 .
04 . . . H113 2 . 1 1 Cl . . .C3 2 .
Cl . . . C4 2 . 8 9 Cl . . .C5 2 .
Cl . . . H51 2 . 7 0 Cl . . . H61 2 .
Cl . . .H62 2 . 1 4 C2 . . .H31 2 .
C2 . . .C4 2 . 5 3 C2 . . .C5 2 .
C2 . . . H51 2 . 8 9 C2 . . . C6 2 .
C2 . . .CIO 2 . 4 4 C3 . . .H41 2 .
C3 . . .C5 2 . 5 3 C3 . . . H51 2 .
C3 . . . C6 2 . 9 9 C3 . . .C7 2 .
C3 . . . H82 2 . 7 6 H31 . . . C4 2 .
H31 . . .C7 2 . 7 7 H31 . . . C8 3.
C4 . . . H51 2 . 1 0 C4 . . . C6 2 .
C4 . . . H62 2 . 7 7 C4 . . .C7 2 .
C4 . . . C12 2 . 5 5 C4 . . . H121 2 .
H41 . . .C5 2 . 0 6 H41 . . . C6 2 .
H41 . . . C12 2 . 7 8 C5 . . . H61 2 .
C5 . . . H62 2 . 1 5 C5 . . . H1 2 1 2 .
C5 . . . H1 2 2 2 . 1 1 H51 . . . C6 2 .
H51 . . . C1 2 2 . 0 2 C6 . . .CIO 2 .
C6 . . . C1 2 2 . 5 6 C6 . . . H122 2 .
H61 . . .CIO 2 . 7 0 H61 . . . C1 2 2 .
H62 . . .CIO 2 . 9 9 H62 . . . C1 2 2 .






























C7 . . .H83 2 . 1 3
C7 . . . H92 2 . 0 7
C8 . . . C9 2 . 4 6
C8 . . .H93 2 . 7 5
H83 . . . C9 2 . 7 4
CIO . . . H112 2 . 6 6
C7 . . . H91 2 . 1 1
C l . . . H93 2 . 1 0
C8 . . .H91 2 . 6 8
H81 . . . C9 2 . 6 9
CIO . . . C l l 2 . 4 0
CIO . . . H113 2 . 6 9
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APPENDIX TWO




Compound (179) was crystallised from ethyl acetate. A blocky crystal of 
approximate dimensions 0.25 x 0.25 x 0.25 mm was selected for data collection. 
Crystal Data: C1 4 H2 3 0 6 N, M = 302.34, monoclinic, a = 11.101(2), b = 14.136(3), c 
= 11.148(3) A, 0 = 111.41(2), U = 1628.4 A3, space group P2 ,/a, Z = 4, 1 . 1 2
gem-3, p(Mo-A'a ) = 0.60 cm' , F(000) = 648. Data were measured at room 
temperature on a Hilger and Watts Y290 four-circle diffractometer in the range 
2<0<24°. 2744 reflections were collected of which 1171 were unique with I>3c(I). 
Data were corrected for Lorentz and polarization effects but not for absorption. The 
structure was solved by conventional direct methods. 1 In the latter stages of 
convergence the 03 , 05 , 0 6  and N1 atoms and carbons 9-13 were refined 
anisotropically. All other atoms were treated isotropically. The hydrogen atoms on 
the sp2  hybridised carbon (C3) and on the nitrogen atom (Nl) were located in the 
penultimate difference Fourier and these positions were refined with a constrained 
bond length of 1.08 A in the final least squares cycles. The remaining hydrogens 
were included at calculated positions. Final residuals after 11 cycles of full-matrix 
least squares were R = Rw = 0.0847 for unit weights. The total number of parameters 
varied was 141. Maximum final shift/esd was 0.004, and the maximum and
NHCCLCMe,
164
minimum residual densities were 0.17 and -0 . 1 2  eA'^repectively. Final fractional 
atomic coordinates and isotopic thermal parameters, hydrogen atom positions, 
anisotropic thermal parameters, bond distances and bond angles are given below 
(Tables 1 to 7). The asymmetric unit is shown in Figure 1, along with the labelling 
scheme used.
1. (a) Sheldrick G.M., SHELX8 6 , a computer program for crystal structure
determination, University of Goetingen, 1986.
(b) Sheldrick G.M., SHELX76, a computer program for crystal structure 
determination, University of Cambridge, 1976.
Table 1 Fractional atomic coordinates and thermal parameters (A) for (179)
Atom X y z U i s o  o r  Ueq
(* * *)
03 0 . 1 9 9 0  (6) - 0 . 2 6 9 7  (5) - 0 . 3 8 4 6 8) 0 . 0 9 0  (6) •k ~k *
05 0 . 3 3 0 0  (5) - 0 . 4 4 6 8  (4) 0 . 2 1 0 0 8) 0 . 0 7 3  (5) k k k
06 0 . 5 1 3 0  (5) - 0 . 3 8 3 5 ( 4 ) 0 . 1 9 7 3 7) 0 . 0 5 1  (4) kkk
N1 0 . 3 3 0 7  (5) - 0 . 3 0 4 1  (4) 0 . 1 1 8 2 8) 0 . 0 4 2 ( 5 ) k k k
C9 0 . 1 8 9 9  (6) - 0 . 2 9 0 6 ( 5 ) 0 . 0 7 9 5 9) 0 . 0 4 0  (5) k k k
CIO 0 . 3 8 5 1  (7) - 0 . 3 8 3 9  (6) 0 . 1 7 7 2 11) 0 . 0 4 7  (6) kkk
C l l 0 . 5 9 7 8  (8) - 0 . 4 6 3 5  (6) 0 . 2 6 9 4 12) 0 . 0 5 4  (7) k k k
C12 0 . 5 5 1 9  (11) - 0 . 5 5 5 1  (7) 0 . 1 9 9 0 14) 0 . 0 8 5  (10) kkk
C13 0 . 7 2 7 3  (8) - 0 . 4 3 5 3  (7) 0 . 2 6 9 0 14) 0 . 0 8 1  (9) kkk
C14 0 . 5 9 8 9  (10) - 0 . 4 6 5 9  (9) 0 . 4 0 4 2 14) 0 . 0 8 8  (11) kkk
01 - 0 . 0 7 0 8  (4) - 0 . 3 5 7 7  (3) 0 . 0 2 2 2 6) 0 . 0 3 8  (1)
02 - 0 . 0 8 7 8  (4) - 0 . 4 9 2 7  (3) - 0 . 1 6 5 2 6) 0 . 0 3 7  (1)
04 0 . 0 3 6 3 ( 6 ) - 0 . 3 5 9 4  (4) - 0 . 5 0 6 0 8) 0 . 0 6 6  (2)
Cl - 0 . 0 3 0 7  (6) - 0 . 3 3 3 1 ( 5 ) - 0 . 0 8 0 8 8) 0 . 0 3 1  (2)
C2 - 0 . 1 0 1 7  (7) - 0 . 3 9 4 4  (5) - 0 . 2 0 1 5 8) 0 . 0 3 2  (2)
C3 - 0 . 0 5 1 9  (7) - 0 . 3 7 8 9  (5) - 0 . 3 0 6 0 10) 0 . 0 3 7  (2)
C4 0 . 0 6 1 3  (6) - 0 . 3 3 4 4 ( 5 ) - 0 . 2 8 9 6 8) 0 . 0 3 3  (2)
C5 0 . 1 4 7 6  (7) - 0 . 2 9 9 9  (5) - 0 . 1 5 8 4 9) 0 . 0 3 6  (2)
C6 0 . 1 1 5 8  (6) - 0 . 3 4 0 8  (5) - 0 . 0 4 8 0 8) 0 . 0 2 8  (2)
Cl 0 . 1 0 5 8  (7) - 0 . 3 1 7 3  (6) - 0 . 3 9 5 6 10) 0 . 0 4 4  (2)
C8 0 . 0 7 4 9  (10) - 0 . 3 4 2 8  (8) - 0 . 6 1 2 0 12) 0 . 0 7 3 ( 3 )
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Table 2 Fractional atomic coordinates for the hydrogen atoms
Atom X y z
HI 0 . 3 7 5 8 - 0 . 2 6 2 2 0 . 0 6 6 3
H l l - 0 . 0 5 6 7 - 0 . 2 5 9 5 - 0 . 0 9 9 4
H21 - 0 . 2 0 2 0 - 0 . 3 7 3 0 - 0 . 2 3 8 3
H31 - 0 . 1 0 1 3 - 0 . 4 0 0 5 - 0 . 4 0 5 6
H41 0 . 2 4 6 2 - 0 . 3 1 8 5 - 0 . 1 4 4 2
H42 0 . 1 3 8 9 - 0 . 2 2 3 9 - 0 . 1 5 6 3
H61 0 . 1 4 5 2 - 0 . 4 1 4 1 - 0 . 0 3 5 8
H81 0 . 0 1 1 9 - 0 . 3 8 0 3 - 0 . 6 9 5 8
H82 0 . 1 7 3 1 - 0 . 3 6 7 1 - 0 . 5 8 8 2
H83 0 . 0 6 9 9 - 0 . 2 6 7 8 - 0 . 6 3 2 4
H91 0 . 1 5 9 8 - 0 . 3 1 9 3 0 . 1 5 3 9
H92 0 . 1 6 7 9 - 0 . 2 1 5 9 0 . 0 6 8 6
H121 0 . 6 1 3 5 - 0 . 6 1 1 9 0 . 2 5 1 9
H122 0 . 5 5 5 7 - 0 . 5 5 0 9 0 . 1 0 3 8
H123 0 . 4 5 3 6 - 0 . 5 6 8 5 0 . 1 9 1 4
H131 0 . 7 9 8 2 - 0 . 4 8 8 0 0 . 3 1 9 1
H132 0 . 7 5 4 6 - 0 . 3 6 7 9 0 . 3 1 6 9
H133 0 . 7 2 2 8 - 0 . 4 2 9 4 0 . 1 7 0 9
H141 0 . 6 5 9 5 - 0 . 5 2 3 1 0 . 4 5 7 4
H142 0 . 5 0 1 5 - 0 . 4 7 6 0 0 . 4 0 1 4
H143 0 . 6 3 6 3 - 0 . 3 9 9 5 0 . 4 5 0 8
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Table 3 Anisotropic thermal parameters (A)
Atom U l l U22 U33 U23 U13 U12
03 0 . 0 7 5  (5) 0 . 1 1 7  (6) 0 . 0 7 8  (8) - 0 . 0 0 9  (5) 0 . 0 3 6  (4) - 0 . 0 5 2  (4)
05 0 . 0 3 5  (3) 0 . 0 5 7  (4) 0 . 1 2 8  (8) 0 . 0 4 6  (4) 0 . 0 1 2  (4) - 0 . 0 0 9  (3)
06 0 . 0 3 0  (3) 0 . 0 4 6  (3) 0 . 0 7 8  (6) 0 . 0 1 8  (3) 0 . 0 1 3 ( 3 ) - 0 . 0 0 1 ( 3 )
N1 0 . 0 2 2  (3) 0 . 0 4 2  (4) 0 . 0 6 2  (7) 0 . 0 1 3  (4) 0 . 0 0 9 ( 3 ) - 0 . 0 0 5 ( 3 )
C9 0 . 0 2 8  (4) 0 . 0 3 2  (4) 0 . 0 6 0  (8) - 0 . 0 0 8  (4) 0 . 0 1 5  (4) - 0 . 0 0 5  (3)
CIO 0 . 0 2 9  (5) 0 . 0 4 5  (5) 0 . 0 6 8  (9) 0 . 0 1 1  (5) 0 . 0 0 2  (4) - 0 . 0 0 9  (4)
C l l 0 . 0 4 4  (5) 0 . 0 5 4  (6) 0 . 0 6 4  (10) 0 . 0 2 3  (5) 0 . 0 0 8  (5) 0 . 0 0 8  (4)
C12 0 . 0 8 9  (8) 0 . 0 5 9  (7) 0 . 1 0 7  (14) - 0 . 0 2 1  (7) 0 . 0 1 6  (7) 0 . 0 0 6  (6)
C13 0 . 0 4 6  (6) 0 . 0 8 0  (7) 0 . 1 1 8  (13) 0 . 0 4 3  (7) 0 . 0 1 8  (6) 0 . 0 1 3  (5)
C14 0 . 0 6 8  (7) 0 . 1 1 8  (11) 0 . 0 7 8  (14) 0 . 0 3 2  (8) 0 . 0 0 2  (7) 0 . 0 2 0  (7)
Table 4 Bond lengths (A)
01 - C l 1 . 4 1 8  (10) 02 -C2 1 . 4 4 0  (8)
03 -Cl 1 . 2 0 3 ( 9 ) 04 -Cl 1 . 3 3 1  (11)
04 -C8 1 . 4 1 6 ( 1 3 ) 05 -CIO 1 . 2 0 9  (10)
06 -CIO 1 . 3 5 4  (9) 06 - C l l 1 . 5 0 3  (10)
N1 -C9 1 . 4 7 5  (8) N1 -CIO 1 . 3 3 4  (10)
Cl -C2 1 . 5 5 2  (11) Cl -C6 1 . 5 3 5  (9)
C2 -C3 1 . 4 7 7  (13) C3 -C4 1 . 3 5 7  (10)
C4 -C5 1 . 5 0 7  (11) C4 -Cl 1 . 4 5 8  (12)
C5 -C6 1 . 5 1 3  (12) C6 -C9 1 . 5 3 2  (11)
C l l -C12 1 . 5 0 3  (13) C l l -C13 1 . 4 9 4  (12)
C l l -C14 1 . 4 9 8  (17)
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Table 5 Bond angles (°)
C8 - 0 4 -C7 1 1 6 . 6 ( 8 ) C l l - 0 6 -CIO 1 2 0 . 0  (7)
CIO -N1 -C9 1 1 9 . 6 ( 7 ) C2 - C l - 0 1 1 1 0 . 8  (6)
C6 - C l - 0 1 1 1 4 . 1 ( 6 ) C6 - C l -C2 1 0 9 . 0 ( 6 )
Cl -C2 - 0 2 1 0 9 . 0  (6) C3 -C2 - 0 2 1 0 9 . 4  (6)
C3 -C2 - C l 1 1 2 . 6  (6) C4 -C3 -C2 1 2 3 . 9  (8)
C5 -C4 -C3 1 2 0 . 7 ( 8 ) Cl -C4 -C3 1 2 2 . 6  (8)
C7 -C4 -C5 1 1 6 . 7 ( 7 ) C6 -C5 -C4 1 1 4 . 3  (6)
C5 -C6 - C l 1 0 8 . 7 ( 6 ) C9 -C6 - C l 1 1 0 . 6 ( 6 )
C9 -C6 -C5 1 1 1 . 8  (6) 04 -Cl - 0 3 122 (1)
C4 -C7 - 0 3 1 2 2 . 9 ( 9 ) C4 -Cl - 0 4 1 1 5 . 0  (8)
C6 -C9 -N1 1 1 1 . 3  (7) 06 -CIO - 0 5 1 2 4 . 7  (8)
N1 -CIO - 0 5 1 2 5 . 7  (7) Nl -CIO - 0 6 1 0 9 . 6 ( 7 )
C12 - C l l - 0 6 1 1 0 . 0  (8) C13 - C l l - 0 6 1 0 2 . 3  (7)
C13 - C l l -C12 112 (1) C14 - C l l - 0 6 1 0 9 . 1  (9)
C14 - C l l -C12 112 (1) C14 - C l l -C13 111 (1)
Table 6 Intermolecular distances (A)








01 . . . N l  2 . 9 0 - 2 1 . 0 0 . 0 0 . 0
01 . . . H I  1 . 9 2 - 2 1 . 0 0 . 0 0 . 0
02 . . . 0 5  2 . 6 9 - 1 0 . 0  - 1 . 0 0 . 0




02 . . . H 8 1  2 . 7 0 - 1 0 . 0  - 1 . 0 - 1 . 0
02 . . . H 9 1  2 . 7 9 - 1 0 . 0  - 1 . 0 0 . 0
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03 . . . H1 2 1 2 . 6 6 - 1 1 . 0 - 1 . 0
oo
03 . . . H2 1 2 . 5 7 - 2 0 . 0 0 . 0 0 . 0
03 . . . H143 2 . 9 4 - 2 1 . 0 0 . 0 1 . 0
05 . . . H2 1 2 . 9 9 - 1 0 . 0 - 1 . 0 0 . 0
06 . . .H83 2 . 7 8 - 2 0 . 0 0 . 0 - 1 . 0
06 . . .H92 2 . 9 7 - 2 0 . 0 0 . 0 0 . 0
HI . . . Cl 2 . 6 1 - 2 0 . 0 0 . 0 0 . 0
C7 . . . H131 2 . 9 6 - 1 1 . 0 - 1 . 0 0 . 0
H92 . . . C13 2 . 9 9 - 2 1 . 0 0 . 0 0 . 0
C14 . . . H142 2 . 8 9 - 1 1 . 0 - 1 . 0 1 . 0
Table 7 Intramolecular distances (A)
0 1 . . . 0 2 2 . 7 8 0 1  . . . H l l 1 .
0 1 . . . 0 2 2 . 4 5 0 1  . . . H21 2 .
0 1 . . . C6 2 . 4 8 0 1  . . .H61 2 .
0 1 . . . C9 2 . 8 9 0 1  . . .H91 2 .
0 2 . . . Cl 2 . 4 4 0 2  . . . H21 2 .
0 2 . . .C3 2 . 3 8 0 2  . . .H31 2 .
0 2 . . .H61 2 . 7 0 03 . . . 04 2 .
03 . . . C4 2 . 3 4 03 . . . C5 2 .
03 . . . H41 2 . 6 3 03 . . . H42 2 .
03 . . . C8 2 . 6 2 03 . . . H82 2 .
03 . . .H83 2 . 6 1 04 . . . C3 2 .
04 . . .H31 2 . 2 7 04 . . . C4 2 .
04 . . . H81 2 . 0 5 04 . . . H82 2 .
04 . . .H83 2 . 0 5 05 . . . 0 6 2 .

















05 . . . C9 2 . 7 9 05 . . .H91 2 .
05 . . . C l l 2 . 8 1 05 . . . C1 2 2 .
05 . . . H123 2 . 2 6 05 . . . C14 2 .
05 . . . H142 2 . 3 2 06 . . . Nl 2 .
06 . . .HI 2 . 4 0 06 . . . C1 2 2 .
06 . . . H122 2 . 7 0 06 . . . H123 2 .
06 . . . C13 2 . 3 3 06 . . . H132 2 .
06 . . .H133 2 . 5 4 06 . . . C14 2 .
06 . . . H142 2 . 6 7 06 . . . H143 2 .
Nl . . . H41 2 . 7 3 Nl . . . C6 2 .
Nl . . .H61 2 . 6 5 Nl . . . H91 2 .
Nl . . .H92 2 . 1 0 HI . . .C5 2 .
HI . . . C6 2 . 9 2 HI . . . C9 2 .
HI . . .CIO 2 . 1 0 Cl . . . H2 1 2 .
Cl . . . C3 2 . 5 2 Cl . . .C4 2 .
Cl . . .C5 2 . 4 8 Cl . . . H42 2 .
Cl . . . H61 2 . 1 6 Cl . . . C9 2 .
Cl . . .H91 2 . 7 0 Cl . . .H92 2 .
H l l . . .C2 2 . 1 8 H l l . . .C3 2 .
H l l . . .C5 2 . 6 4 H l l . . . C6 2 .
H l l . . . C9 2 . 7 7 C2 . . . H31 2 .
C2 . . . C4 2 . 5 0 C2 . . .C5 2 .
C2 . . . C6 2 . 5 1 C2 . . .H61 2 .
H21 . . . C3 2 . 0 7 C3 . . .C5 2 .
C3 . . . C6 2 . 8 5 C3 . . . C l 2 .
H31 . . . C4 2 . 0 2 H31 . . . C l 2 .
C4 . . . H41 2 . 1 1 C4 . . . H42 2 .






























C5 . . . H 6 1 2 . 1 2 C5 . . . C7 2 .
C5 . . . C 9 2 . 5 2 C5 . . . H92 2 .
H41 . . . C6 2 . 1 2 H41 . . .Cl 2 .
H41 . . . C 9 2 . 8 1 H42 . . . C6 2 .
H42 . . . C 7 2 . 8 8 H42 . . . C9 2 .
C6 . . . H 9 1 2 . 1 4 C6 . . .H92 2 .
H61 . . . C9 2 . 1 2 H61 . . .CIO 2 .
C7 . . . C8 2 . 3 4 C7 . . . H82 2 .
C7 . . . H 8 3 2 . 6 2 C9 . . .CIO 2 .
H91 . . . C I O 2 . 5 9 CIO . . . C l l 2 .
CIO . . . H 1 2 3 2 . 7 0 CIO . . . C14 3 .
CIO . . . H 1 4 2 2 . 6 9 C l l  . . . H121 2 .
C l l  . . . H 1 2 2 2 . 1 3 C l l  . . .H123 2 .
C l l  . . . H 1 3 1 2 . 1 2 C l l  . . .H132 2 .
C l l  . . . H 1 3 3 2 . 1 2 C l l  . . . H141 2 .
C l l  . . . H 1 4 2 2 . 1 2 C l l  . . .H143 2 .
C12 . . . C 1 3 2 . 4 8 C12 . . .H131 2 .
C12 . . . H 1 3 3 2 . 7 0 C12 . . . C14 2 .
C12 . . . H 1 4 1 2 . 7 2 C12 . . . H142 2 .
H 1 2 1 . . . C13 2 . 7 7 H121. . . C14 2 .
H 1 2 2 . . . C13 2 . 6 7 H 1 2 3 . . . C14 2 .
C13 . . . C 1 4 2 . 4 6 C13 . . . H141 2 .
C13 . . . H 1 4 3 2 . 6 2 H 1 3 1 . . . C14 2 .




























2 x l'-H2 x OMe 5-H, 2 x 6-HN-H3-H, 4-H2-H P P M




4 -H ,2 x l'-H 6p-H,5-H6a-HHOD 3-H2-H P P M




HOD l'-H l'-H 6oc-H 5-H, 6p-H3-H 4-H2-H P P M




2 x l'-H 6a-H 6P-H, 5-H3-H 4-HHOD2-H P P M
lH NMR Spectrum of (196) (270 MHz, D20 )
HO'
OH
4-HHOD 3-H 6cx-H 5-H 6p-H2-H P P M




3'-H 6a-H 5,3 -H 6p-Hl'-H HOD2-H 4-H1 -H P P M3-H
lH NMR Spectrum of (212) (270 MHz, D20 )
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SYNTHESIS OF (±)-HOMOGABACULINE AND (±)-HOMOSHIKIMIC ACID 
Malcolm M.Campbell*, Mary F.Mahon, Malcolm Sainsbury*, and Philip A.Searle 
School of Chemistry, University of Bath, Bath BA2 7A Y, U.K. 
and
Gareth M.Davies 
ICI Pharmaceuticals, Mereside, Macclesfield., Cheshire, SK10 4TG
Summary: Syntheses of homogabaculine and homoshikimic acid are described utilising the base 
mediated ring opening of the cycloadducts of methyl acrylate and N-carbamoyl-l,2-dihydropyridines.
We have developed a brief and stereocontrollcd synthesis of shikimic acid (1) involving a Diels Alder 
reaction between furan and methyl acrylate, followed by ring opening of the adducts with lithium 
hexamethyldisilazide (LHMDS) (schfmc l)1 (for chiral routes based upon this strategy and intermediates 
see references 2a and 2b).
, L LHMDS





(ii) AgOAc. I2 .AcOH









We now describe a further cycloaddition sequence leading to the homologue (2, R=H) of gabaculinc (3) 








It is known3 that the l,2-dihydropyridinc (5, R=Me) reacts with methyl acrylate to form the mixed exo and 
endo adducts (6, R=Mc), in the ratio 7:5. The ‘butyl adducts (6, R=‘Bu) are similarly produced from the 
l,2-dihydropyridine (5, R=*Bu)4, but now in the ratio l : l .  When treated with LHMDS at -78°C in THF the 
adducts (6, R=Me) afford the methyl 5,6-dihydrobenzoate (7), which can be hydrolysed with 2M sodium 
hydroxide in refluxing THF/H20  to give homogabaculine (2, R=H) in 37% yield together with its 
carbamoyl derivative (2, R=C02Mc), *n 56% yield. Extended reaction periods tend to diminish the yield of 








Methyl homogabaculine is formed directly from the adduct (6, R=‘Bu) by treatment with trifluoroacetic 
acid in 90% yield, and this compound when reacted with 4-nitrobenzenesulphonyl chloride (NsCl) in the 
presence of triethylamine affords the sulphonamide (8). Further treatment of this product with sodium 
hydride and 4-nitrobenzenesulphonyl chloride forms the disulphonimide (9)5. Overall yield for the two 
steps is 42%.
Osmylation6 of the disulphonimide gives a mixture of the three diols (10), (l l), and (12) in 16, 8,and 10% 
yields respectively, whereas a Pr6vost hydroxyacetoxylation reaction1 affords two hydroxyacetates as an 
inseparable mixture, which on hydrolysis with aqueous ammonium hydroxide/methanol produces the dio!
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(10)7 in 35% overall yield. This compound may then be protected, prior to treatment with potassium iodide 
in DMF at 130°C. This reaction leads to a mixture of the iodide (13). the diene (14), and the formate ester
(15) in 23%, 9%, and 33% yields respectively, whereas treatment of the acetonidc with potassium iodide in 
refluxing toluene containing 18-crown-6 gives only the iodide in 63% yield.
Hydrolysis of the formate ester to homoshikimic acid is accomplished in two steps: first, treatment with 
Amberlyst-15 acid ion exchange resin in methanol, followed by glacial acetic acid in aqueous THF at 60°C 
affords the triol (16) in 63% yield. This is reacted with 2M NaOH to give homoshikimic acid (4) in 
quantitative yield.
Alternatively the triol (16) can be prepared by treatment of the iodide (13) with sodium acetate in DMF at 
110°C to give the acetate (17) (63%), hydrolysis to the alcohol (18) (aqueous ammonia, methanol, 81%) 
and removal of the acetonide group (acetic acid, aqueous THF, 55°C, 70%).
CC^M
(i) NSCl. E13N
(u) NSCl, N«H NRNs
(8) R = H
OsO,












(16) (17) R = Ac
(18)R = H
All the numbered compounds described are fully characterised. A single X-ray crystallographic 
determination of the iodide (13) has been carried out. Full data have been deposited at the Cambridge data 
bank. Relevant details are as follows: A 01
the compound crystallised (from light petroleum
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Dc-1.687gcm3 for Z=2 at room' temperature. 
The structure was solved by direct methods 
using 1704 unique reflections with 1i> 3oI, and
ether) in space group PI with a=5.660(2), 
b=8.252(4), c=15.014(3)A°, <x=97.32(3), 
(3=95.59(2), y=94.34(3)°, U=689A°3, and
refined by full matrix least squares to final 
residuals of R=RW=7.87% for unit weights.
ORTEP diagram of (13).
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